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Abstract 
In this thesis, a rabbit coronary artery ligation model was used to study the cardiac 
mechanical performance, Ca2+ handling and ventricular activation / repolarisation in heart 
failure. Significant cardiac dilatation and contractile dysfunction were demonstrated in vivo 
on echo cardiography 7 weeks after the initial myocardial infarct resulting from the coronary 
artery ligation procedure. In addition, liver, lung and heart weights were increased 
indicating significant organ congestion, cardiac remodelling and hypertrophy as seen in the 
human clinical syndrome of heart failure. Impaired mechanical performance was also 
demonstrated in vitro in the isolated failing hearts both in the working heart configuration 
and during Langendorff perfusion, with significant systolic and diastolic dysfunction. The 
Frank-Starling relationship was attenuated in the failing hearts and there was also a blunted 
slow response to step increase in pre.load, which may partly explain the findings of the 
Frank-Starling relationship in the failing hearts. Epicardial Ca2+ transients measured from 
the isolated failing hearts were found to have a prolonged time course. Impaired relaxation 
was shown to be associated with the prolonged Ca2+ transient durations in the failing hearts 
and there was an increased variation of Ca2+ transient durations over the left ventricular 
epicardial surface in the failing hearts. Monophasic Action Potentials (MAPs) measured 
from the left ventricular epicardial surface of failing hearts also had a prolonged time course 
and there was also an increased variation of MAP durations. The prolonged Ca2+ transient 
durations appeared to be associated with prolonged MAP durations in the failing hearts. 
Finally. delayed ventricular activation with impaired intraventricular conduction was 
demonstrated in the failing hearts, which may be an additional contributory factor in the 
mechanical dysfunction in heart failure. 
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CHAPTER! 
HEART FAILURE - AN OVERVIEW 
1 
Chapter I Heart failure - an overview 
Congestive heart failure is a common clinical problem with significant morbidity and 
mortality. Despite its frequent occurrence, the condition has been difficult to define. Heart 
failure is not a diagnosis per se, but rather a clinical syndrome with a multitude of 
symptoms and signs resulting from haemodynamic disturbances in the circulatory system. 
Braunwald (1992) described heart failure as "the pathophysiological state in which an 
abnormality of cardiac function is responsible for failure of the heart to pump blood at a rate 
commensurate with the requirements of the metabolising tissue or can do so only from an 
elevated filling pressure". To truly interpret and apply this definition, one has to know the 
metabolic requirements of the perfused tissues. Although the definition helps one 
understand the pathophysiology of heart failure, it is of less use in the clinical setting. 
Packer (1988) offered an alternative definition which focuses more on the clinical 
consequences of heart failure: "Congestive heart failure represents a complex clinical 
syndrome characterised by abnormalities of left ventricular function and neurohormonal 
regulation which are accompanied by effort intolerance, fluid retention, and reduced 
longevity". Since "abnormal cardiac function" was mentioned in both definitions, one has 
to understand the normal "function" of the heart in order to study the condition of heart 
failure. 
Cardiac "function" 
The term "cardiac function" implies a certain degree of autonomy on the heart's part as an 
organ to govern its own business and to fulfil its duty or purpose. A series of questions 
would emerge if one wishes to study abnormal cardiac "function":- What is the normal 
"function" of the heart? How can cardiac "function" be measured? What is the gold 
standard for measuring cardiac "function"? Can cardiac "function" really be measured? 
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Normal function of the heart 
It has been a long-accepted fact that the heart acts as a pump to circulate blood within the 
body. However, there was some controversy when William Harvey first compared the 
heart's action to a pump and his views were not widely accepted in the 17th century. In his 
notes for the Lumleian lecture of April 17, 1616, long before his definitive publication De 
Motu Cordis, he remarked: " ...... the movement of the blood is constantly in a circle, and 
is brought about by the beat of the heart. It is a question, therefore, whether this is for the 
sake of nourishment or of heat, the blood ...... being in turn warmed by the heart" 
(Franklin, 1933). Further prominent investigators on the circulation and the heart like Carl 
Ludwig and Adolph Fick later developed the concepts of blood pressure and blood flow 
within the circulation and consolidated Harvey's original suggestion of the heart's function 
as a pump. The heart generates pressure and also generates flow of the blood around the 
circulatory system. Which is the primary product of the two? If indeed one is the more 
important, then measurement of that parameter will give a direct assessment as to how well 
or poorly the heart is "functioning". However, the answer is not that simple as the heart can 
generate enonnous pressure and yet no flow if its outlet has been blocked or if there is a 
high after-load which will decrease flow. The parameters of pressure and flow are probably 
interdependent and are not simply governed by the "function" of the heart but also by the 
rest of the circulatory system to which the heart is connected. 
Blood can only flow in the vasculature when pumped by the heart. Once the heart stops 
pumping, blood flow in the circulation slows down, pressure in the whole system drops 
until everything is at a standstill. In simple physical tenns, the heart is providing the 
hydraulic energy required to sustain circulation and that is probably an appropriate simple 
description of the "function" of the heart. Considering the Law of Conservation of Energy, 
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the heart can be viewed as an energy-converter transforming chemical energy into hydraulic 
energy. It is this energy that provides the pressure and the flow in the system. The product 
of the 2 parameters (pressure x flow) gives the amount of energy provided by the heart per 
unit time, i.e. power. The heart is thus essentially a power generator from which pressure 
and flow in the circulatory system originate. 
Measuring cardiac 'function' 
Considering the heart as a power generator from which pressure and flow in the circulatory 
system originate, what is the best way to assess the heart's "function"? Some workers 
advocate the use of cardiac power output (Tan, 1987), estimating the amount of energy 
provided by the heart over time. This is a logical estimate of the overall cardiac "function" 
as the heart appears to be a power generator. In order to calculate the power output of the 
heart, measurements of perfusion pressure and cardiac output have to be made. The value 
obtained at rest is probably of little clinical value as suboptimal cardiac "function" may 
masquerade as being normal at rest as the metabolic demands on the heart are low and 
hence the power output is not expected to be high. An abnormal heart will not be capable of 
generating the same degree of power output in response to inotropic stimulation such as 
exercise. Cardiac reserve is the difference between the power output achieved by the heart 
during maximal stimulation and that at rest and is probably a more meaningful description 
of the "function" of the heart. However, these measurements of power output and cardiac 
reserve are indirect and involve a certain degree of intervention which may not be widely 
applicable in the clinical setting. 
Many other measurements are used to assess cardiac "function" clinically and are at best 
approximations and surrogates of the true capability of the heart as a pump. Various terms 
are used in the description and assessment of cardiac "function". I personally prefer the term 
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"cardiac performance", which simply describes what the heart does - to perform as a pump. 
The term "ventricular function" is used widely and loosely but its description involves 
measurements of pressure, volume and / or dimensions which are interdependent variables. 
"Contractility" is another term frequently used to describe the heart's pumping "function" 
but it actually represents the intrinsic property of the cardiac myocyte reflecting the level of 
activation and cross-bridge kinetics independent of the effects of load. The performance of 
the heart can be described at various levels:- (a) myocardial level, at which contractility is a 
proper description; (b) at the pump level, various parameters are used to describe so-called 
"ventricular function"; and (c) output level, at which the integrated cardiac output will 
reflect the heart's "function" in the light of its loading conditions. Thus, one has to be 
careful and clear when describing and measuring the pumping capability of the heart. 
Measurements of cardiac "function" used clinically include:-
1) Cardiac output / index - cardiac output is the volume of blood ejected by the heart per 
unit time and represents blood flow generated by the heart and cardiac index is the cardiac 
output corrected for body mass. 
2) End-diastolic and peak systolic pressure - these are parameters of intraventricular 
pressure used to estimate pump "function". 
3) Ejection fraction - the fractional change in volume of the heart during systole which can 
be measured with imaging techniques like angiography or echocardiography. 
4) Fractional shortening and velocity of shortening - these are calculated from segment 
length measurements made usually with echocardiography. Fractional shortening is the 
fractional change in linear dimension and velocity of shortening is the change in length or 
linear dimension per unit time. 
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5) End-systolic pressure-volume relationship - the peak left ventricular pressure in an 
isovolumetrically contracting heart increases as diastolic pressure increases giving a straight 
line in the physiological range which is described as the end-systolic pressure-volume 
relationship (ESPVR). The upper left comer of pressure-volume loops of variably loaded 
beats in the ejecting heart fall close to the isovolumetric ESPVR. The slope of this line, 
termed end-systolic elastance, describe the contractility or myocardial contractile state of 
the heart. 
6) Maximum rate of ventricular pressure rise [dP.dr\max)l - an isovolumetric phase index 
which reflects the contractility of the heart. 
These indices or measurements describe different aspects of the pumping capability of the 
heart and there is probably not one that can describe the overall pumping performance of 
the heart. In the clinical setting, some of these measurements provide information that can 
be obtained quickly and used to make management decisions. A more detailed use of these 
pieces of information will require caution and understanding as to what aspect of cardiac 
performance they address. 
What is heart failure? 
If a simple definition of the "function" of the heart is to provide hydraulic energy to the 
circulation, a simple definition of heart failure would be "the heart failing to 'function' as it 
should", It is usually caused by an intrinsic defect in myocardial contraction, with primary 
myocardial failure leading to the ultimate syndrome. However, the syndrome can also occur 
in patients with apparently normal myocardial "function" with sudden changes in other 
components of the circulation which cause the heart to "fail" and one may wish to 
distinguish such cases as circulatory rather than myocardial failure. 
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Clinical causes of heart failure 
A decreased pump efficiency of the heart can be the result of many pathological conditions 
including:- (a) myocardial disease, (b) arrhythmias, (c) valve disease, (d) pericardial 
disease, and (e) congenital heart disease. 
The commonest cause of myocardial failure in the Western world is coronary artery disease 
(Teerlink et al. 1991). This is usually the result of coronary thrombosis with myocardial 
infarction leading to a reduction in the total number of functioning myocytes; and regional 
wall motion abnonnality in the infarcted area can lead to further deterioration in pump 
efficiency as a result of poor co-ordination in contraction. More recent concepts of 
myocardial "stunning" (Braunwald and Kloner, 1982) and "hibernation" (Rahimtoola, 
1989) state that regional contraction can be abnonnal in the absence of the total arterial 
occlusion. Cardiomyopathy encompasses a group of conditions where there is a primary 
myocardial abnonnality in the absence of other cardiac disease. Traditionally, there are 3 
types:- Dilated, Hypertrophic and Restrictive. Although the initial definition of these 
conditions was based on the fact that they were idiopathic and the causes were unknown, 
recent researchers have identified risk factors and links between the cardiomyopathies and 
their underlying causes of which there are many, including genetic disorders, 
immunological mechanisms, alcohol, haemochromatosis, etc. Another cause of myocardial 
failure is chronic hypertension which when untreated can lead to pressure overload of the 
heart and subsequent decompensation and is itself a risk factor for coronary artery disease. 
Rarer causes of myocardial failure include drugs and injection. 
Other pathological conditions like arrhythmias, valvular, pericardial and congenital heart 
diseases cause decreased cardiac pump efficiency as a result of haemodynamic disturbances 
with subsequent chronic volume and / or pressure overload of the heart. 
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Pathophysiology of heart failure 
The ultimate syndrome of heart failure is arrived at through a cascade of changes in the 
heart and other organs and systems in the body (Poole-Wilson, 1993). Increased wall stress 
appears to be the first stimulus to initiate pathophysiological changes in the heart itself. 
Pressure overload as a result of outflow obstruction or increased after-load leads to 
myocardial hypertrophy which is commonly described as concentric where there is a 
predominant increase in myocyte width. There is an increase in mass : volume ratio with no 
chamber dilatation (unless there is decompensation). Volume overload, on the other hand, 
leads to what is termed eccentric hypertrophy in which there is chamber dilatation 
accompanying hypertrophy. Myocyte slippage and reorientation are believed to be 
mechanisms accompanying an increase in cell length which lead to an enlarged equilibrium 
volume (LeJemtel and Sonnenblick, 1993) with little change in the mass: volume ratio of 
the chamber. Hypertrophy tends to normalise wall stress across the myocardium (Wong and 
Rautaharju, 1968) and the response has been shown to be the result of genetic 
reprogramming to adapt to increased haemodynamic demands or to compensate for the 
impaired contractile performance of the pump (Chien et al. 1991). Recent evidence suggests 
that the hypertrophic response may be mediated via different signalling pathways. 
Angiotensin II has been implicated in mediating myocardial hypertrophy (Dzau, 1993) with 
predominantly an increase in myocyte width as a result of parallel addition of sarcomeres. A 
number of other growth factors, like a.-adrenergic agonists and endothelin-l, are also 
believed to mediate myocardial hypertrophy in a similar way as angiotensin II through G-
protein coupled receptors (Hefti et al. 1997). Recent work (Wollert et al. 1996) identified a 
cytokine, cardiotrophin-l, which can mediate a specific form of cardiac myocyte 
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hypertrophy characterised by an increase in cell length (with addition of sarcomeres in 
series) but no significant change in cell width. 
Despite the fact that hypertrophy is a well-recognised pathophysiological finding in failing 
hearts, little is understood of the cellular or molecular events that lead from the adaptive 
phase to the decompensated stage. Myocyte cell loss is believed to play an important role as 
it has been documented in both humans and animals during the normal process of ageing, 
following long-term pressure or volume overload and in idiopathic dilated cardiomyopathy 
(Anversa et al. 1996). The general belief has been that it is the result of cell necrosis, until 
recently when studies have demonstrated that apoptosis is a significant form of myocyte 
death in the heart. Apoptosis can be viewed as a programmed suicide of cells which is an 
energy-requiring process with distinct morphological, biochemical and molecular changes; 
and is frequently referred to as programmed cell death. It has been shown in animal hearts 
to occur in ischaemia-reperfusion injury, myocardial infarction, rapid ventricular pacing, 
pressure overload and in spontaneously hypertensive rats (Colucci, 1996). Mechanical 
stretch has been implicated in the process (Cheng et ai. 1995) although other factors may 
also be responsible. Recently, apoptosis has also been shown to occur in myocytes isolated 
from patients with end-stage heart failure (Narula et ai. 1996). In addition to myocyte loss, 
intrinsic biochemical changes to surviving myocytes with resulting mechanical dysfunction 
(and defects in excitation-contraction coupling which will be discussed below) contribute 
towards the gradual deterioration of contractile performance of the heart. There are also 
changes in the failing heart in the non-contractile components with fibrosis, collagen 
replacement and changes in cytoskeleton resulting in progression to heart failure 
(Scheuermann, 1993; Wagoner and Walsh, 1996). 
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Epidemiology of heart failure 
How common is heart failure and why is it important to tackle the problem? Congestive 
heart failure has been described as a "major public health problem" (Garg et al. 1993) and 
as increasing in "epidemic proportions" (Massie and Shah, 1996). This is no exaggeration. 
Chronic heart failure is the only common cardiovascular condition that is increasing in 
incidence and prevalence. Despite an overall decline in age-adjusted cardiovascular disease 
mortality in industrialised countries over the last few decades (Sytkowski et al. 1990), heart 
failure continues to present a significant and intensifying health care problem with large 
human and economic costs. 
Although reliable epidemiological data are scarce due to the lack of consensus on diagnostic 
criteria, surveys indicate that heart failure afflicts I - 2 % of the population in Europe and 
the USA (Ho et al. 1993b; Cowie et al. 1997) with an estimated 15 million patients with 
heart failure worldwide (Eriksson, 1995). This prevalence is dependent on age, increasing 
sharply to nearly 10 % above age 80 (Massie and Shah, 1996). Incidence of heart failure 
also increases with age; with 1 to 5 cases per 1000 population per annum in the general 
population and 40 cases per 1000 population per annum in those aged over 75 years. With 
an estimated increase of 30 % in the number of elderly people over the next 10 years, it is 
no exaggeration that heart failure is increasing in epidemic proportions. 
Patients with heart failure are often symptomatic with fatigue, lethargy and breathlessness 
and their quality of life is adversely affected. Regular outpatient consultation is required as 
well as hospitalisation which is often prolonged and recurrent. About 120,000 people 
require hospitalisation for heart failure each year in Scotland (McMurray et al. 1993a) 
which is equivalent to 0.2 % of the popUlation. It follows that the economic cost of 
managing heart failure is high. McMurray et al. (1993b) estimated the direct cost to the 
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National Health Service (NHS) to be £360 million per year, equivalent to about 1.2 % of the 
total NHS expenditure. 
Prognosis of heart failure 
Apart from being a costly and growing public health problem with significant morbidity, 
congestive heart failure is also a lethal condition with poor prognosis. In the original report 
of the first population-based study - the Framingham study, 62 % of men and 42 % of 
women died within 5 years after the development of heart failure (McKee et at. 1971). A 
more recent report (Ho et at. 1993a) with the 40-year follow-up data on the Framingham 
cohort confirmed the trend and showed that only 25 % of men and 38 % women were alive 
at 5 years once heart failure had developed. The median survival was only 1.7 years in men 
and 3.2 in women which reflects a mortality rate 6 to 7 times that of the general population 
of the same age. Other hospital-based studies (Franciosa et at. 1983) and pharmacological 
trials in heart failure (Cohn et al. 1986; Swedberg, 1987; The SOL VD investigators, 1991), 
which involved highly selected groups of patients, also showed similar results with marked 
reduction in life expectancy at all ages. 
Mortality from heart failure increases with clinical severity of the condition as assessed by 
functional class according to the New York Heart Association (NYHA) criteria. In the 
SOLVD study (The SOLVD investigators, 1991), mortality for patients (given placebo) 
with NYHA class IV heart failure was 64% over a mean follow-up of 41.4 months, 
compared with 51 %, 35% and 30% for those with class III, II and I disease respectively. 
The same investigators also showed that resting left ventricular ejection fraction is a 
powerful predictor of prognosis in heart failure. 
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Mode of death in heart failure 
Not only do patients with heart failure die as a result of haemodynamic deterioration 
leading to what has been called pump failure deaths, but many also die suddenly. In the 
Framingham study, sudden death occurred in 25 % of men and 13 % of women with heart 
failure (Kannel and Belanger, 1991). This rate was reported to be 5 times the rate for the 
general population. Although the abrupt onset of symptoms and death within 1 hour is 
defined as sudden cardiac death, the mode of death is frequently difficult to determine. This 
problem with classifying heart failure death is highlighted in a recent article by Narang et 
al. (1996). In this review of heart failure studies, it was found that documentation of mode 
of death was less than adequate. In those studies where sudden and pump failure deaths 
were defined, between 30 and 40 % of deaths were sudden. It was found that pump failure 
deaths were more common in studies with a lower mean ejection fraction whilst modes of 
death other than sudden or pump failure were commoner in studies with higher mean 
ejection fraction. 
In a population of patients with advanced (NYHA class III or IV) heart failure hospitalised 
for cardiac transplantation evaluation and adjustment of anti-failure treatment, Luu et al. 
(1989) showed that there were various causes or mechanisms behind sudden death in 
patients with heart failure. A later report and update on their data by Stevenson et al. (1993) 
stated that ventricular tachycardia or fibrillation was the cardiac rhythm at the time of 
cardiac arrest in 52 % of cases whilst bradyarrhythmias or electromechanical dissociation 
was the rhythm in the remainder. Although no clear precipitating factors could be found in 
many of these sudden deaths, a variety of potential causes were identified in 14 arrests (48 
%) including acute coronary occlusion, pulmonary embolism, Torsade de Pointes caused by 
hypokalaemia or drugs that prolong the QT interval, and hyperkalaemia. Despite being a 
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small series of hospitalised patients, this study helped to highlight the diversity in the 
mechanisms behind sudden death in heart failure. However, the relative frequency of 
different mechanisms of sudden death in patients with heart failure outside the hospital is 
still unknown. 
Although ventricular arrhythmias are common in patients with heart failure and are 
potential causes of sudden death in these patients, Packer (1992) questioned the direct 
association between ventricular arrhythmias and sudden death in heart failure. His reasons 
were that (a) complex ventricular arrhythmias on ambulatory monitoring in heart failure 
patients predicted total cardiac mortality but not sudden death (Califf et al. 1982); and (b) 
Stevenson et al. (1988) found that the ability to induce ventricular tachycardia or fibrillation 
in patients with ventricular dysfunction did not reliably predict sudden death. Packer (1992) 
suggested that complex ventricular arrhythmias may be a nonspecific manifestation of a 
poorly functioning left ventricle rather than a specific arrhythmogenic substrate. Other 
workers (Chakko and Gheorghiade, 1985; Podrld et al. 1992) also raised another counter-
argument against the link between ventricular arrhythmias and sudden death in heart failure 
in that antiarrhythmic drugs have not been convincingly shown to be effective for 
preventing sudden death and in some cases may be proarrhythmic and increases the 
incidence of sudden death (CAST Investigators, 1989). A recent report from the 
investigators of the GESICA trial, which was a large multi-centre study involving more 
than 500 patients with heart failure (Doval et al. 1996), showed that nonsustained 
ventricular tachycardia was an independent marker for increased overall mortality rate and 
sudden death and the relative risk was 2.8 for sudden death if such arrhythmias were 
present. These results suggest that the failing heart is indeed electrophysiologically 
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abnormal and is prone to arrhythmias. Ventricular arrhythmias may well be a surrogate for 
ventricular dysfunction but many of these arrhythmias can lead to sudden cardiac death. 
Ventricular arrhythmias in heart failure 
As mentioned above, ventricular arrhythmias are extremely common in patients with heart 
failure. Complex ventricular premature beats are observed in 80 - 90 % of cases (Chakko 
and Gheorghiade, 1985; Francis, 1986; Podrid et al. 1992) and non-sustained ventricular 
tachycardia is also highly prevalent (50 - 80 %). The pathogenesis of arrhythmias in heart 
failure is not fully understood but there are many possible causes (Pye and Cobbe, 1992; 
Aronson and Ming, 1993). They can be grouped into the usual arrhythmogenic mechanisms 
which include re-entry, enhanced automaticity and triggered activity. The latter 2 
mechanisms give rise to abnormal impUlse generation whilst re-entry is an expression of 
abnormal impulse propagation (Josephson, 1993). Abnormal impulse generation may be the 
result of either enhanced phase 4 automaticity of normal or abnormal cells or can be 
triggered leading to early or delayed afterdepolarisations (EADs and DADs). There are 3 
well-recognised prerequisites for re-entry:- (a) at least 2 distinct pathways that join 
proximally and distally to form a closed circuit, (b) unidirectional block in one of the 
pathways, and (c) slow conduction down the unblocked pathway allowing the blocked 
pathway to recover excitability. The pathways involved in re-entry may be anatomically 
distinct or can be functionally different giving rise to the "leading circle" phenomenon 
suggested by Allessie and co-workers (1977). Re-entry can also occur with a combination 
of anatomical and functional abnormalities resulting in anisotropy where conduction is 
faster in one direction in the myocardium than in another. 
Coronary artery disease is the major cause of heart failure in the Western world and the 
majority of patients have had myocardial infarction which gives rise to scar tissue. Dead 
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and surviving myocardium overlap at the border zone of the infarct giving rise to ideal 
conditions for re-entrant arrhythmias. Ventricular arrhythmias due to re-entry around the 
border zone have been demonstrated in both animals and humans (Wit et al. 1982; De 
Bakker et al. 1988). Re-entry may also occur in regions remote from the infarcted tissue. In 
the chronically infarcted heart, remodelling with hypertrophy and interstitial fibrosis 
(Assayag et al. 1997) occurs which leads to cellular uncoupling and the remodelled 
myocardium is prone to arrhythmias (Qiu et al. 1996). The expression of gap junction 
proteins (connexins) has also been shown to be abnormal in the remodelled myocardium 
with a reduction in gap junction density and altered isoform expression (Peters et al. 1993). 
Slow conduction and dispersion of refractoriness (Ramdat-Misier et al. 1995) in these 
regions can cause re-entry (Pogwizd et al. 1992). Re-entrant tachycardias have also been 
demonstrated in patients with non-ischaemic cardiomyopathy (Kottkamp et al. 1995). 
As mentioned above, a fixed anatomical circuit is not mandatory for re-entry. In the failing 
heart, anomalous intrinsic properties of the myocardium can give rise to the favourable 
environment for re-entry to take place. One such phenomenon is dispersion of 
repolarisation or refractoriness, which will be discussed in greater detail below. In essence, 
the difference in recovery of excitability in neighbouring myocardial tissues I cells creates 
the perfect condition for re-entry. Another phenomenon is mechano-electric or contraction-
excitation feedback (Lab, 1982; Taggart et al. 1992a) where mechanical changes result in 
altered cardiac electrophysiology. Sudden death frequently follows haemodynamic 
decompensation in patients with heart failure. Several investigators have shown in animals 
that acute ventricular dilatation in the normal heart shortens refractoriness or action 
potential duration (Reiter el al. 1988; Coulshed and Cowan, 1991; Halperin el al. 1993), 
increases the incidence of arrhythmias (Franz et al. 1989; Franz et al. 1992; Jalal et al. 
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1992) and dispersion of refractoriness is also increased (Reiter et al. 1988). These changes 
were also observed with sustained load in the whole heart (Zabel et al. 1996). Similar 
changes were demonstrated in humans with shortening of monophasic action potential 
(MAP) duration during transient aortic occlusion (Taggart et al. 1992b). The 
arrhythmogenic tendency of ventricular dilatation has been shown in models of heart failure 
(Wang et al. 1994; Pye and Cobbe. 1996) and was enhanced in the presence of 
hypokalaemia (Reiter et al. 1993; Evans et al. 1995). These electrophysiological changes 
are believed to be mediated via stretch-activated channels (Hansen et al. 1991; Lerman, 
1996) but their significance in the pathophysiology of arrhythmias remains to be elucidated. 
Electrophysiological abnormalities in the failing myocardium 
Apart from structural remodelling, it has also been shown that failing myocardium 
undergoes electrical remodelling with intrinsic changes that promote arrhythmia initiation 
and propagation (Aronson and Ming, 1993; Hart, 1994). One consistent finding in studies 
on the failing myocardium was that the action potential is prolonged and repolarisation 
delayed (Rossner and Sachs, 1978; Beuckelmann et al. 1993; Ming et al. 1994; Kaab et al. 
1996; Qiu et al. 1996; Rozanski et al. 1997) (see Table 1.1). This is also true in 
hypertrophied, non-failing tissues and myocytes (Ryder et al. 1993; Jauch et al. 1994; Hicks 
et al. 1995; Rials et al. 1995; McIntosh et al. 1998). Intuitively, from a clinical point of 
view, one would think that this should be anti-arrhythmic since prolongation of 
refractoriness is the main action of class Ia and III anti-arrhythmic drugs (Roden, 1996). 
According to the wavelength theory of re-entry (Rensma et al. 1988), the likelihood of re-
entry is inversely related to the product of the conduction velocity and refractory period of 
the tissue involved. Prolongation of refractoriness lengthens the path of the re-entrant wave 
and makes it less likely to sustain a tachycardia. However, in the failing myocardium, the 
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prolonged action potential has a prominent plateau phase which is known to be labile 
(Tomaselli et al. 1994). It is a time of high membrane resistance during which small 
changes in current can lead to large changes in membrane potential either way. It is during 
this labile prolonged repolarisation phase that EADs are likely to be provoked. 
What causes the action potential prolongation in failing myocardium? There is reasonable 
evidence to suggest against L-type Ca2+ current being a contributing cause. The majority of 
workers failed to demonstrate any change (Beuckelmann et aJ. 1991; Mewes and Ravens, 
1994; Kaab et af. 1996; Qiu et af. 1996; Rozanski et af. 1997) whilst some demonstrated a 
decreased L-type Ca2+ current in failing myocytes (Rossner, 1991; Hatem et al. 1994; Ming 
et at. 1994). Several repolarisation currents involved with K+ conductance, including the 
inward rectifier (IKI) and transient outward (Itol) currents, have been found to be depressed 
in heart failure both in humans (Beuckelmann et aJ. 1993; Niibauer et at. 1993) and in 
animals (Kaab et al. 1996; Qiu et al. 1996; Thuringer et al. 1996; Rozanski et al. 1997). 
These have been suggested to be the main cause for the action potential prolongation in 
heart failure. The Na+ / Ca2+ exchanger current has also been found to be abnonnal in heart 
failure (Hatem et al. 1994; Zhang et al. 1996) but the results were not consistent. Changes 
in this current can have dynamic effects on the repolarisation phase of the action potential 
and it has been shown to be able to produce EADs (Szabo et al. 1994). This may be 
especially important in heart failure with altered intracellular [Ca2+] and I or [Na+] as a result 
of altered excitation-contraction coupling, which will be discussed later. Data on other 
potassium currents in heart failure are lacking but a decrease in the delayed rectifier current 
(IJ has been shown in a feline model of cardiac hypertrophy (Kleiman and Houser, 1989). 
Alterations of the delayed rectifier current or the relative contribution of its 2 components 
(lKr and IKs) may be involved in the action potential prolongation and I or electrical 
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instability in the failing myocyte. Recent evidence (Beuckelmann et al. 1995; Cerbai et al. 
1997) also suggests that a hyperpolarisation activated current, If, is expressed in myocytes 
isolated from patients with heart failure which can be potentially arrhythmogenic. 
To summarise, there is general consensus in the literature that the main electrophysiological 
abnormality in heart failure is a prolonged action potential with delayed repolarisation. 
Changes have been demonstrated in the properties of various ion channels. It would appear 
that a decreased activity in some repolarising currents is the main mechanism underlying 
delayed repolarisation and that changes in other currents may contribute towards the 
electrical instability and arrhythmogenicity in heart failure. 
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Table 1.1 Electrophysiological changes in heart failure. 
Effect First author Year Species Aetiology Prep 
Action Potential Duration 
t Rossner 1978 Hamster CM PapM 
t Beuckelmann 1993 Human DCM/CAD Myo 
t Ming 1994 Guinea-pig AB/HF Myo 
t Qin 1996 Rat Post-infarct Myo 
t Kaab 1996 Dog Pacing Myo 
t Rozanski 1997 Rabbit Pacing Myo 
L-type Ca2+ current 
-1, Rossner 1991 Hamster CM Myo 
~ Beuckelmann 1991 Human DCM I CAD Myo 
~ Mewes 1994 Human DCM I CAD Myo 
-1, Hatem 1994 Hamster CM Myo 
-1, Ming 1994 Guinea-pig AB/HF Myo 
~ Qin 1996 Rat Post-infarct Myo 
~ Kaab 1996 Dog Pacing Myo 
~ Rozanski 1997 Rabbit Pacing Myo 
Na+-Ca2+ exchanger current 
t Hatem 1994 Hamster CM Myo 
-L. Zhang 1996 Dog Post-infarct Myo 
Inward rectifier current OKI} 
-1, Beuckelmann 1993 Human DCM I CAD Myo 
-L. Thuringer 1996 Hamster CM Myo 
-1, Kaab ·1996 Dog Pacing Myo 
~ Rozanski 1997 Rabbit Pacing Myo 
Transient outward current (ltol! 
-1, Beuckelmann 1993 Human DCM/CAD Myo 
-1, Thuringer 1996 Hamster CM Myo 
-1, Qin 1996 Rat Post-infarct Myo 
-1, Kaab 1996 Dog Pacing Myo 
-L. Rozanski 1997 Rabbit Pacing Myo 
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"Extra-cardiac" triggers for arrhythmias in heart failure 
Many extrinsic factors have been found to contribute to the arrhythmogenic tendency in the 
failing heart. Irrespective of the aetiology, chronic heart failure is accompanied by high 
sympathetic tone and abnormalities of baroreceptor responsiveness (Cohn et at. 1984; 
Ferguson et at. 1984). Sympathetic stimulation increases susceptibility to ventricular 
fibrillation during ischaemia, promotes afterdepolarisations and triggered activity, and alters 
ventricular conduction and refractoriness (Schwartz et at. 1992). Heart rate variability, a 
clinical parameter used as a surrogate for autonomic function, is abnormal in patients with 
previous myocardial infarction (Kleiger et al. 1987; La Rovere et al. 1998), resuscitated 
cardiac arrest (Dougherty and Burr, 1992) and heart failure (Casolo et al. 1989; Kienzle et 
al. 1992); and has been shown to be a strong prognostic marker. 
Patients with heart failure are subject to electrolyte disturbances due to treatment with 
diuretics and angiotensin converting enzyme (ACE) inhibitors (Packer and Lee, 1986). 
Potassium and magnesium depletion has been shown to provoke triggered activity with 
delayed afterdepolarisations and automaticity in failing myocardium (Vermeulen et at. 
1994). 
The renin-angiotensin system is known to be activated in heart failure. Although less well 
studied, this is believed to enhance arrhythmogenesis by producing electrolyte shifts and 
altered haemodynamics (Podrid et al. 1992). There is some evidence in the ACE inhibitor 
trials (Cohn et al. 1991; Pfeffer et al. 1992) that inhibition of the renin-angiotensin system 
reduces the risk of sudden death in patients with heart failure. 
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Dispersion of repolarisation and heart failure 
As mentioned above, dispersion of repolarisation or refractoriness creates a favourable 
environment for re-entrant arrhythmias to be initiated and sustained. It is not a new concept 
at all but has only recently received attention in the pathophysiology of arrhythmogenesis in 
heart failure and been found to be of prognostic significance. 
Non-uniform recovery of excitability 
In 1964, Han and Moe (1963) demonstrated that non-uniform recovery of excitability exists 
in ventricular muscle. They discovered that dispersion of recovery was increased by 
conditions that predispose to ventricular fibrillation, e.g. sympathetic stimulation and 
cardiac glycoside toxicity; and that the dispersion was associated with lowered ventricular 
fibrillation threshold. In the 1970s, Allessie et al. (1976; 1977) showed in rabbit atrial 
muscle that non-uniform recovery of excitability makes re-entrant arrhythmias favourable 
and that a fixed anatomical circuit is not required. Elegant experiments by Kuo et al. 
(l983b) on mongrel dogs demonstrated the initiation of re-entrant ventricular arrhythmias 
with a critical level of dispersion of MAP duration. 
"Physiological" dispersion 
However, nonuniformity is not an exclusively pathological phenomenon. A physiological 
role is recognised for the modulation of cardiac performance (Brutsaert, 1987). Electrical, 
mechanical, spatial and temporal non-uniformity exist in the normal heart. Studies have 
shown heterogeneity in the action potential duration of myocytes from different regions of 
the ventricular myocardium (Cohen et al. 1976; Watanabe et al. 1983), with longer action 
potentials in sub-endocardial cells than in sub-epicardial cells and action potentials from the 
base being longer than from the apical region. Action potentials recorded in vivo and in 
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vitro from the ventricular sub-epicardium of several animal species demonstrate a 
prominent notch between phases 1 and 2, leading to a distinct "spike and dome" 
morphology which is absent in the sub-endocardium (Antzelevitch et ai. 1991). The 
differences in action potential duration and morphology between sub-epicardial and sub-
endocardial ventricular myocytes have been shown to be due to regional variations in the 
transient outward current (Ito) which is much more prominent in the sub-epicardial than in 
the sub-endocardial cells (Litovsky and Antzelevitch, 1988; F edida and Giles, 1991; Liu et 
ai. 1993; Niibauer et ai. 1996). Regional variations in other K+ currents have also been 
implicated in contributing towards the regional differences in action potential configuration 
(Furukawa et ai. 1992). 
QT dispersion 
Regional variation in ventricular repolarisation has been shown in the whole heart by the 
demonstration of dispersion of MAP durations recorded from different regions of the 
ventricle (Kuo et al. 1983a; Zabel et al. 1995). In the study by Zabel et al. (1995), an 
isolated rabbit heart preparation was used where MAP and 12-lead volume-conducted 
electrocardiogram (ECG) recordings were made. It was found that dispersion of MAP 
durations correlated well with QT dispersion on the 12-lead ECG, which was calculated as 
the difference between the longest QT interval and the shortest QT interval measured. These 
results supported the previously proposed clinical use of QT dispersion as a simple non-
invasive measurement of dispersion of repolarisation (Day et al. 1990). Since increased 
dispersion of repolarisation has been widely acknowledged to signify a considerable 
arrhythmogenic risk (Han and Moe, 1963; Kuo et al. 1983 b), many workers sought to 
validate QT dispersion as a predictor of arrhythmias in different patient groups (Day et al. 
1990; Priori et al. 1994; Pye et al. 1994; Higham et al. 1995) and demonstrated its potential 
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value. However, there are technical limitations (Statters et al. 1994) in the measurement of 
QT dispersion as it is not always possible to confidently define the end of the T wave and 
the ECG may not be of sufficiently good quality to allow QT interval measurements in all 
12 leads. Other studies also failed to show the predictive value of QT dispersion in certain 
patients (Davey et al. 1994; Surawicz, 1996) thus casting doubt on its prognostic 
significance. 
Long QT syndrome and heart failure 
The long QT syndromes are a group of clinical conditions where a long QT interval is noted 
on the 12-lead ECG (James, 1996) together with a high incidence of ventricular 
arrhythmias, especially in the fonn of Torsade de Pointes polymorphic ventricular 
tachycardia. It may be acquired, especially with the use of drugs which prolong 
repolarisation; or it can be congenital, which can be associated with some phenotypic 
abnonnalities e.g. deafness. Recent research has shown that the congenital long QT 
syndromes are associated with various genetic defects leading to abnonnalities in the Na+ 
and K+ channel activity (Roden et al. 1996). The hallmarks of long QT syndrome are a 
prolonged QT interval on ECG signifying delayed repolarisation and an increased QT 
dispersion which suggests increased dispersion of repolarisation. QT dispersion has been 
shown consistently in this group of patients to be a marker of arrhythmogenic tendency and 
to be of prognostic value (Day et al. 1990; Hii et al. 1992; Priori et al. 1994). As mentioned 
above, repolarisation is delayed in heart failure (Beuckelmann et al. 1993). Recent studies 
(Barr et al. 1994; Fu et al. 1997) in patients with heart failure also showed that there was a 
strong association between an increased QT dispersion and sudden cardiac death (presumed 
to be arrhythmic in origin) thus suggesting that QT dispersion is indeed of prognostic 
significance. Other invasive studies also showed an increased dispersion of repolarisation or 
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refractoriness in patients with dilated cardiomyopathy (Dinerman et al. 1997) and with 
remodelled myocardium from previous myocardial infarction (Vassallo et al. 1988; 
Ramdat-Misier et al. 1995). The results of these studies suggest a parallel between the 
electrophysiological abnormalities in the long QT syndromes and in heart failure, namely 
prolongation of repolarisation and its increased dispersion. One may postulate that the well-
recognised arrhythmogenic mechanism in long QT syndrome, with triggered activity 
causing Torsade de Pointes arrhythmia, may well be an important phenomenon in the 
arrhythmogenesis in heart failure. 
Ca2+ and arrhythmias 
The transient rise of intracellular [Ca2+] initiated by the action potential underlies the 
mechanism of excitation-contraction coupling in cardiac muscle. Spontaneous oscillations 
of intracellular [Ca2+] have been shown in cardiomyocytes (Orchard et al. 1983) especially 
when the cells are Ca2+~overloaded, e.g. with inhibition of the Na+ I K+ pump by cardiac 
glycosides or enhancement of Ca2+ influx by catecholamines. The oscillations are believed 
to be mediated via Ca2+ -induced Ca2+ release from the sarcoplasmic reticulum (Fabiato and 
Fabiato, 1975) and have been implicated in the production of aftercontractions following 
the normal contraction. The elevated intracellular [Ca2+] also produces a transient inward 
current (Iii) (Berlin et al. 1989) which is thought to be able to generate arrhythmias. The Iii 
current is thought to consist of an inward Na+ I Ca2+ exchange current along with a Ca2+-
activated chloride current and I or a Ca2+-activated cationic current (Laflamme and Becker, 
1996). Elevated intracellular [Ca2+] has also been shown to be related to the genesis of 
EADs and DADs in single cells (Deferrari et al. 1995) and to the initiation of arrhythmia in 
an isolated multicellular myocyte model of arrhythmia (Thandroyen et al. 1991). It has also 
been shown that elevated intracellular [Ca2+] can increase electrical heterogeneity in the 
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myocardium and promote re-entrant activity (Didiego and Antzelevitch, 1994). In the whole 
heart, Ca2+ -overload with elevated intracellular [Ca2+] has been shown to facilitate the 
induction of ventricular fibrillation (Merillat et al. 1990; Billman et al. 1991; Kihara and 
Morgan, 1991). Experiments by Merillat et al. (1990) using Ca2+ -channel blockers 
suggested that increases in slow channel Ca2+ flux were important in the initiation and 
maintenance of ventricular fibrillation. Kihara et al. (1991) demonstrated an important role 
Ca2+ oscillations played as a trigger for ventricular fibrillation, by measuring intracellular 
[Ca2+] with the bioluminescent dye, aequorin; and the oscillations were found to be 
augmented after transition to ventricular fibrillation suggesting a role in the maintenance of 
the arrhythmia. 
Many pathological states are associated with Ca2+ -overload and have a high incidence of 
arrhythmias. Myocardial ischaemia is known to cause significant changes in the intra- and 
extra-cellular ionic environment with electrophysiological changes which are associated 
with a high incidence of arrhythmias (Cascio et al. 1995). Ischaemia causes changes in 
intracellular [Ca2+] (Lee et al. 1988; Allen et al. 1989) and these changes may be non-
uniform in different regions of the heart (Figueredo et al. 1993). It has also been known for 
some time that arrhythmias occur not only during ischaemia but also upon reperfusion 
(Tennant and Wiggers, 1935). Changes in intracellular [Ca2+] have also been shown to be 
associated with reperfusion-induced ventricular tachycardia and fibrillation (Brooks et al. 
1995) suggesting again an important role of Ca2+ in these arrhythmias. As mentioned above, 
there is a high incidence of arrhythmias in heart failure. The role of Ca2+ in the pathogenesis 
of arrhythmias in heart failure has not received much attention. This should be pursued as 
extensive research on Ca2+ homeostasis in heart failure has identified abnormalities in 
various aspects of Ca2+ handling which can directly or indirectly affect intracellular [Ca2+]. 
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Excitation-contraction coupling in heart failure 
Congestive heart failure is characterised by a reduced pump efficiency of the heart. There is 
mechanical dysfunction with reduced contractile performance (Hasenfuss et al. 1992) and 
an abnormal relaxation profile (Grossman, 1990). The mechanisms underlying the systolic 
and diastolic dysfunction are unknown, but changes have been noted in the extracellular 
matrix and in the structure and function of the myocyte (Scheuermann, 1993; Davies et al. 
1996). Recent studies have focused on excitation-contraction coupling in heart failure and 
have demonstrated defects in many of the processes involved (reviewed by Figueredo and 
Camacho, 1995; Gwathmey and Ingwall, 1995). 
Normal excitation-contraction coupling 
Normal excitation-contraction coupling (Bers, 1991) in the ventricular myocyte begins with 
depolarisation of the cell membrane leading to the opening of voltage-gated Na+ and Ca2+ 
channels (Lederer et al. 1990). The L-type Ca2+ channel contains a high-affinity receptor for 
l,4-dihydropyridine ligands and the ligands can act as antagonists or agonists of the 
channel. Opening of the L-type Ca2+ channel leads to Ca2+ influx which occurs during the 
plateau of the action potential. This Ca2+ current, which is partially responsible for 
maintaining the action potential plateau, triggers Ca2+ release via the ryanodine receptors 
from the sarcoplasmic reticulum (SR). This process is believed to be the result of Ca2+_ 
induced Ca2+ release (Fabiato, 1983). The increase in cytosolic [Ca2+] initiates contraction 
by binding to the contractile proteins resulting in cross-bridge cycling. Relaxation occurs 
when Ca2+ is removed from the cytosol by (a) Ca2+ reuptake into the SR and (b) extrusion 
from the cell (mainly via the Na+ / Ca2+ exchanger). The rise and fall in intracellular [Ca2+] 
with each cardiac cycle is commonly known as the Ca2+ transient. 
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The reuptake of Ca2+ into the SR is mediated by the SR Ca2+ ATPase (or SR Ca2+ pump) 
which is a Ca2+ transport protein (named SERCA2) concentrated in the longitudinal 
component of the SR. Phospholamban is a regulator protein that binds to and inhibits Ca2+ 
transport by the SR Ca2+ -ATPase. Phosphorylation of phospholamban (via cyclic AMP -
dependent protein kinase, Ca2+ calmodulin - dependent protein kinase or Ca2+ phospholipid -
dependent protein kinase at distinct sites) removes the inhibition on the SR Ca2+ ATPase 
and facilitates Ca2+ reuptake (Sasaki et a/. 1992). After uptake by the SR pump, Ca2+ is 
bound to calsequestrin (primarily located in the junctional SR), which is the major Ca2+-
binding protein in cardiac muscle. 
During relaxation, the fall in intracellular [Ca2+] is brought about mainly by SR reuptake 
but, in addition, some Ca2+ is extruded from the cell. This is mainly via the sarcolemmal 
Na+ / Ca2+ exchanger which is responsible for 20 - 30 % of the decrease in intracellular 
[Ca2+] during the decay phase of the Ca2+ transient. The Na + / Ca2+ exchanger is a counterion 
transporter on which 3 Na+ are exchanged for each Ca2+. There is also a sarcolemmal Ca2+ 
ATPase which also helps Ca2+ extrusion during diastole but its contribution is minimal. 
During steady state, the amount of Ca2+ entering the myocyte via the L-type Ca2+ channel 
with each beat should be equal to that extruded from the cell during diastole and the amount 
of Ca2+ released via the SR ryanodine receptors to the cytosol should equate the amount 
removed by the SR Ca2+ pump. 
Abnormalities of excitation-contraction coupling in heart failure 
Over the last decade or so, investigators have identified defects In various processes 
involved in excitation-contraction coupling in heart failure (Figueredo and Camacho, 1995; 
Gwathmey and Ingwall, 1995). These studies have been performed both in tissues from 
human subjects with heart failure and also in various animal models of heart failure. Since 
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hypertrophy is a prominent feature in the failing heart (Parmley, 1989), many studies have 
involved animal models of hypertrophy to try and understand the pathophysiology of heart 
failure. There are many well-established genetic models of hypertrophy and animals with 
hypertrophy and no heart failure tend to be easier to handle with a lower mortality (Smith 
and Nuttall, 1985; Elsner and Riegger, 1995). Although there are some similar findings in 
studies on hypertrophy and heart failure, many differences exist and as a result, more 
questions have been raised than answered. Some of these discrepancies may be explained 
by species difference but it must be emphasised that results obtained from different models 
may only be relevant to the individual model. It has been discussed above that there may be 
different signalling pathways for specific kinds of hypertrophy. The stimulus used to 
achieve hypertrophy, rather than simply the presence of hypertrophy itself, must have an 
important role to play in the results generated by the particular model. It is also difficult to 
find one single animal model of heart failure (or hypertrophy for that matter) that fully 
mimics the human scenario. One good example is the conflicting results obtained from 
various models of hypertrophy and heart failure on the L-type Ca2+ current density (Hart, 
1994). In the review by Hart (1994), 3 of the 16 studies discussed showed significant 
reductions in Ca2+ current density, 2 showed reductions of 50 % while 2 models showed a 
significant increase with the remaining 9 studies showing no significant change. Therefore, 
one has to be careful in handling data obtained from studies on heart failure and 
hypertrophy especially when they come from different models, species and / or 
preparations. It is an over-simplification to extrapolate results obtained from models of pure 
hypertrophy (without decompensation) to draw conclusions about the situation in heart 
failure. The review below summarises the abnormalities in the processes involved in 
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excitation-contraction coupling identified in tissues from patients with or animal models of 
heart failure but not from hypertrophy alone. 
The intracellular Ca2+ transient in heartfailure 
Most studies on excitation-contraction coupling in heart failure have demonstrated 
significant mechanical abnormality in the failing myocardium (Hasenfuss et al. 1992; 
Mulieri et al. 1992; Davies et al. 1995). There is usually reduced peak tension, reduced 
maximum rate of tension rise and a prolonged relaxation phase. Ca2+ handling was the first 
target of investigation to elucidate the cause for the abnormal force production. Several 
investigators have studied Ca2+ transients in failing myocardium to establish the relationship 
between Ca2+ homeostasis and the abnormal mechanical profile (Table 1.2). 
Gwathmey et al. (1987) were the first to show that intracellular Ca2+ transients recorded in 
ventricular trabeculae from patients with heart failure were abnormal. Using aequorin, the 
Ca2+ -sensitive light signal showed 2 distinct components in the myopathic muscle. The Ca2+ 
transient in failing myocardium was prolonged and was associated with delayed relaxation. 
Although the distinct components were not reported by other investigators, Ca2+ transients 
obtained from failing myocardium or myocytes were consistently abnormal in animals 
(Bing et al. 1991; Siri et al. 1991; Wikman-Coffelt et al. 1991a; Perreault et al. 1992; 
Capasso et al. 1993) and in humans (Beuckelmann et al. 1992; Vahl et al. 1994) verifying 
that Ca2+ handling is indeed abnormal in the failing heart. Some discrepancies exist. 
however, in the results obtained from different animal models and in human tissue. The 
majority of the evidence supports a prolonged time course of the Ca2+ transient (Gwathmey 
et al. 1990; Beuckelmann et al. 1992; Perreault et al. 1992; Capasso et al. 1993; Vahl et al. 
1994). Beuckelmann et al. (1992) were the first to report this finding in isolated myocytes 
from patients with heart failure. They also showed that the peak amplitude of the Ca2+ 
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transients was decreased whilst the resting [Ca2+] was raised in the failing myocytes 
suggesting that the failing myocardium has a low systolic [Ca2+] but a high diastolic [Ca2+], 
a feature which was also shown by other workers (Wikman-Coffelt et al. 1991 a; Capasso et 
al. 1993). In contrast, several groups have reported no change in the amplitude of the Ca2+ 
transient in failing myocardium at low (0.3 to 1 Hz) stimulation rates (Gwathmey et al. 
1990; Perreault et al. 1992; Brooks et al. 1994; Vahl et al. 1994). Brooks et al. (1994) 
found that there was a significant decrease in peak systolic [Ca2+] when the stimulation rate 
was increased above 2.0 Hz in failing rat hearts and a similar rate-dependent alteration in 
Ca2+ transient amplitude has also been reported by Pieske et al. (1995) in failing human 
myocardium. Vahl et al. (1994) found that the Ca2+ transients recorded from human failing 
myocardium were similar to controls under isometric conditions but when the muscle 
preparations were allowed to shorten with step-wise after-load reduction, the amplitude of 
the Ca2+ transient was increased, time to peak delayed and diastolic decay prolonged in 
failing myocardium. These discrepancies may be due to methodological factors or 
limitations but suggest that stimulation frequency and muscle shortening may differentially 
affect Ca2+ handling in heart failure. 
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Table 1.2 Changes in the intracellular Ca1+ transient in heart failure. 
First author 
Gwathmey 
Gwathmey 
Bing 
Siri 
(Peak = peak amplitude, TTP = time to peak, RT = relaxation time, Dias = 
diastolic level) 
Year Ca1+ transient Species Aetiology Prep 
1987 t Human DCMlCAD LVIRVtrah 
1990 ~ t t Human DCMlCAD LVPapM 
1991 t -J, Rat SHR LVPapM 
1991 ,!, ~ ~ ~ Guinea pig AB LVMyo 
Wikman-Coffelt 1991 ,!, t Hamster CM Heart 
Perreault 1992 ~ i i ~ Dog Pacing LV/RVtrab 
Beuckelmann 1992 ,!, t t Human DCMlCAD Myo 
Capasso 1993 ,!, i t i Rat Ischaemia LVIRVMyo 
Brooks 1994 ~/,!, Rat SHR Heart 
Vahl 1994 ~/t ~/i t Human DCM LV strips 
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L-type Ca2+ channels in heart failure 
As mentioned above, the majority of workers failed to demonstrate any functional 
abnormality in the L-type Ca2+ channels with no change in the Ca2+ current (Beuckelmann et 
al. 1991; Mewes and Ravens, 1994; Kaab et al. 1996; Qiu et al. 1996; Rozanski et al. 1997) 
whilst some demonstrated a decreased current in failing myocytes (Rossner, 1991; Hatem et 
al. 1994; Ming et al. 1994). The picture becomes more confusing when the abundance of 
the Ca2+ channel was investigated by examining the expression of the dihydropyridine 
(DHP) receptor and the number of DHP binding sites (see Table 1.3). Early studies on the 
cardiomyopathic hamster, using specific Ca2+ channel photoaffinity ligands, indicated an 
increase in DHP binding sites especially in the early stages (3 - 4 months old) of 
cardiomyopathy (Finkel et al. 1986; Wagner et al. 1986; Finkel et al. 1987; Kobayashi et 
al. 1987; Kuo et al. 1987). This suggested an increase in Ca2+ channels which was presumed 
to cause Ca2+ overload - believed to be behind the pathogenesis of the condition. Finkel 
(1987) found that these differences disappeared by 10 months, indicating a relative decrease 
over time with the pathological process. However, subsequent studies failed to show any 
difference in this animal model (Howlett and Gordon, 1987; Bazan et al. 1991) and the 
study by Bazan et al. (1991) even showed a small decrease at 8 to 9 months. In humans, 
DHP binding studies by Rasmussen (1990) showed no difference in idiopathic dilated 
cardiomyopathy. Takahashi et al. (1992a) found that the level ofmRNA encoding the DHP 
receptor was decreased in myocardium from patients with heart failure as was the number 
of DHP binding sites. These discrepancies may be due to species difference or to the 
difference in the pathogenesis of the disease process or the progression of the disease with 
time. There are also suggestions that different DHP binding sites (high or low affinity) were 
being examined in the individual studies (Bazan et al. 1991). 
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Taking all the data as a whole, it seems that there should be an adequate Ca2+ trigger in the 
failing ventricular myocardium as the bulk of the evidence suggests against gross 
abnormality in the Ca2+ current. Defects in other processes have to be sought to explain the 
abnormal Ca2+ handling and force production in heart failure. 
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Table 1.3 Changes in L-type Cal + channels in heart failure. 
Effect First author Year Species Aetiology Prep 
m-RNA level for DHP receptors 
Takahashi 1992 Human DCM/CAD RNA 
DHP binding 
i Finkel 1986 Hamster CM Memb 
i Wagner 1986 Hamster CM Memb 
i/~ Finkel 1987 Hamster CM Memb 
i Kuo 1987 Hamster CM Memb 
i Kobayashi 1987 Hamster CM Memb 
~ Howlett 1987 Hamster CM Memb 
~ Rasmussen 1990 Human DCM Memb 
~ I'" Bazan 1990 Hamster CM Memb 
'" 
Takahashi 1992 Human DCM/CAD Memb 
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SR Ca2+ -release (Ryanodine) channels in heart failure 
The first study on mRNA coding of Ca2+-release channels in patients with heart failure by 
Brillantes et al. (1992) showed that the expression was decreased in ischaemic 
cardiomyopathy whilst there was a non-significant increase in idiopathic dilated 
cardiomyopathy. Subsequent studies showed decreased expression in patients with heart 
failure of various aetiology (Arai et al. 1993; Go et al. 1995). This was, however, not 
matched by a decrease in the amount of protein, with the study by Meyer et al. (1995) 
showing no change in the level of the Ca2+-release channel (see Table 1.4). 
Ryanodine binding studies produced an even more confusing picture. Two studies on the 
cardiomyopathic hamster (Finkel et al. 1992; Sapp and Howlett, 1994) showed an increase 
in radioligand binding capacity with no change in affinity suggesting an increase in 
ryanodine binding sites. Lachnit et al. (Lachnit et al. 1994) did not confinn these results 
but, rather, showed a decrease in ryanodine binding site density associated with a decreased 
mRNA level for the channel in the myopathic hamster. Studies on the dog with dilated 
cardiomyopathy or pacing-induced heart failure also showed a decrease in ryanodine 
binding sites (Cory et al. 1993; Vatner et al. 1994) whilst two studies on other models of 
heart failure (rabbit and rat) showed no change (Bouanani et al. 1994; Gomez et al. 1997). 
Despite the conflicting data described, it would seem that the majority of the evidence is 
suggesting a downregulation of the Ca2+ -release channel in heart failure. This is supported 
by functional studies (D'Agnolo et al. 1992; Cory et ai. 1993) which showed a decreased 
activity of the Ca2+ -release channel. The decreased expression, amount and / or activity of 
the SR Ca2+ -release channel may explain the decreased peak amplitude of the Ca2+ transient 
(or systolic [Ca2+]) in heart failure as the Ca2+ trigger appears to be adequate. The 
radioligand binding studies by Lachnit et al. (1994) and Vatner et al. (1994) showed no 
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difference in DHP receptor density but that there was a decrease in ryanodine receptor 
density. This altered ryanodine to DHP receptor ratio may play an important role in the 
abnormal excitation-contraction coupling in heart failure with a direct effect on the Ca2+-
amplification (Ca2+-induced Ca2+ release) process. A recent study (Gomez et al. 1997) also 
showed that the effectiveness of the trigger Ca2+ to evoke Ca2+ release may also be impaired 
in heart failure as a result of altered micro-architecture in the arrangement between L-type 
Ca2+ channels and SR Ca2+-release channels. In this study, Gomez et al. (1997) showed a 
reduced amplitude of the Ca2+ transient in a hypertension-induced heart failure model of the 
rat. There was no change in Ca2+ current density or SR Ca2+ -release channels as measured 
by ryanodine binding. However, the ability of Ca2+ influx to trigger SR Ca2+ -release was 
significantly impaired with a reduced probability of evoking Ca2+ sparks (fundamental SR 
Ca2+-release events). The authors concluded that, in the absence of changes in the L-type 
Ca2+ channels or SR Ca2+ -release channels, the defect was in the architectural arrangement 
between the two, as it was believed that SR Ca2+ -release is very sensitive to the geometric 
arrangement of the 2 groups of channels. 
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Table 1.4 Changes in SR Cal+-release (Ryanodine) channels in heart failure. 
Effect First author Year Species Aetiology Prep 
m-RNA level 
J, Brillantes 1992 Human CAD RNA 
~ Brillantes 1992 Human DCM RNA 
J, Arai 1993 Human DCM/CAD RNA 
J, Go 1995 Human DCM/CAD RNA 
Protein level 
Meyer 1995 Human DCM L V homogenate 
Ryanodine binding 
t Finkel 1992 Hamster CM Membrane 
J, Cory 1993 Dog DCM /pacing Membrane 
~ Bouanani 1994 Rabbit V + P overload Membrane 
t Sapp 1994 Hamster CM Membrane 
J, Lachnit 1994 Hamster CM Membrane 
J, Vatner 1994 Dog Pacing Membrane 
~ Gomez 1997 Rat Hypertension SR vesicles 
Activity 
Cory 1993 Dog DCM /pacing Membrane 
Gating mechanism 
D'Agnolo 1992 Human DCM Skinned fibres 
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SR Ca2+-ATPase in heartfailure 
As mentioned above, prolonged diastolic Ca2+ decay was found to be a consistent feature in 
studies of intracellular Ca2+ transients in heart failure. Much attention has been focused 
upon Ca2+-reuptake by the SR (Table 1.5). Studies on the expression of SR Ca2+-ATPase 
have uniformly demonstrated depressed mRNA levels in failing myocardium (Mercadier et 
aZ. 1990; Feldman et al. 1991; Kuo et al. 1992; Takahashi et al. 1992b; Arai et al. 1993; 
Studer et al. 1994; Schwinger et al. 1995; Linck et al. 1996). There is, however, debate as 
to the level of SERCA I1a protein in heart failure with some groups showing a decrease 
(Hasenfuss et al. 1994; Studer et al. 1994; Kiss et al. 1995; Meyer et al. 1995; Gupta et al. 
1997) that was not confirmed by others (Movsesian et al. 1994; Schwinger et al. 1995; 
Linck et al. 1996). This may be the result of differences in the preparation of tissues studied 
or variation in the underlying aetiology and in control tissues. The discrepancy in the results 
of protein level studies contrast with the agreement in the finding of a decreased mRNA 
level in heart failure, leading some authors to suggest that the regulation of protein levels 
may be independent of the encoding mRNA levels (Schwinger et al. 1995; Linck et al. 
1996). 
The majority of functional studies on the SR Ca2+ pump examining Ca2+ uptake have shown 
a decreased SR Ca2+-ATPase activity in heart failure (Limas et al. 1987; Whitmer et al. 
1988; Kuo et al. 1992; Cory et al. 1993; Bouanani et al. 1994; Kiss et al. 1995; Gupta et al. 
1997). Movesesian et al. (1989) did not find a difference in left ventricular vesicle 
preparations from patients with dilated cardiomyopathy. Schwinger et al. (1995) found a 
decreased Ca2+ uptake activity in crude membrane preparations but no difference in vesicle 
preparations. The difference in the results between membrane preparations and vesicle 
preparations may be the direct effect of the isolation procedure, with changes in the 
38 
Chapter I Heart failure - an overview 
preparation during the gradient centrifugation process affecting subsequent Ca2+ -uptake 
activity. Denvir et al. (1995; 1996) examined SR Ca2+-loading ability using caffeine-
induced contractures in saponin-skinned trabeculae from patients with heart failure (Denvir 
et al. 1995) and in a rabbit coronary artery ligation model (Denvir et al. 1996). It was found 
that SR Ca2+-loading ability decreased with increasing severity of heart failure in human 
subjects whilst it was shown to be enhanced in the rabbit model. This rather anomalous 
result in the rabbit heart failure model may be due to a reduced SR Ca2+ leak in the failing 
myocardium (with an increased net accumulation of Ca2+ despite a possibly reduced 
uptake), increased total volume of SR or to changes specific to the rabbit model (Denvir et 
al. 1996). 
Taking all the results as a whole, the expression of SR Ca2+-ATPase is decreased in heart 
failure. This is translated into decreased function with reduced Ca2+ -uptake activity 
demonstrated in the majority of studies, although there is still debate as to the level of the 
SR Ca2+ pump protein. These findings correspond with the prolonged decay phase of 
intracellular Ca2+ transients measured in the failing myocardium. 
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Table 1.5 Changes in SR Ca1+ -ATPase in heart failure. 
Effect First Year Species Aetiology Prep 
author 
m-RNA levels 
-L. Mercadier 1990 Human DCM/CAD RNA 
-L. Feldman 1991 Human DCM RNA-PCR 
-L. Takahashi 1992 Human OCM/CAD RNA 
-L. Kuo 1992 Hamster CM RNA 
-L. Arai 1993 Human OCM/CAD RNA 
-L. Studer 1994 Human DCM/CAD RNA 
-L. Schwinger 1995 Human DCM RNA 
-L. Linck 1996 Human DCM/CAD RNA 
Protein levels 
-L. Hasenfuss 1994 Human DCM/CAD L V homogenate 
~ Movsesian 1994 Human DCM LV vesicles 
-L. Studer 1994 Human DCM/CAD L V homogenate 
-L. Meyer 1995 Human DCM L V homogenate 
-L. Kiss 1995 Guinea-pig AB/HF L V homogenate 
~ Schwinger 1995 Human OCM vesicles / membrane 
~ Linck 1996 Human DCM/CAD L V homogenate 
-L. Gupta 1997 Dog ICE LV vesicles 
Activity 
-L. Limas 1987 Human DCM RV Biopsy 
-L. Whitmer 1988 Hamster CM Homogenate 
~ Movsesian 1989 Human DCM LV vesicles 
-L. Kuo 1992 Hamster CM SR membranes 
-L. Cory 1993 Dog DCM/pacing SR membranes 
-L. Bouanani 1994 Rabbit V + P overload L V homogenate 
-L. Kiss 1995 Guinea-pig AB/HF L V homogenate 
-L. Schwinger 1995 Human DCM membrane 
~ Schwinger 1995 Human DCM vesicles 
-L. Denvir 1995 Human OCM/CAD RV skinned trab 
t Denvir 1996 Rabbit CAL LV /RV skinned trab 
-L. Gupta 1997 Dog ICE LV vesicles 
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Phospholamban in heartfailure 
Studies on the expression of phospholamban in human heart failure have been consistent in 
showing a decreased mRNA level (Feldman et al. 1991; Arai et al. 1993; Schwinger et al. 
1995; Linck et al. 1996) (Table 1.6). However, the results of the level of phospholamban 
protein in heart failure were less congruous with some groups reporting a decrease in 
protein level (Kiss et al. 1995; Meyer et al. 1995; Hasenfuss et al. 1996) and others 
showing no difference between failing myocardium and control tissue (Bohm et al. 1994; 
Movsesian et al. 1994; Schwinger et al. 1995; Linck et al. 1996). 
Phospholamban is a regulatory protein that normally inhibits SR Ca2+ -ATPase. De~reased 
expression and or level of phospholamban would remove the inhibition on the SR Ca2+ 
pump and improve Ca2+ reuptake by the SR. This could be seen as a compensatory 
mechanism for the reduced SR Ca2+ -ATPase activity in heart failure. In the study by Kiss et 
al. (1995), there was reduction in both SR Ca2+-ATPase (by 15% compared to controls) and 
phospholamban levels (by 35% compared to controls). Even with the relatively greater 
reduction of phospholamban level than SR Ca2+ pump, Ca2+ uptake rate by the SR was still 
reduced. However, Movesesian et al. (1990) showed that phospholamban-mediated 
stimulation of SR Ca2+ uptake was unchanged in patients with idiopathic dilated 
cardiomyopathy. Phosphorylation of phospholamban normally removes its inhibition on the 
SR Ca2+-ATPase. Bohm et al. (1994) found no change in cyclic AMP - dependent 
phosphorylation of phospholamban whilst others demonstrated a decrease (Bartel et al. 
1996; Schmidt et al. 1996). Basal cyclic AMP content was found to be reduced by Bohm et 
al. (1994) which would agree with the well-recognised fact that adrenergic effects are 
blunted in the failing heart as a result of Pl-adrenoceptor down-regulation. This may help 
explain the finding of reduced cyclic AMP - dependent phosphorylation in heart failure but 
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does not exclude the possibility of phosphorylation via other protein kinase systems (Currie 
and Smith, 1996). One study (Rouetbenzineb et ai. 1996) showed a decrease in protein 
kinase C activity and expression of Ca2+ -dependent protein kinase C isoforms in a rabbit 
model of heart failure whilst another report (Kirchhefer et ai. 1997) suggested an increase in 
Ca2+ / calmodulin· dependent protein kinase activity in hwnan heart failure. Either of these 
kinase systems may affect the phosphorylation of phospholamban and hence SR Ca2+-
ATPase activity. These results bring further confusion as to the functional significance of 
phospholamban in the abnormal Ca2+ handling and pathogenesis in heart failure. 
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Table 1.6 Changes in phospholamban in heart failure. 
Effect First author 
-J, 
-J, 
-J, 
-J, 
~ 
~ 
-J, 
-J, 
~ 
~ 
-J, 
Feldman 
Arai 
Schwinger 
Linck 
Movsesian 
Bohm 
Meyer 
Kiss 
Schwinger 
Linck 
Hasenfuss 
Movsesian 
Bohm 
Bartel 
Year 
1991 
1993 
1995 
1996 
1994 
1994 
1995 
1995 
1995 
1996 
1996 
1990 
1994 
1996 
Species 
m-RNA levels 
Human 
Human 
Human 
Human 
Protein levels 
Human 
Human 
Human 
Guinea-pig 
Human 
Human 
Human 
Activity 
Human 
Phosphorylation 
Human 
Human 
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DCM 
DCM/CAD 
DCM 
DCM/CAD 
DCM 
DCM I CAD 
DCM 
AB/HF 
DCM 
DCM I CAD 
DCM/CAD 
DCM 
DCM/CAD 
DCM/CAD 
Prep 
RNA-PCR 
RNA 
RNA 
RNA 
LV vesicles 
Homogenate 
L V homogenate 
L V homogenate 
vesicles/membrane 
L V homogenate 
L V homogenate 
LV vesicles 
Homogenate 
Homogenate 
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Na+ / Ca2+ exchanger in heart failure 
Studies on the expression, protein level and activity of the Na+ / Ca2+ exchanger suggest an 
upregulation in the trans-sarcolemmal counterion transporter in human heart failure (Table 
1.7). Studer et al. (1994) and Flesch et al. (1996) both showed increased mRNA and protein 
levels of the Na+ / Ca2+ exchanger in failing human myocardium. Reinecke et al. (1996) also 
showed an increase in the exchanger protein level and, in addition, the activity of the 
exchanger as measured by Na+ gradient-induced Ca2+ transport was also increased. This is 
thought to be a compensatory mechanism for the reduced activity of the SR Ca2+ -ATPase in 
the failing myocardium but is also thought to play a potentially arrhythmogenic role in 
generating inward currents with Na+ influx. However, there are also reports on animal 
models of hypertrophy (Naqvi and MacLeod, 1994) that the exchanger activity may also be 
reduced in hypertrophied cardiomyocytes. As mentioned 10 the section 
"Electro physiological abnormalities in the failing myocardium ", studies on the Na+ / Ca2+ 
exchanger current have shown abnormal activity in heart failure but it has been shown to be 
both increased (Hatem et al. 1994) and decreased (Zhang et ai. 1996) in different animal 
models of heart failure. Despite the rather conflicting results from animal models, human 
studies provide compelling data that the Na+ / Ca2+ exchanger is upregulated in heart failure 
and it may play an important role in the altered Ca2+ homeostasis in heart failure. 
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Table 1.7 Changes in Na+ I Ca1+ exchanger in heart failure. 
Effect First author 
t 
t 
t 
t 
t 
t 
Studer 
Flesch 
Studer 
Flesch 
Reinecke 
Reinecke 
Year 
1994 
1996 
1994 
1996 
1996 
1996 
Species 
m-RNA levels 
Human 
Human 
Protein levels 
Human 
Human 
Human 
Activity 
Human 
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DCM/CAD 
DCM/CAD 
DCM I CAD 
DCM I CAD 
DCM I CAD 
Prep 
RNA 
RNA 
L V membranes 
Homogenate 
L V membranes 
DCM I CAD L V membranes 
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SR Ca2+ storage in heartfailure 
There is consistent information that both the expression (Takahashi et al. 1992a; Arai et al. 
1993) and level (Movsesian et af. 1994; Meyer et af. 1995) of the SR Ca2+ binding protein 
calsequestrin are unchanged in human heart failure (Table 1.8). The amount of another Ca2+ 
binding protein found in the SR, calreticulin was also found to be unchanged in human 
heart failure (Meyer et al. 1995) indicating that there is no major abnormality in SR Ca2+ 
storage in heart failure. 
Myofilament abnormalities in heart failure 
The majority of studies examining Ca2+ sensitivity of skinned myocardial fibres (Wankerl et 
al. 1990; D'Agnolo et al. 1992; Hajjar and Gwathmey, 1992; Denvir et al. 1995; Denvir et 
al. 1996) showed no significant change in heart failure (Table 1.9). There are some studies 
suggesting an increase in Ca2+ sensitivity in the failing myocardium (Schwinger et al. 1994; 
Wolff et al. 1995). The lack of evidence that myofilament Ca2+ sensitivity is reduced in 
heart failure suggests that this is not the mechanism behind the systolic impairment in the 
failing heart. Despite the fact that myofibrillar content and myofibrillar Mg-ATPase activity 
appear to be reduced in the failing heart (Pagani et al. 1988; Hasenfuss et al. 1992), the 
major disturbance in systolic force production appears to lie in the Ca2+ control mechanisms 
rather than the contractile units per se in heart failure. 
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Table 1.8 Calsequestrin in heart failure. 
Effect First author 
Takahashi 
Arai 
Movsesian 
Meyer 
Year 
1992 
1993 
1994 
1995 
Species 
m-RNA levels 
Human 
Human 
Protein levels 
Human 
Human 
Aetiology 
DCM/CAD 
DCM/CAD 
DCM 
DCM 
Table 1.9 Myofilament Ca2+ sensitivity in heart failure. 
Effect First author Year Species Aetiology 
~ Wankeri 1990 Human DCM I CAD I MVD 
~ Hajjar 1992 Human DCM 
~ D'Agnolo 1992 Human DCM 
t Schwinger 1994 Human DCM 
~ Denvir 1995 Human DCM/CAD 
t Wolff 1995 Dog Pacing 
~ Denvir 1995 Rabbits CAL 
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Prep 
RNA 
RNA 
LV vesicles 
L V homogenate 
Prep 
skinned fibres 
skinned fibres 
skinned fibres 
skinned fibres 
skinned fibres 
skinned myocytes 
skinned fibres 
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There is no doubt that excitation-contraction coupling is abnormal in the failing heart. 
Changes in the various processes involved may be directly or indirectly related to the 
systolic and diastolic dysfunction seen in the remodelled failing myocardium. Ca2+ handling 
is abnormal and depressed SR function appears to be the major defect in the abnormal 
excitation-contraction coupling process. Investigations are already underway focusing on 
the SR as the potential target for gene therapy (Luo et al. 1996; Hajjar et al. 1997) with a 
view to correcting the contractile abnormality in heart failure. Disappointing results from 
clinical trials on positive inotropic agents (e.g. phosphodiesterase inhibitors), which 
increased morbidity and mortality in patients with heart failure despite haemodynamic 
benefits (Packer et al. 1991), serve to provide a cautionary note. Even in drugs that have 
been shown to be of prognostic benefit in heart failure, like angiotensin converting enzyme 
inhibitors (Swedberg, 1987; The SOLVD investigators, 1991) and third-generation p-
blockers (e.g. carvedilol) (Bristow et al. 1996; Packer et al. 1996), their therapeutic effects 
are not full understood particularly at the tissue level. Clearly, much work has still to be 
done to investigate the relationship between the various abnormal processes involved in the 
pathogenesis and progression of heart failure. 
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Aims of study 
As discussed in Chapter 1, congestive heart failure is a common and growing problem with 
high morbidity and mortality. Despite the vast amount of research work over the years, 
there are still many gaps in our knowledge about much of the pathophysiology behind the 
clinical syndrome. Many animal and human studies yielded different results. This may be 
partly explained by species difference but in some cases, the animal models of heart failure 
are not representative of the human situation. The main aim of this study is to examine heart 
failure using an animal model which is clinically relevant and to study such changes in the 
isolated heart under conditions as close to those in vivo as possible. A rabbit coronary artery 
ligation model was used which had been developed and characterised by Pye et al. (1996) at 
the Department of Medical Cardiology, Glasgow Royal Infirmary. Rabbits were allowed to 
develop heart failure over time after coronary artery ligation. This process is similar to the 
scenario in the commonest cause of human heart failure in the Western world in which 
failure occurs months or years after myocardial infarction. The degree of cardiac 
dysfunction was assessed in vivo by echocardiography. In vitro mechanical dysfunction was 
studied in greater detail in the isolated heart using Langendorff perfusion and the working 
heart configuration. Ca2+ handling in heart failure was examined by developing a technique 
that allowed the measurement of changes of [Ca2+] with the cardiac cycle (Le. Ca2+ 
transients) from different regions in Langendorff-perfused whole hearts. Electrical events of 
activation and repolarisation were studied in the same regions from where the Ca2+ 
transients were sampled. With these measurements, the mechanical, Ca2+ -handling and 
electrical properties of hearts from rabbits with heart failure were studied and correlated 
using the same clinically relevant model. 
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Thesis layout 
Chapter 3 outlines all the methods involved in the experimental work described in this 
thesis. These include:-
a) the coronary artery ligation procedure to produce myocardial infarction and 
subsequent heart failure in the rabbit. 
b) echocardiography to assess in vivo cardiac dysfunction. 
c) the working heart configuration for studying mechanical performance of the isolated 
heart. 
d) measurements of [Ca2+] from the epicardial surface of Langendorff-perfused hearts. 
e) measurements of Monophasic Action Potentials from the epicardial surface of 
Langendorff-perfused hearts. 
t) assessment of heart failure and cardiac remodelling by organ weights. 
Chapter 4 describes the assessment of the degree of cardiac dysfunction and remodelling 
produced by the coronary artery ligation model in rabbits used for the experimental studies. 
These include echocardiographic measurements and organ / tissue weight measurements. 
Chapters 5 and 6 describe the results of the experiments looking at the mechanical 
performance of the isolated heart. Chapter 5 summarises the results of experiments on the 
working heart configuration in normal stock rabbit hearts. The response of the isolated 
working heart to load changes and the Frank-Starling mechanism were studied. In Chapter 
6, the mechanical performance of the failing heart in the working heart configuration was 
studied as well as the response to load changes. The mechanical performance of the failing 
heart in the Langendorff mode was also described. The in vitro cardiac performance of the 
failing hearts were correlated with in vivo echocardiographic measurements. 
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Chapters 7 and 8 include the results of [Ca2+] measurements in the isolated Langendorff 
perfused heart. The novel method of measuring Ca2+ transients from different regions of the 
left ventricular epicardial surface in the isolated beating heart was described and 
characterised in Chapter 7. Chapter 8 summarises the analysis of the data obtained from 
failing hearts and controls. 
Chapter 9 describes the results of experiments examining ventricular repolarisation in the 
failing heart by measuring Monophasic Action Potentials (MAPs) over the left ventricular 
epicardial surface of the isolated beating heart. 
Chapter 10 attempts to correlate the changes seen in the failing heart in mechanical 
performance, Ca2+ handling and ventricular repolarisation and discusses their significance in 
the pathophysiology of the syndrome. 
Chapter 11 addresses a separate issue which is the effect of altered conduction on the 
mechanical performance of the failing heart. Analysis of data on Ca2+ transients and MAP 
signals revealed significant abnormality which may be attributable to abnormal electrical 
conduction pattern in the failing heart. The potential contribution of such abnormality to the 
impaired mechanical performance seen in heart failure was investigated and discussed. 
Chapter 12 is a synopsis of the thesis summarising the results from all the experimental 
studies and attempts to relate these results with our current knowledge of the 
pathophysiology of heart failure. 
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Coronary artery ligation in the rabbit 
Background 
Many animal models have been used to study heart failure (Smith and Nuttall, 1985; Elsner 
and Riegger, 1995), with different causes of the final heart failure state. The pathogenesis of 
heart failure may be specific to the individual models and what happens in the human 
clinical syndrome may be quite different. If an animal model of heart failure is to be used, it 
has to reflect the human situation so that the results from such studies can be applied to 
provide insights into the human condition. 
A rabbit coronary artery ligation model of heart failure was used for this study. This model 
was established and developed in the Department of Cardiology, Glasgow Royal Infirmary 
by Dr. Maurice Pye and Prof. Stuart Cobbe. Coronary artery disease is by far the 
commonest cause of heart failure in the Western world with myocardial infarction giving 
rise to contractile dysfunction and pump failure. The rabbit coronary artery ligation model 
has been characterised and shown to produce heart failure as a result of left ventricular 
dysfunction arising from myocardial infarction (Pye et al. 1996), thus making it a clinically 
relevant model. The rabbit has a poorly developed collateral coronary circulation (Maxwell 
et al. 1987), similar to humans and the pig. Ligation of a coronary artery produces a well 
defined myocardial infarct, which leads to cardiac remodelling in a similar way to that seen 
in humans. The severity of subsequent contractile dysfunction varies according to the size 
of the initial infarct and the remodelling process or compensatory mechanisms - this allows 
a range of cardiac performance to be studied and compared. In addition, processes involved 
in excitation-contraction coupling including electrophysiology and Ca2+ handling are 
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relatively similar to humans in the rabbit compared to other common laboratory animals 
like the rat or mouse. 
Method 
Adult male New Zealand White rabbits (2.5 - 3.0 kg) were premedicated with 0.4 ml.kg-I 
intramuscular Hypnorm [fentanyl citrate (0.315 mg.ml"l) : fluanisone (10 mg.ml-I), Janssen 
Pharmaceuticals]. Anaesthesia was induced with 0.25 - 0.5 mg.kg-I midazolam (Hypnovel, 
Roche) given via an indwelling cannula in the marginal ear vein. The rabbit was intubated 
with an uncuffed size 3 - 3.5 endotracheal tube inserted over a soft-tipped wire introducer 
with the aid of a Wisconsin paediatric straight blade (size 1) laryngoscope. The 
endotracheal tube was secured by taping to the operating table and was connected to a 
Harvard small animal ventilator. The rabbit was ventilated with a 1: I mixture of nitrous 
oxide and oxygen containing 1 % halothane at a tidal volume of 50 ml and a frequency of 
40 min-I. Preoperative antibiotic prophylaxis was given with I ml Amfipen (ampicillin 100 
mg.ml-t, Mycofarm UK Ltd) intramuscularly and the rabbit was placed on a pre-warmed 
table with body temperature maintained by means of a thermostatically controlled heating 
mat. The anterior chest wall was shaved and cleaned with Hibidil in isopropyl alcohol. 
A left thoracotomy was performed through the 4th intercostal space. The left lung was gently 
retracted exposing the heart. The pericardium was incised and the heart was lifted up with a 
tie placed through the ventricular apex to allow easier manipulation. Quinidine 
hydrochloride 10 mg.kg-I (Sigma Pharmaceuticals) was administered intravenously prior to 
coronary artery ligation to reduce the incidence of ventricular fibrillation. Coronary 
circulation in the rabbit is different from that in humans. The left anterior descending artery 
is short and only supplies a small area of the interventricular septum. The left circumflex 
coronary artery gives off a marginal branch which supplies the left ventricular apex and 
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most of the left ventricular free wall. This artery was identified and ligated halfway between 
the atrioventricular groove and the ventricular apex using 6 / 0 Ethicon suture to produce an 
ischaemic area of 30 - 40 % of the left ventricle. As there is relatively little collateral 
circulation in the rabbit, a homogenous apical infarct was produced. Ventricular fibrillation 
occurred in approximately 30 % of cases, usually 8 to 12 min following occlusion and 
defibrillation was undertaken with a 5 - 10 J DC shock using small sterilised paddles 
applied directly on the epicardial surface of the heart. 
Once the animal was stable, the left lung, which would normally be collapsed, was re-
inflated by occluding the outlet of the ventilator. The chest was then closed in layers using 2 
/ 0 interrupted catgut sutures for the deep layer bringing the ribs together, 4 I 0 catgut 
continuous suture for the subcutaneous layer and 2 / 0 Dexon for a continuous subcuticular 
suture to close the skin. The animal was then given 20 ml of isotonic saline intravenously to 
replace perioperative fluid losses and allowed to convalesce in a warm clean environment 
with adequate monitoring for any early signs of distress. Analgesia was given with 0.04 
mg.kg- I intramuscular Vetergesic (buprenorphine hydrochloride 0.3 mg.ml"!, Reckitt & 
Colman Products Ltd) immediately after surgery and the next morning. Heart failure was 
allowed to develop in these rabbits for 8 weeks prior to sacrifice for the experimental 
studies. 
Sham-operated rabbits which underwent thoracotomy, pericardium incision and had the 
heart manipulated in a similar fashion as ligated animals but without coronary artery 
ligation were used as controls. Experimental studies were again carried out 8 weeks after 
the surgical procedure so that the control animals would be of a similar maturity as the 
ligated animals at the time of sacrifice. 
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Ecbocardiograpby 
Background 
Echocardiography is a diagnostic technique using high frequency ultrasound (2 to 7 MHz) 
to assess structural, functional and haemodynamic status of the cardiovascular system. Edler 
and Hertz (1954) were the first to record movement of cardiac structures with ultrasound in 
1954. In 1965, Feigenbaum et al. (1965) reported the first ultrasound detection of 
pericardialeffusion and introduced the technique into the clinical practice of cardiology. 
Echocardiography is now widely used clinically for assessing cardiac chamber sizes, 
valvular function and ventricular performance. It can be performed in a transthoracic 
manner which is non-invasive and the heart and its motion during the cardiac cycle can be 
visualised in real-time. Chronic impairment in ventricular performance can lead to volume 
overload with dilatation of cardiac chambers which can be seen easily with 
echocardiography. Left ventricular ejection fraction has been shown to be a reasonable 
estimate of ventricular performance with clinical and prognostic significance (Nelson et al. 
1975). Measurements can be made from two-dimensional echocardiography of ventricular 
volumes from which ejection fraction can be calculated. This has been shown to be reliable 
in human studies (Stamm et al. 1982) and also in dogs (Buda and Zotz, 1986). Pye et al. 
(1996) in the Department of Cardiology, Glasgow Royal Infirmary have shown that 
echocardiography provides a non-invasive yet powerful means of characterising 
haemodynamic performance of the heart in vivo in the same model of heart failure used in 
this thesis. 
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Method 
Echocardiography was performed 1 week prior to sacrifice for the experimental studies to 
assess in vivo cardiac performance, using a 5 MHz paediatric probe with a Toshiba 
sonograph (Sonolayer 100). The rabbit was sedated with 0.3 mg.kg-1 Hypnorm and a small 
area of the anterior chest wall was shaved to allow a satisfactory echo window. The animal 
was placed in the left lateral position and a parasternal long-axis view was obtained to 
assess the left atrial dimension (LAD) and left ventricular end-diastolic dimension 
(LVEDD) in the M-mode (see Figure 3.1). Ejection fraction (EF) was assessed in the short-
axis view at a level just below the tips of the mitral valve leaflets. Using the end-diastolic 
and end-systolic frames captured, the endocardial border was marked and the enclosed area 
automatically computed (Figure 3.2). EF was calculated as the percentage area reduction 
with systole. 
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Figure 3.1 Parasternal long-axis view (right panel) on echocardiography in a rabbit 
with heart failure with M-mode recordings (left panel) at the level of aortic valve (A V) 
showing measurements for aorta (Ao) and left atrium (LA). 
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Figure 3.2 Transverse view on echocardiography in a rabbit with hC~lrt failure with 
endocardial circumference during diastole and systole marked with circles. Ejection 
fraction is measured as the fractional decrease in area on systole (see text). 
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In vitro cardiac performance in isolated ejecting working rabbit hearts 
Background 
The ejecting working heart configuration was originally described by Neely et al. (1966) in 
which an isolated rat heart preparation was capable of pumping fluid and performing in 
vitro mechanical work. The aorta and left atrial appendage were cannulated and perfusate 
was introduced into the left atrium and left ventricle through the mitral valve. Left 
ventricular'contraction pumped the perfusate out via the aorta which then perfused the heart 
via the coronary arteries. Thus, the heart performed work and it was perfused in the same 
way as in vivo in the anterograde direction - as opposed to retrograde aortic perfusion of the 
non-working heart by the Langendorfftechnique (Langendorff, 1895). 
The working heart preparation allows the contractile behaviour of the heart to be examined 
under controlled conditions without the influence of in vivo haemodynamic changes and 
autonomic influence. Loading conditions and heart rate can be controlled and the heart can 
perform work in vitro in a similar manner as it does in vivo. 
Methods 
The apparatus originally set up by Dr. Maurice Pye in the Department of Cardiology, 
Glasgow Royal Infirmary was used initially. It was found that the pre-load arrangement in 
the original set-up was providing a phasic fluid flow into the heart. Although a steady mean 
pre-load pressure could be maintained, the phasic nature of the inflow into the heart was 
undesirable for the measurement of instantaneous haemodynamic changes. The pre-load 
arrangement was therefore substantially modified to provide a constant pre-load pressure 
and thus fluid inflow into the heart. The experimental set-up is shown in Figure 3.3. 
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Figure 3.3 Schematic diagram of the in vitro Langendorff and working heart 
apparatus. The representation of an isolated rabbit heart is shown with the right 
ventricular outflow tract (RVOT), left atrium (LA), right atrium (RA) and left 
ventricle (LV) detailed. See text for description of the various components of the 
perfusion apparatus. 
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Initial preparation and Langendorff perfusion 
At the beginning of the experiment the whole perfusion system was primed with modified 
Tyrode's solution of the following composition (mM): Na 138, K 4.0, Ca 1.8, Mg 1.0, 
HC03 24.0, H2P04 0.4, C1121, glucose II. The pH of the solution was maintained at 7.4 by 
continuously bubbling with 95 % O2 / 5 % CO2 mixture. Water-baths were used both for 
heating the perfusion solution and for supplying warm water to water-jackets in the 
glassware to reduce heat loss, thus maintaining a temperature of 37°C at the heart. Care 
was taken to ensure that there were no air bubbles in the perfusion apparatus prior to 
starting the experiment. 
Rabbits were sacrificed with an intravenous injection of 0.5 ml.kg- I Euthatal (sodium 
pentobarbitone 200 mg.ml- I , Rhone Merieux) mixed with 500 IU of heparin. After ensuring 
that there was absence of corneal and withdrawal reflexes, the abdominal cavity was opened 
by making a transverse subcostal incision with scissors. The diaphragm was transected and 
lateral incisions made along both sides of the rib cage. The anterior chest wall was folded 
back exposing the contents of the mediastinum. The heart was picked up and protected with 
fingers and incisions were made (a) at the inferior vena cava, (b) at both lung hila, and (c) at 
the great vessels and superior vena cava. Care was taken to ensure that the left atrium was 
not lanced or incised and that an adequate length of the ascending aorta was preserved. The 
isolated heart was then put into a beaker containing modified Tyrode's solution chilled to 4 
°C to reduce metabolic rate and inhibit contraction. 
The heart was then picked up by the aorta with fine-tipped forceps and slipped onto the 
aortic cannula of the perfusion apparatus and held in place with a bulldog clip. The cannula 
was made of stainless steel, grooved about 1 mm from the tip to accommodate ligatures. It 
was important to ensure free flow of perfusate during the cannulation to prevent air emboli 
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into the coronary arteries. The aorta was then secured with silk ligatures and the bulldog 
clip was removed. A small incision was then made at the pulmonary artery which was often 
occluded with the aortic ligatures. This allowed free flow of the coronary effluent, collected 
from the coronary sinus into the right heart, when Langendorff perfusion was started with 
the resumption of cardiac contraction. The time from asystole to reperfusion was usually 
under 3 min. The height of the fluid level in the Langendorff reservoir was kept at around 
70 em above the level of the aorta by topping up with perfusate. 
Working heart configuration 
Set-up. Once the heart was being perfused in the Langendorff mode, time could be taken to 
clean up adherent fatty and fibrous tissue. The heart was rotated to position the atrial 
cannula next to the left atrium. The atrial cannula was similar to the aortic cannula except 
that it was angulated for easy attachment of the left atrium. The lumina of the pulmonary 
veins were located and the surrounding tissues were cut to produce a single hole large 
enough to receive the atrial cannula. Again free flow of perfusate was ensured during the 
cannulation to prevent air entry and embolism. The atrial tissue was secured onto the 
cannula with a bulldog clip and then a silk ligature. The silicone tubing leading to the atrial 
cannula could be unclamped briefly to allow flow of the perfusate to ensure there was no 
leakage in the atrium or at the connection with the cannula. Leakage could be easily stopped 
with a second silk ligature. 
Perfusion. After the left atrial cannula had been connected and the heart had stabilised for 
about 15 min, perfusion was switched from Langendorff mode to working heart mode. This 
was achieved by switching off / clamping the Langendorff perfusion inlet (T)) and 
simultaneously opening / unclamping the left atrial inflow from the pre-load chamber (T2) 
and the aortic outflow to the compliance chamber (T3)' Perfusate would enter the heart via 
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the left atrium and be pumped out from the left ventricle via the aorta - the same way as 
blood would enter the left heart and be ejected in vivo. Coronary perfusion would then occur 
via anterograde aortic flow as in vivo as opposed to via retrograde aortic flow during 
Langendorff perfusion. 
Pre-load chamber. The height of the pre-load chamber can be adjusted. A constant fluid 
level was maintained by the use of 2 high-speed roller pumps (Watson-Marlow SOSS) with 
one pump (supply pump, PI) being used to supply the chamber with perfusate and the other 
(removal pump, P 2) pumping perfusate out via a vertically placed glass tubing connected to 
the pump via silicone tubing. The rate of the removal pump was set faster than that of the 
supply pump so that the fluid would be kept at the level of the tip of the vertical glass 
tubing. A baseline pre-load level of 10 cm above the level of the aorta was found to be the 
minimal input required to provide a steady output from the ejecting heart. The perfusate in 
the pre-load chamber was bubbled with 95 % O2 / 5 % CO2 mixture to maintain pH of 7.4 
and adequate oxygenation. 
Compliance chamber. The aortic cannula was connected to a "bubble trap" (B 1) which was 
used as a compliance chamber. The "bubble trap" was a glass chamber with rubber bung 
fitted with stainless steel cannulae. It was found that a compliance chamber was necessary 
to mimic the vascular compliance in vivo. Otherwise, the performance of the ejecting heart 
would deteriorate and heart would become unstable. The compliance provided by the 
chamber was adjusted by altering the volume of air inside the chamber using a silicone 
tubing and syringe connected to the top of the bubble trap. In a set of control experiments, it 
was found that the cardiac output obtained (see later) was positively correlated with the 
volume of air inside the compliance chamber up to 25 ml after which a plateau was 
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obtained. All the experiments were therefore performed with the volume of air inside the 
compliance chamber set at 25 ml. 
After-load chamber. The compliance chamber was connected to an analogue calibrated low 
resistance flow meter for an estimate of the aortic flow. This was then connected to a 
"bubble trap" (B2). The fluid column between this second "bubble trap" and the aortic valve 
provided the hydrostatic pressure the left ventricle had to contract against and hence 
represented the after-load. This second "bubble trap" therefore acted as the after-load 
chamber and its height was set at 75 cm above the aorta, representing a pressure of about 55 
mmHg. This pressure is regarded as representative of a physiological equivalent to the mean 
systemic aortic pressure in vivo. 
Recirculation of perfusate. After the after-load chamber, the perfusate would flow back via 
silicone tubings to the working heart reservoir inside the heated water bath. The reservoir 
was also bubbled with 95 % O2 / 5 % CO2 mixture to maintain pH and oxygenation. 
Coronary effluent flowing out of the pulmonary artery was collected in the heart chamber, 
also water-jacketed to keep the heart warm, and returned to the working heart reservoir via a 
low-speed pump (P3). Temperature at the epicardial surface of the heart was monitored with 
an electronic probe (Libra Medical ET 250 temperature monitor, Berks., England) and 
maintained at 35°C. This would give a consistent intracardiac temperature of37 °C. 
The recirculated solution would inevitably contain particulate material after perfusion 
through the heart. Filters (a prefilter, pore size 70 ).lm, Millipore ;and a filter, pore size 5.0 
J.lm, Whatman International Ltd, England) were housed in a tight-fitting filter holder placed 
between the supply pump and the pre-load chamber so that the perfusate would be filtered 
prior to flowing into the left atrium to prevent micro-embolism of the coronary circulation 
which may cause myocardial infarction and deterioration of the preparation. Filters were 
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changed regularly during the course of the experiment and the perfusion fluid was also 
replaced every hour to ensure adequate glucose concentration. 
Pacing. A pair of platinum electrodes (Grass Instruments, USA) were inserted into the right 
atrial appendage for atrial pacing using an electrical stimulator (Digitimer Ltd. DS2A) 
driven by a custom-written computer program. 
Cardiac performance assessment 
Cardiac output. As mentioned above, an analogue calibrated low resistance flow meter, 
connected between the compliance and after-load chambers, was used to obtain a rough 
estimate of the mean aortic flow. This measurement was used as a guide to the condition 
and stability of the preparation. It was found in previous work using a similar apparatus 
(Pye, 1992) that healthy, stable preparations should be able to produce a consistent aortic 
flow of above 80 ml.minol • Hearts which produced an aortic flow of less than this value 
were excluded from the study. Total cardiac output included aortic flow and coronary 
circulation. Coronary effluent could be collected from the heart chamber over a period of 
time to estimate the coronary flow. Together with the aortic flow, an estimate of the total 
cardiac output could be made. Coronary effluent was also collected at various points during 
the experiments and the samples were sent to the Biochemistry Department at Glasgow 
Royal Infirmary for assessment of lactate concentration to ensure that there was no 
significant acidosis resulting from hypoxia or "ischaemia". 
Since one of the aims of the study was to examine the instantaneous, beat-to-beat and 
potentially small changes in haemodynamic parameters in the isolated working heart, a 
more elaborate method of assessing cardiac output was employed. An ultrasonic probe 
(Transonic Systems Inc., 3 mm diameter), vertically placed in series between the aortic 
cannula and the compliance chamber, was used to measure the beat-to-beat variation in flow 
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in the aortic cannula using crystal doppler technology with the Transonic Systems Inc. 
(New York) T106 flow-meter. 
Intraventricular pressure. Left ventricular pressure was measured with an I8-gauge cannula 
inserted into the free wall of the left ventricle. The cannula was connected to a stiff wide-
bore piece of plastic tubing leading to a Gould Inc. pressure transducer. The signal from the 
pressure transducer was calibrated using a sphygmomanometer with known pressure prior 
to each experiment and a "zero" pressure was obtained at the end of each experiment by 
keeping the cannula at the same level and removing the heart, thus opening the cannula to 
air. 
Cardiac dimensions. Measurements of the left ventricular dimension and the beat-to-beat 
variations during the cardiac cycle were made using sonomicrometry. This was first 
described by Rushmer et al. (1956) who showed that it was possible to measure cardiac 
dimensions and changes during contractions accurately, using barium titanate crystals based 
on the sonar principle. In the current study, a pair of sonomicrometer crystals (Triton 
Technology Inc., 2 mm diameter) were placed subepicardially along the anteroposterior axis 
of the left ventricle. The sonomicrometer crystals were half-spherical structures with the 
convex ultrasonic emission and receiving surface on one side and a flat electrical 
connection surface on the other. With a needle, a small hole was made in the left ventricular 
epicardium, halfway between the atrioventricular groove and the left ventricular apex, just 
next to the left anterior descending artery. The hole was expanded with a pair of fine-tipped 
forceps to create a small space underneath the epicardium. The first crystal was inserted into 
this space. In a similar manner, the second crystal was inserted into a space made at the 
posterior surface of the left ventricle just next to the posterior descending artery, along the 
anteroposterior axis at the same level as the first crystal. The distance measured between the 
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crystals (resolution of 0.05 nun) should be the maximal diameter of the epicardial 
circumference of the left ventricle at that level. The two crystals were connected to 2 
sonomicrometry amplifiers connected to a 6-channel mainframe (Triton Technology Inc.) 
and the beat-to-beat changes in cardiac dimension were measured. 
Signal measurement and analysis 
The signals recorded from the ultrasonic flow probe, pressure transducer and 
sonomicrometer crystals were displayed continuously on a Gould Inc. (Cleveland, Ohio) 
2800S 6-channel chart recorder and stored on video tape using a Medical Systems 
Corporation PCM 8-channel videocassette recorder adapter. These signals were digitised at 
1 kHz with 12-bit precision using the program WCP (Dr. J. Dempster, Strathc1yde 
Electrophysiology Software). Ten successive sweeps (representing a continuous recording 
of about 5 s) were averaged before the waveforms of the various signals were analysed. 
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[eaH ] measurements in Langendorff perfused rabbit hearts 
Background 
Chemical light has been employed by humans in various ways for a long time (Campbell 
and Sala-Newby, 1993). It ranges from the practical use of fireflies in torches or lamps to 
the less practical luminous golf balls. Chemiluminescence is the emission of light as a result 
of a chemical reaction and bioluminescence is visible light emission from luminous 
organisms. Such light emission properties from chemical reaction within living cells, tissues 
and organs, and other biochemical reactions with a similar basis have been applied 
scientifically to the study of many biological processes and phenomena. 
Ca2+ is one of the most important intracellular messengers. It carries various messages like 
nerve cell signal transmission, hormone secretion and immune cell activation. In cardiac 
cells, Ca2+ plays a pivotal role in the process of excitation-contraction coupling and the 
measurement of fluctuations in cytosolic [Ca2+] is central to the understanding of cardiac 
contractile function. The evolution of techniques for measuring intracellular ion 
concentration has allowed the study of intracellular [Ca2+] in cardiac myocytes, muscle 
preparations and the whole heart. Several methods have been developed to examine Ca2+ in 
its physiological role and in disease states (Bentivegna et al. 1991; Cannell and Thomas, 
1994):-
1) Dye absorbance - the early optical methods for measuring ion concentration involved the 
measurement of dye absorbance with metallochromic indicators like murexide, arsenazo or 
antipyrylazo. The low level of absorbance in small preparations limit its use only in large 
invertebrate cells or muscle fibres. 
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2) Bioluminescence - the photoprotein, aequorin, has been used for bioluminescent 
measurements of intracellular [Ca2+]. Photoproteins are enzymes that catalyse the oxidation 
ofa bound prosthetic group (e.g. coelenterazine) and a photon is given off as a result of the 
oxidation reaction, with Ca2+ regulating the catalytic process. Hence, light is emitted when 
the photoprotein combines with free, ionised Ca2+. Difficulty in introducing the 
photoprotein into the cell is one of the main drawbacks of this technique. Aequorin has to 
be injected into the preparation (Allen and Kurihara, 1980; Kihara et al. 1989) and Ca2+ 
transients can only be measured from a localised area of myocardium where the aequorin 
has been injected. In addition, aequorin has limited sensitivity in the lower range of [Ca2-!-], 
making measurement of diastolic [Ca2+] difficult; and a time-dependent consumption of the 
photoprotein is recognised. 
3) Fluorescent indicators - these are relatively new agents which have been developed and 
used over the last 2 decades for the study of ionic activity. Light is emitted from both 
fluorescent indicators and bioluminescence probes with the return of an excited state to the 
ground state when photons are released. The main difference between the two is that 
external energy is required to excite the electron in the case of fluorescence whilst the 
energy to excite the electron comes from the chemical reaction in bioluminescence. 
Fluorescent indicators will be discussed in greater detail below. 
4) Nuclear Magnetic Resonance (NMR) spectroscopy - this technique has been used in the 
study of Ca2+ homeostasis especially in the whole heart using the Ca2+ -sensitive fluorescent 
indicator 5,5' -F2-1,2-bis(0-aminophenoxy)ethane-N,N,N' ,N' ,tetraacetic acid (SF-BAPTA). 
The 19F NMR spectra acquired consist of 2 peaks - one representing the free ligand of SF-
BAPT A and the other representing the Ca2+ -bound species. [Ca2+] can be calculated from 
the areas under the 2 peaks (Marban et al. 1990). This technique has the advantage of 
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allowing the simultaneous measurement of other ions and metabolites (using 31p NMR 
spectroscopy to obtain values for inorganic phosphate, ATP, phosphocreatine and 
intracellular pH). However, several cardiac cycles would have to be averaged in order to 
obtain meaningful NMR spectra. As a result, alterations in Ca2+ handling cannot be detected 
with NMR on a beat-to-beat basis. Only an estimate of the Ca2+ transient may be 
constructed using gated averaging to obtain [Ca2+] measurements at various stages during 
the cardiac cycle (Marban et al. 1990). In addition, significant buffering occurs with the 
introduction of the indicator causing significant impairment of contractile function with 
prolongation of both time to peak pressure and rate of relaxation. 
Fluorescence 
Fluorescence is the emission of light as a result of a three-stage process that occurs in 
certain molecules (generally polyaromatic hydrocarbons or heterocycles) called 
fluorophores or fluorescent dyes / indicators (Cannell and Thomas, 1994). The first stage of 
the fluorescence process involves the supply of a photon by an external source (e.g. an 
incandescent lamp or laser) to the fluorophore which is excited to a higher-energy "singlet" 
state. The excited state lasts for a short time (about 1 to 10 nanoseconds) during which the 
fluorophore undergoes conformational changes and descends the vibrational ladder with the 
molecule returning to the ground state with the emission of a photon. The emitted photon 
may be reabsorbed or there may be other molecular interactions like collisional quenching, 
fluorescence energy transfer and intersystem crossing which may dissipate energy without 
emitting photons. The number of emitted photons are generally less than the number of 
absorbed photons and the ratio between them is called the fluorescence quantum yield or 
quantum efficiency (typically about 0.3 in modem fluorophores). As energy is dissipated on 
returning from the singlet state to ground state, the energy of the emitted photon is lower, 
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and hence its wavelength longer, than the excitation photon. The difference in energy or 
wavelength, called the Stokes shift, is fundamental to the sensitivity of fluorescence 
techniques as it allows emission photons to be detected against a low background, isolated 
from excitation photons. Unless the fluorophore is irreversibly destroyed in the excited state 
(a phenomenon known as photobleaching), the same fluorophore can be repeatedly excited 
and detected. 
Fluorescent Ca2+ indicators 
As mentioned above, ion-sensitive fluorescent indicators are molecules that emit light on 
excitation with a given wavelength and the intensity of the emitted light is a function of the 
amount of ion bound to the molecule. The resulting fluorescence is used as a measure of the 
free ionic concentration in the medium studied. However, the measured fluorescence 
depends on a number of factors including (a) concentration of the indicator, (b) extinction 
coefficient of the indicator, (c) optical pathlength, (d) excitation source intensity and 
stability, (e) quantum yield of the indicator, (f) fluorescence collection efficiency of the 
detection system, (g) tissue or cell autofluorescence, and (h) concentration of the ion the 
indicator is measuring. 
Second generation fluorescent Ca2+ indicators have made a major contribution to advances 
in the understanding of the role of Ca2+ in cellular regulation since their introduction in 
1985. These were developed by Dr Roger Tsien and collaborators (Grynkiewicz et al. 1985) 
and indo-l and fura-2 are the two most widely used dyes for measuring intracellular [Ca2+]. 
These indicators combine a stilbene fluorophore with an octacoordinate tetracarboxylate 
chelating site characteristic of EGTA and BAPTA. These indicators have many advanced 
features over their predecessor, quin-2:-
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a) they offer up to 30-fold brighter fluorescence with much greater quantum yield, 
b) there are major changes in wavelength upon Ca2+ binding in addition to intensity in the 
second generation dyes, with spectral shift which will be discussed below, 
c) they have slightly lower affinities for Ca2+ than quin-2, hence less likely to cause 
buffering and less likely to be saturated at micromolar levels, 
d) the preferred excitation wavelength for quin-2 is 339 nm which is too short and can cause 
significant autofluorescence and biological side effects whereas the excitation wavelengths 
required for the newer dyes are slightly longer, and 
e) the newer dyes have much greater selectivity for Ca2+ over other divalent cations like 
Mg2+ than quin-2. 
When compared to the bioluminescent indicator, aequorm, the second generation 
fluorescent indicators have a higher quantum yield and are more sensitive in the lower 
(diastolic) range of [Ca2+]. 
Spectral shifts and ratiometric measurements 
In some of the second generation fluorescent dyes, the fluorescence excitation spectrum or 
the emission spectrum (or both) will shift on binding Ca2+. For indo-I, the emission 
spectrum shifts to shorter wavelengths with increasing [Ca2+] and Ca2+ -binding. This means 
that when excited at a certain wavelength (360 run), the emitted fluorescence at a shorter 
wavelength (405 om) increases with Ca2+ -binding whilst that at a longer wavelength (495 
nm) decreases. This allows the ion concentration to be estimated from the relative levels of 
fluorescence measured at 2 different wavelengths. This is known as ratiometric fluorescence 
measurement. The ratio has the advantage that it is insensitive to factors which 
proportionally affect both intensities identically such as indicator concentration and to a 
certain extent, motion artefacts. There are emission or excitation wavelengths in these 
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ratiometric dyes called isosbestic points, where fluorescence does not change with Ca2+ 
binding. The emission wavelengths (or excitation wavelengths) will have to be chosen on 
either side of the isosbestic point for ratio measurements in excitation-shifted (or emission-
shifted) fluorescent dyes. 
Introduction into cells. tissues and organs 
For the measurement of intracellular [Ca2+], it is necessary to introduce fluorescent Ca2+ 
indicators into the cells, tissues or organs studied. This is usually carried out by direct 
injection or by the ester loading technique. 
Direct injection 
In cellular studies, the fluorescent dyes may be injected into the cell through a 
microelectrode (Cannell and Thomas, 1994) or loaded through the electrode when the cell-
attached patch recording technique is used. The indicators may also be micro-injected using 
iontophoresis into myocardial cells at different sites of the trabeculae (Backx and ter Keurs, 
1993) which then diffuse via gap junctions to give a more uniform distribution for the study 
of isolated muscle preparations. For the whole heart, injection techniques have been used 
with the bioluminescent indicator, aequorin (Kihara et al. 1989). Intramyocardial injection 
of the acetoxy-methyl ester form of fluorescent indicators (Mohabir et al. 1991) has also 
been described in the isolated heart but cellular loading of the indicator is by trans-
sarcolemmal diffusion of the ester (see below). 
Ester loading 
A popular technique in loading myocytes with fluorescent Ca2+ indicators is by using the 
acetoxy-methyl (AM) ester form of the indicator (Tsien, 1981). This avoids the potentially 
disruptive nature of direct injection; and cells (Sipido and Callewaert, 1995) and tissues 
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(Hanley and Loiselle, 1998) can be easily incubated and the whole heart (Lee et al. 1987) 
perfused with the ester-containing solution for indicator loading. Fluorescent indicators are 
mUltiply charged molecules (with carboxyl groups in most) at physiological pH. By 
esterifying into the AM form, the derivative is not an active indicator but is lipophilic 
enough to permeate the cell membrane. After entering the cell, intracellular esterases cleave 
the derivative to release the active indicator. As the indicator will become highly charged 
again, it will stay inside the cell. 
However, loading the fluorescent indicator into the cells, tissues or whole heart is not 
without its potential problems. There may be (i) unhydrolysed AM ester in the cytosol 
which is fluorescent but not Ca2+ -sensitive, (ii) loading of mitochondria and other 
organelles, (iii) autofluorescence which may be substantial, (iv) binding to intracellular 
protein altering the spectral properties and Ca2+-affinity, and (v) loading of non-myocyte 
component, e.g. vascular endothelium, in the case of muscle preparations and whole heart. 
All these may affect the interpretation of collected fluorescence as a measure of intracellular 
[Ca2+] (Bassani et al. 1995). These will be discussed in greater detail in Chapter 7. 
Calibration and concentration 
In order to translate the fluorescence measured into [Ca2+], the signals have to be calibrated 
against known [Ca2+]. For ratiometric dyes, the free [Ca2+] is related to the fluorescence ratio 
R (Grynkiewicz et al. 1985) by the formula:-
where S is a scaling factor given by the fluorescence at the denominator wavelength (495 
nm for indo-l) of R at zero [Ca2+] divided by the fluorescence at a saturating [Ca2+] and !\nin 
and Rnax are the ratio at zero and saturating [Ca2+] respectively. 
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It is obvious the calculation of absolute free [Ca2+1 in the cytosol depends on Kd in addition 
to fluorescence and ratio measured. Kt obtained in vivo may be significantly different from 
that in vitro (Bassani et al. 1995) and will directly affect the [Ca2+1 measured. 
Methods 
Langendorff perfusion 
Rabbits were sacrificed with an intravenous injection of 0.5 ml.kg-t Euthatal (sodium 
pentobarbitone 200 mg.ml"t, Rhone Merieux) mixed with 500 IU of heparin. The hearts 
were rapidly excised and perfused in the Langendorff mode with Tyrode's solution of the 
following composition (mM): Na 115, K 4.7, Ca 1.8, Mg 1.0, HC03 25.0, H2P04 0.5, Cl 
135, glucose 10, probenecid OJ. The pH of the solution was maintained at 7.4 by 
continuously bubbling with 95 % O2 / 5 % CO2 mixture. Temperature at the heart was 
maintained at 37°C by the use of water-jackets in the glassware connected to a heated water 
bath. A constant perfusion rate of 50 ml.min-t was maintained using a Gilson Minipuls 3 
peristaltic pump. A 6 cm long, 6 F polypropylene catheter (Portex, Kent, England) was 
inserted at the apex of the left ventricle for draining thebesian venous effluent. 
Intraventricular pressure was monitored with a fluid-filled latex balloon connected with a 6 
F cannula to a pressure transducer (Triton Technology Inc, San Diego, California) and 
inserted into the left ventricle via the left atrium. The volume of the balloon was adjusted to 
give zero end-diastolic pressure. Perfusion pressure was monitored with a second pressure 
transducer in series with the aortic cannula. Pairs of platinum electrodes (Grass Instruments, 
USA) were inserted into the right atrial appendage and the posterior aspect of the right 
ventricular apex for atrial and ventricular pacing respectively. Under control conditions the 
hearts were paced via the right atrium at a cycle length of 350 ms. 
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Fluorescence measurement system 
Fluorescence from areas of the left ventricular epicardial surface were measured using a 
custom-built apparatus shown in Figure 3.4. Illumination was provided by a Nikon 75 W 
Xenon lamp filtered at 360 ± 10 run (Ft) and focused via a 385 run long-pass dichroic 
mirror (D l ) onto a 3 mm-diameter liquid light guide (Ultrafine Technology, UK) in contact 
with the left ventricular epicardial surface of the isolated heart. Emitted light from the 
preparation was collected by the same light guide and light with wavelengths greater than 
385 nm passed through the dichroic mirror (D) and was subsequently split by a second 
dichroic mirror (D2). Light with wavelengths greater than 460 run passed through the 
second dichroic mirror onto a photomultiplier (Thorn EMI, UK) fitted with an optical band-
pass filter centred on 495 ± 20 run. The remaining light was reflected onto a second 
photomultiplier with a band-pass filter centred on 405 ± 35 run. The output of the 
photomultipliers were passed to an electronic ratio circuit so that an effectively continuous 
signal of fluorescence intensity ratio (F 40sIF 49S) could be obtained. This analogue ratio 
signal, the fluorescence intensity of the individual wavelengths and the electrical signals 
representing intraventricular pressure and perfusion pressure were displayed continuously 
on a Gould TA-ll chart recorder and stored on video tape using a CRC VR-IOOB digital 
recorder (Instrutech Corp, USA). 
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Figure 3.4 Schematic diagram of the optical arrangement used to measure Indo-l 
fluorescence from the epicardial surface of the isolated Langendorff perfused rabbit 
heart. Dl is a 385 run long-pass dichroic mirror and D2 is a 460 om long-pass dichroic 
mirror. Fl' F2 and F3 are optical filters with peak transmission wavelengths and band-
widths as shown on the diagram. The representation of an isolated rabbit heart is 
shown with the right ventricular outflow tract (RVOT), left atrium (LA), right atrium 
(RA) and left ventricle (LV) detailed. 
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Indo-} loading 
Loading solution. Indo-l AM (Molecular Probes Inc, Ohio) stock solution was initially 
prepared by dissolving 1 mg of indo-! AM in 1 ml dimethyl sulphoxide (DMSO) / 25 % 
(w/v) pluronic acid F-127 solution. This was then added to 100 ml Tyrode's solution with 5 
% foetal calf serum to make up a concentration of 10 IlM indo-l AM. 
Loading protocol. After an initial equilibration period of 30 min with normal Tyrode's 
solution, the hearts were perfused with the indo-} AM containing solution at a rate of 25 
ml.min-t at room temperature (25°C) for a period of 60 min and atrial pacing was slowed to 
60 beats.min- t • The solution was recirculated but not bubbled with 95 % O2 / 5 % CO2 
mixture during the loading period. HEPES buffer (0.6 ml of 500 mM stock solution) was 
added prior to loading to keep the pH of the loading solution at 7.4. The loading of the 
myocardium with the fluorescence indicator was observed by illuminating the preparation 
for lOs at regular intervals, with the light guide being held at the same position throughout 
the loading procedure. At the end of this period, the hearts were perfused with normal 
Tyrode's solution for 15 min with the perfusion rate increased back to SO ml.min- t and 
temperature back to 37°C. This ensured that the intracellular indo-l AM was fully cleaved 
to the Ca2+-sensitive free acid form and that the indo-} AM containing solution was washed 
out of the circulation prior to intracellular Ca2+ measurements. 
Comments. This loading protocol was arrived at after some initial control experiments and 
was found to be effective in loading the myocardium of the beating heart with indo-l giving 
stable and reasonably long-lived fluorescence signals without significant buffering of the 
heart as evident from the unaltered intraventricular pressure signal after loading (see later). 
Initial trial experiments without the use of probenecid showed that fluorescence signals as a 
result of indo-l loading were short-lived. After initial indo-} loading, the signals would 
80 
Chapter 3 Methods 
only last for about 1 hr, with deterioration of signal quality with time. This was clearly not 
desirable as one of the aims of the study was to measure the fluorescence signals at different 
parts of the beating heart which could be time-consuming. Probenecid is an organic anion 
transport protein inhibitor (Di Virgilio et al. 1990). Indo-l transport outside the dye-loaded 
myocyte would be inhibited by probenecid. As in several other studies (Mohabir et al. 
1991; Turvey and Allen, 1994),0.3 mM of probenecid was used in these experiments and 
was shown to produce good-quality fluorescence signals after indo-l loading which lasted 
for a considerable amount of time (up to 5 hours) and showed no significant deterioration in 
quality. 
Loading at a slower perfusion rate at a low temperature and heart rate was shown to produce 
more substantial increase in fluorescence, and hence better indo-l signals. In the initial trial 
experiments when indo-l loading was carried out at 37°C, oxygenation of the perfusion 
solution was required. As a result of the detergent nature of the DMSO in the solution, 
significant amount of froth was produced in the bubbled, recirculated solution which posed 
a danger of overflow and solution spillage. 'When loading was subsequently carried out at 
low temperature, it was found that extra oxygenation was not necessary as the heart was 
working at a low metabolic rate. No change in the pressure profile of the beating heart was 
observed with or without bubbling the loading solution with the 95 % O2 / 5 % CO2 
mixture. Thus, the loading solution was not bubbled and the problem of frothing was 
solved. However, pH of the loading solution had to be buffered to 7.4 with the use of 
HEPES as a result. Lactate samples were taken for several control experiments and verified 
that there was no significant hypoxia / acidosis during the course of the low temperature, 
low flow perfusion period. 
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Signal Measurements and Analysis 
Indo-l fluorescence measurements were made at 15 sites over the left ventricular epicardial 
surface. The locations of the sites were based on anatomical features (see Figure 3.5) with 
the left anterior descending artery forming the left border and the posterior descending 
artery forming the right. Measurements were made at each of the 15 sites sequentially. 
Signal reproducibility was verified by repeated sampling at the initial sites at 30 min 
intervals. Intraventricular pressure recordings indicated the stability of the preparation 
during the course of the experiments. 
Pressure and fluorescence signals were digitised at 1 kHz with 12-bit precision using the 
computer program WCP (Dr. J. Dempster, Strathclyde Electrophysiology Software). Using 
this software, 30 successive sweeps were averaged before measurements were made. 
Another computer program "Transient Analyser" was written (using Microsoft Visual Basic 
4.0 programming language) with the help of Dr. F. L. Burton, University of Glasgow, to 
analyse the time course and amplitude of the signals. This program allowed the digitised 
signals to be imported from WCP and the individual transient signals could be analysed in a 
semi-automated fashion. 
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Apex 
Figure 3.5 A representation of the left ventricular epicardial surface illustrating the 
15 sites used for fluorescence measurements. The anatomical features used as points 
of reference are shown:- Atrio-ventricular (A V) groove, Anterior descending artery, 
Posterior descending artery, Marginal branch of the left circumflex artery and Apex. 
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Monophasic Action Potential measurements in isolated Langendorff 
perfused rabbit hearts 
Background 
The use of glass micropipettes or microelectrodes to make intracellular electrical recordings 
began with the pioneering work of Ling and Gerard (1949) who measured resting potentials 
in frog muscle. The technique has seen many improvements over the years and is now 
widely used to study the electrical properties of living cells, including cardiac myocytes. 
However, this is not feasible in the beating heart, because of obvious problems with 
instability and artefact. An alternative was available even before intracellular action 
potential measurements were made. This is the Monophasic Action Potential (MAP) which 
is an extracellularly recorded signal that reflects changes in the intracellular action potential 
(Franz, 1991). Even as early as 1882, Burdon-Sanderson and Page recorded MAPs in the 
frog heart by placing one electrode on the intact epicardial surface and the other on an 
injured site. Schultz devised a refined technique in 1931 which gave better and longer-
lasting MAPs and later introduced the suction electrode in 1935 which produced MAPs 
with less damage to the heart, greater simplicity and better quality (Schultz, 1936). The 
principle of the suction electrode is that the electrode inside the suction tube presses on the 
myocardium that is drawn into the tube and membranes of the cells in this region are 
depolarised and made non-excitable. The recording electrode is situated just outside the 
suction tube and the potential difference between the 2 electrodes reflects changes during 
the action potential at the recording electrode. There are fundamental differences however 
between the MAP signal and intracellular action potential:- (a) the MAP signal is not 
representative of the absolute voltage of resting and action potential amplitude as the 
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reference potential for the MAP signal is mildly depolarised myocardium and not 0 m V; (b) 
the upstroke of the MAP signal is slower than the phase 0 upstroke of the intracellular 
action potential; and (c) the MAP signal represents an averaged record from a collection of 
cells over an area. Despite the fundamental differences, the MAP signal has been shown to 
accurately reflect the onset of depolarisation and the entire repolarisation phase of the 
transmembrane action potential recorded from cells in the same vicinity (Hoffman et al. 
1959). The main advantage of MAP recording is that it allows recordings from the intact 
beating heart both in vitro and in vivo and MAPs have been used extensively in studying the 
effects on repolarisation of drugs, ischaemia, heart mechanics, etc. in normal and diseased 
myocardium (Franz et al. 1984; Lab, 1991; Yuan et al. 1994). 
Methods 
Monophasic Action Potential recording 
Monophasic Action Potential (MAP) was measured using a suction electrode applied to the 
epicardial surface of the Langendorff perfused heart. The suction electrode was a custom-
made bipolar electrode constructed using Silver / Silver Chloride pellets (1 mm diameter), 
wire and rubber tubing and insulated with silicone rubber gel. Suction was applied using a 
high-flow water Venturi pump to maintain the electrode on the epicardial surface of the 
beating heart. The pellet inside the suction catheter would impale the epicardium and 
partially depolarise the cells at that site whilst the MAP signal could be recorded at the 
second pellet situated just outside the suction catheter 2 mm away. The signal was amplified 
by a custom-made high input impedance differential amplifier with a frequency response 
from DC to 1.25 kHz. A DC offset control was incorporated to compensate for the high 
electrode DC polarisation appearing on the electrodes. A 20 m V signal was available in the 
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amplifier for calibration. The MAP signals may contain artefact or be of low amplitude if 
there was poor contact of the electrode with the heart or if either of the pellets was in 
contact with fibrous or vascular tissue. The signals were considered unacceptable for 
analysis if any part of the repolarisation phase fell below baseline or the amplitude of the 
plateau fell below 15 mY. In these cases, suction was adjusted or the MAP electrode was re-
orientated, which usually rectified the problem. The amplified MAP signal was then 
displayed on a Gould TA-ll chart recorder and stored on video tape using a CRC VR-IOOB 
digital recorder (Instrutech Corp, USA) as in the fluorescence signals. 
Signal Measurements and Analysis 
MAPs were recorded sequentially at the same 15 left ventricular epicardial sites as for the 
fluorescence signals. The recorded MAP signals were digitised and analysed in a similar 
manner using the computer programs WCP and Transient Analyser respectively. Since the 
signal to noise ratio was greater in the MAP signals than fluorescence signals, only 10 
successive sweeps of the MAP signals were averaged prior to analysis, representative of a 
lOs continuous recording period, as opposed to 30 sweeps in the fluorescence analysis. 
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. Cardiac remodelling and organ congestion 
Background 
It has been shown in animals (Pfeffer, 1991) and in humans (McKay et af. 1986) that there 
are significant structural changes to the heart after myocardial infarction. This has been 
termed remodelling (Braunwald and Pfeffer, 1991) which includes significant degree of 
hypertrophy in an attempt to compensate for contractile dysfunction resulting from the 
infarction. 
In the clinical syndrome of chronic heart failure, organ congestion is one of the well-
recognised hallmarks (Katz et af. 1960). Contractile dysfunction of a pumping chamber will 
lead to increased back-pressure in the vasculature and organs proximal to that chamber. 
Hence, left ventricular failure leads to pulmonary congestion and oedema and right 
ventricular failure leads to raised systemic venous pressure and hepatic congestion. The 
commonest cause of right ventricular failure is left ventricular failure when long-standing 
pulmonary congestion leads to pulmonary hypertension and right ventricular overload. 
Methods 
An attempt was made to assess the degree of compensatory hypertrophy I remodelling and 
of organ congestion in this rabbit model of heart failure as a result of left ventricular 
myocardial infarction. Liver and lungs were excised from the animals at the time of 
sacrifice, blotted to remove excess blood and their wet weights were measured. After each 
experiment, the heart was removed carefully from the perfusion apparatus, taking care to 
preserve the aorta and other structures. The heart was blotted and the wet weight was 
measured. It was then cut along the atrioventricular groove, separating the atria and great 
vessels from the ventricles. The right ventricular free wall was carefully dissected away 
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from the left ventricle and both were dried in an oven heated to 50°C for 2 weeks after 
which their dry weights were obtained. 
Data presentation and Statistical analysis 
All experimental data presented in the subsequent Chapters are expressed as mean ± 
standard error. Comparison between groups of data was made with Student's t-test (paired 
when appropriate) unless otherwise stated. Two-tailed p-value of less than 0.05 was 
considered significant. 
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Introduction 
Fluid retention and organ congestion are well-recognised features in the clinical syndrome 
of heart failure. Left heart failure results in increased back pressure in the pUlmonary 
vasculature with pulmonary congestion and interstitial oedema (Katz et al. 1960). With time 
and if untreated, this causes right ventricular overload and failure with increased filling 
pressure in the systemic venous system and hepatic congestion. Activation of the renin-
angiotensin system causes further Na+ and water retention perpetuating the vicious cycle 
(Parmley, 1989). Wall stress is increased in the heart as a result of the haemodynamic 
changes and this is believed to be the stimulus for the remodelling process (Braunwald and 
Pfeffer, 1991) in the myocardium of the failing heart with hypertrophy, fibrosis and other 
cellular changes (Weber and Brilla, 1991; LeJemtel and Sonnenblick, 1993). 
Methods 
The degree of cardiac dysfunction and remodelling as a result of coronary artery ligation 
and its systemic consequences were assessed in the rabbit heart failure model. 
Echocardiography was performed in all of the rabbits 1 week prior to sacrifice for the 
experiments. In the working heart experiments, 8 rabbits in the heart failure group were 
compared with 8 sham-operated animals. For the Ca2+ measurement experiments, 17 rabbits 
with heart failure were studied with 13 controls. MAP measurements were made in some of 
the hearts used in the Ca2+ measurement experiments. Echocardiographic data were 
available, therefore, in 25 (17 + 8) rabbits in the heart failure group and 21 (13 + 8) sham-
operated rabbits. 
Heart, liver and lung weights were not measured in all of the experiments but were available 
in 20 rabbits in the heart failure group and 18 controls. 
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Results 
Cardiac dysfunction and Chamber dilatation 
Echocardiographic data showed that significant in vivo cardiac dysfunction was produced 
by the rabbit heart failure model 7 weeks after coronary artery ligation. Ejection fraction 
was significantly lower in rabbits in the heart failure group and cardiac chambers were 
significantly enlarged as measured by the left atrial and left ventricular end-diastolic 
dimensions (see Table 4.1). This shows that cardiac performance in these rabbits was 
impaired leading to volume overload and ventricular dilatation. Ejection fraction was 
significantly correlated with left atrial dimension (r = -0.86, p < 0.001) and left ventricular 
end-diastolic dimension (r = -0.77, P < 0.001) (Figure 4.1). 
Distension of the left atrium could be the result of increased filling pressure or due to mitral 
regurgitation as a result of annular dilatation or papillary muscle dysfunction. Post-mortem 
examination of the heart after the experiments frequently showed infarction of one or both 
of the papillary muscles attached to the mitral valve as a result of the coronary artery 
ligation procedure. 
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Table 4.1 Comparison of echo cardiographic parameters and organ and tissue 
weights between rabbits with heart failure (HF) and controls (Sham). 
For body weight and echocardiographic parameters, n = 25 for HF and n = 21 
for Sham. For organ and tissue weights, n = 20 for HF and n = 18 for Sham.. 
(LAD = left atrial dimension, L VEDD = left ventricular end-diastolic 
dimension) 
HF Sham p value 
Body weight (kg) 3.60 ± 0.05 3.56 ± 0.07 NS 
Ejection fraction (%) 42.6 ± 1.3 71.2 ± 1.4 < 0.001 
LAD (mm) 15.8 ± 0.3 10.9 ± OJ < 0.001 
LVEDD(mm) 20.0 ± OJ 16.8 ± 0.3 < 0.001 
Liver wet weight (g) 93.0 ± 2.4 81.0 ± 4.0 <0.02 
Lung wet weight (g) 13.1 ± 0.8 10.9 ± 0.3 <0.01 
Heart wet weight (g) 13.1 ± 0.4 11.3 ± 0.4 < 0.005 
LV dry weight (g) 1.40 ± 0.06 1.15 ± 0.04 <0.002 
RV dry weight (g) 0.57 ± 0.05 OJ9 ± 0.02 <0.005 
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Figure 4.1 Plots of (A) left atrial dimension (LAD) and (B) left ventricular end-
diastolic dimension (LVEDD) against ejection fraction (EF) from sham-operated (0) 
and heart failure (.) groups. Solid lines represent linear regression of the pairs of 
parameters with correlation coefficients (r) and significance values (p) shown in the 
shaded boxes. 
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Organ congestion 
Liver and lung weights from rabbits in the heart failure group were increased when 
compared to controls (see Table 4.1). The increased organ weights were associated with the 
degree of left ventricular dysfunction as assessed by echocardiography (Figure 4.2 A & B) 
with the lung and liver weights when corrected for body weight being significantly 
correlated with ejection fraction. This suggests that left ventricular dysfunction in the heart 
failure group led to increased back-pressure in the lungs and in the liver causing congestion 
in these organs. The presence of right ventricular hypertrophy was demonstrated by the 
increased right ventricular dry weight (Table 4.1) in the heart failure group which was also 
correlated with ejection fraction (Figure 4.2 C). This shows that the left ventricular 
dysfunction produced by the rabbit coronary artery ligation model gave rise to right heart 
failure as a result of right ventricular overload which is the common sequence of events 
seen in human congestive biventricular failure. The link between right ventricular 
hypertrophy and liver congestion was further demonstrated in Figure 4.2 D in that the right 
ventricular dry weight and liver weight, both corrected to body weight, were significantly 
correlated (r = 0.52, P < 0.005). The distribution of the data suggests that this relationship 
may not be linear; this may be explained by the occurrence of liver cirrhosis in rabbits in the 
heart failure group with extreme right ventricular overload. Indeed, some post-mortem liver 
specimens had shrunken, cirrhotic appearances in addition to the honeycomb appearance 
associated with congestion. 
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Figure 4.2 Plots of (A) corrected lung weight (lungsC), (B) corrected liver weight 
(IiverC) and (C) corrected right ventricular dry weight (dry RV c) against ill vivo 
ejection fraction (EF) from sham-operated (0) and heart fai lure (e) groups. Panel D 
shows the plot of corrected liver weight (IiverC) against corrected right ventricular 
dry weight (dry RVc) from the two groups. Solid lines represent linear regression of 
the pairs of parameters with correlation coefficients (r) and significance values (p) 
shown in the shaded boxes. 
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Cardiac remodelling 
Hearts from rabbits with heart failure had increased left ventricular dry weight when 
compared to controls (see Table 4.1). There was a significant correlation between the left 
ventricular dry weight, corrected to body weight, and ejection fraction (Figure 4.3). This 
shows that significant compensatory hypertrophy occurred in rabbits with heart failure as a 
result of the left ventricular dysfunction caused by myocardial infarction. Despite a loss of 
tissue due to the infarct, there was increased left ventricular tissue mass. 
• 
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Figure 4.3 Plot of corrected left ventricular dry weight (dry LVc) against ejection 
fraction (EF) in sham-operated (0) and heart failure (e) groups. The solid line is a 
linear regression of the two parameters (r = -0.49, p < 0.002). 
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Discussion 
The echocardiographic data and the organ / tissue weight measurements demonstrated that 
the rabbit coronary artery ligation model of heart failure produced both local and systemic 
changes which parallel those seen in the human clinical syndrome. In human coronary 
artery disease, myocardial infarction produces an area of abnormal contraction in the 
ventricle which leads to increased wall tension. This stimulates a hypertrophic response 
attempting to compensate for the contractile dysfunction. As a result of the volume overload 
and increased back pressure from the left ventricle, pulmonary congestion, right ventricular 
overload and hepatic congestion follow. This is the usual sequence of events seen in 
patients who develop congestive biventricular failure as a result of left ventricular 
dysfunction which is commonly caused by myocardial infarction in the Western world. 
There were similar changes in this rabbit model of heart failure with increased lung weight 
suggesting significant pulmonary congestion as a result of left ventricular dysfunction and 
increased liver weight indicating significant hepatic congestion from right heart failure 
secondary to left heart failure. Changes in the heart were also demonstrated with dilated left 
heart chambers seen on echocardiography and ventricular hypertrophy measured by the 
increased left and right ventricular dry weights. This cardiac remodelling process was likely 
to be caused by increased stress in the ventricle resulting from contractile dysfunction 
secondary to the myocardial infarct and is distinct from other animal models of hypertrophy 
used to study heart failure using pressure overload e.g. hypertension or aortic banding. This 
rabbit coronary artery ligation model is, therefore, a clinically relevant model of heart 
failure and structural and functional changes seen in these "failing" hearts should reflect the 
changes seen or expected in the human situation. 
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Introduction 
The relation between muscle length and developed tension in cardiac muscle has been 
extensively studied and the cellular mechanisms of this length-tension relation were 
reviewed by Allen and Kentish (1985). It has been known for a long time that cardiac 
muscle produces more tension when stretched. Otto Frank was the first to extend the 
knowledge of length-tension relationship in skeletal muscle to cardiac muscle. He showed 
in his landmark paper (Frank, 1895) that in a frog ventricle contracting isovolumetrically, 
the developed intraventricular pressure was a function of end-diastolic filling and volume -
peak pressure increased with end-diastolic filling up to a certain level beyond which it 
declined. It took more than a decade before Ernest Starling and his colleagues (Patterson et 
al. 1914) described a similar phenomenon in the warm-blooded mammalian heart which 
was later called the Law of the Heart. It was shown in the dog heart-lung preparation that 
cardiac output increased with venous filling pressure when aortic pressure was held 
constant. The phenomena described by Frank and Starling are distinct but clearly related 
and describe the length-tension relationship that exists in the heart which has become 
known as the Frank-Starling relationship. This has been shown to be an important 
mechanism by which cardiac output is regulated. In addition to heart rate and contractility, 
the Frank-Starling mechanism plays a significant part in increasing cardiac performance 
during haemodynamic challenges such as exercise. Although a descending limb of the 
Frank-Starling relationship has been described, its functional significance is questionable. 
Over the last several decades, many investigators have focused on the length-tension 
relationship in cardiac muscle and have examined the phenomenon in isolated preparations 
including trabeculae (intact or skinned) and myocytes. The length-tension relationship in 
cardiac muscle is much steeper than one would expect if it is simply the result of the 
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physical sliding of myofilaments over the physiological range. It was discovered that 
activation factors have to playa central role and hence length-dependent activation has been 
shown to be the important mechanism behind the cardiac length-tension relationship. 
Parmley and Chuck (1973) were the first to show in papillary muscles that following a 
sudden increase in length, there was an immediate increase in tension followed by a further 
slow increase over several minutes. This has been confirmed by other investigators on the 
isolated muscle preparation (Lakatta and Jewell, 1977). Allen and Kurihara (1982) studied 
Ca2+ transients from cat and rat papillary muscles micro-injected with aequorin. They 
showed that after an increase in muscle length, the peak amplitude of the Ca2+ transient was 
unchanged whilst there was an immediate increase in tension. This was followed by a slow 
increase in the peak amplitude of the Ca2+ transient which followed the time-course of the 
slow increase in tension. This suggests that the immediate changes in tension are due to 
changes in myofilament Ca2+ sensitivity as a result of the immediate length change whilst 
the slow changes are due to changes in Ca2+ handling which could be the result of altered 
Ca2+ entry and / or Ca2+ release and uptake by the sarcoplasmic reticulum. Kentish et al. 
(1992) showed that the slow changes in tension as a result of length change can be reversed 
by isoprenaline in isolated rabbit papillary muscles. These results suggest that the slow 
tension responses to length change may be mediated via cyclic AMP. 
The slow response to length change has also been described in single guinea-pig ventricular 
myocytes (White et al. 1995). Its presence in the whole heart has been described by Tucci et 
al. (1984) and Lew (1988) in the dog heart but Noble et al. (1994) questioned its role in 
humans. Tucci et al. performed experiments in isolated isovolumetric blood-perfused dog 
hearts whilst Lew's experiments were performed in situ in anaesthetised dogs. Both groups 
showed a time-dependent increase in contractility in response to myocardial stretch with 
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increased diastolic filling. Noble et al. studied 8 human subjects undergoing left heart 
catheterisation and used body-tilt to alter ventricular filling and produce stretch (causing a 
mean increase in left ventricular end-diastolic pressure of 8 mmHg). Some but not all of the 
patients were paced either at the atrium or the ventricle. The heart rate and haemodynamic 
and loading conditions of the patients at rest were variable. In addition, patients were given 
~-blockers to "prevent reflex and heart rate effects". This could affect cyclic AMP levels 
which could directly affect the slow response. This group did not demonstrate any slow 
component although there was an estimated 18% immediate increase in stroke volume with 
the body tilt. All but 2 of the patients had coronary artery disease with 4 patients having 
impaired left ventricular function with ejection fractions of 40% or less. All these factors 
may have contributed to the lack of slow response in the study by Noble et al. 
This Chapter describes experiments using the working heart configuration to assess in vitro 
cardiac performance of the isolated rabbit heart. The relationships between various 
parameters measured using the working heart configuration were studied. Contractile 
function of the working heart was studied by altering ventricular filling pressure in order to 
examine the Frank-Starling relationship. The possibility of time-dependent activation of 
myocardium subsequent to a step change in pre-load was examined. The contribution of this 
'slow response' to the overall Frank-Starling mechanism was studied. 
Methods 
The performance of the isolated heart in the working heart configuration was studied in 5 
normal stock New Zealand White rabbits. No cardiac surgery had been performed in these 
rabbits. They were healthy and their cardiac function was presumed to be normal. The heart 
was harvested from the sacrificed animal in a similar way as described in Chapter 3. As 
opposed to the coronary ligation and sham-operated animals where the pericardium had 
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been incised during cardiac surgery, the normal stock rabbits had not been operated on and 
the pericardium was still intact. The pericardium had to be incised and inverted in order that 
the heart could be "freed" to be mounted onto the working heart apparatus. After the heart 
had been properly attached and connected to the apparatus, perfusion was switched from 
Langendorff mode to working heart mode. At a baseline pre-load of 10 cmH20 (8 mmHg) 
and after-load of75 cmH20 (55 mmHg) and with the heart being paced at a cycle length of 
300 ms at the right atrium, a mean aortic flow of 80' ml.min-t or above was ascertained 
before including in the study as previous work on a similar set-up (Pye, 1992) demonstrated 
that healthy hearts could produce that level of cardiac output. Intrinsic cycle length of the 
isolated beating heart in the working heart configuration at 37°C had been found to be 
around 330 ms to 350 ms and thus a pacing cycle length of 300 ms was chosen to ensure a 
constant, atrially paced rhythm during the experiments. 
Measurements of cardiac dimension, intraventricular pressure and cardiac output were made 
as described in Chapter 3. The Frank-Starling relationship was examined by raising the pre-
load from 10 to 25 cmH20 (i.e. 8 to 18 mmHg) in 5 cmH20 steps with an equilibration 
period of 15 min after each step increase - the after-load and pacing rate being kept 
constant. The effect of the step change in pre-load on the various parameters were 
continually monitored and recorded. 
Results 
Characteristics of the parameters measured in the isolated, ejecting working heart 
Figure 5.1 shows the recordings from a typical experiment with the changes in pressure in 
the left ventricle, cardiac output as measured by the ultrasonic flow probe and cardiac 
dimension with time. The tracings represent an average of 10 successive sweeps during a 
103 
Chapter 5 Cardiac performance in working rabbit hearts 
continuous 5 s recording. The hearts were all paced via the right atrium at a cycle length of 
300 ms with a baseline pre-load of 10 cmH20 (8 mmHg) and a baseline after-load of 75 
crnH20 (55 mmHg). The relationship between the pressure, flow and cardiac dimension 
tracings allows the various phases of the cardiac cycle to be analysed and the timing of the 
opening and closing of cardiac valves (mitral and aortic) to be inferred. When 
intraventricular pressure reached the level of the pre-load, i.e. point 'a' in Figure 5.1, the 
pressure rose sharply. This represented the closure of the mitral valve and the beginning of 
isovolumic contraction. Cardiac dimension stayed relatively constant during this period. 
When the intraventricular pressure exceeded the after-load (point 'b'), the aortic valve 
opened and positive flow could be detected in the ultrasonic flow probe. Cardiac dimension 
started to decrease during this ejection phase. Intraventricular pressure decreased when fluid 
was ejected from the heart whilst aortic flow continued. When intraventricular pressure fell 
below after-load (point 'c'), the aortic valve closed and isovolumic relaxation began. 
Intraventricular pressure fell sharply until it was lower than pre-load (point 'd') when mitral 
valve opened again and ventricular filling resumed with another cardiac cycle. The interval 
between points 'c' and 'd' represents the isovolumic relaxation time. However, cardiac 
dimension according to the sonomicrometer crystals was not constant during this period. As 
the crystals were place on the subepicardial surface of the left ventricle, the slight increase 
in cardiac dimension recorded during the isovolumic relaxation phase could represent an 
increase in ventricular wall thickness whilst the intraventricular volume might have stayed 
the same. Aortic flow measured with the flow probe showed a sinusoidal pattern during the 
cardiac cycle. This will be discussed below. 
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The profile of the left ventricular pressure tracings from the 5 normal stock hearts and the 
timing of the various phases of the cardiac cycle are summarised in Table 5.1 under baseline 
pre-load and after-load conditions. 
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Figure 5.1 Representative tracings of left ventricular pressure (Pressure), aortic 
flow (Flow) as measured with the ultrasonic flow probe and cardiac dimension 
(Dimension) as measured with sonomicrometer crystals in the isolated working heart, 
paced via the right atrium at 300 ms cycle length. Recordings were made at a baseline 
pre-load level of 10 cmHzO (8 mmHg) and after-load level of 75 cmHzO (55 mmHg) 
both marked with horizontal broken lines. Vertical broken lines represent the timing 
of (a) the beginning of systole, (b) aortic valve opening, (c) aortic valve closure and (d) 
mitral valve opening. Isovolumic contraction phase is represented by the interval (a • 
b), ejection phase by interval (b - c), isovolumic relaxation phase by (c • d) and 
ventricular filling phase by (d • a). 
106 
Chapter 5 Cardiac performance in working rabbit hearts 
Table 5.1 Different phases of the cardiac cycle in 5 normal isolated rabbit hearts in 
the working heart configuration under baseline conditions. 
Measurements were made at a pre-load 10 cmH20 (8 mmHg) and after-load of 
75 cmH20 (55 mmHg) with right atrial pacing at a cycle length of 300 ms. 
(IVeT = isovolumic contraction time, dP.dr\max) = maximum rate of change of 
pressure, A V = aortic valve, MY = mitral valve, IVRT = isovolumic relaxation 
time) 
Normal hearts (n = 5) 
Isovolumic Contraction Phase 
IVCT(ms) 30.9 ± 1.3 
2.34 ± 0.12 
Ejection Phase 
Ejection time (ms) 150.4 ± 1.3 
+ dP.dt-\mlX) (mmHg.ms-l) 1.75±0.10 
- dP.drl(mlX) (mmHg.ms-l) 1.65 ± 0.03 
Isovolumic Relaxation Phase 
A V closure time (ms) 178.1 ± 3.5 
MV opening time (ms) 223.2 ±4.8 
IVRT(ms) 45.1 ± 2.9 
- dP.dr\maK) (mmHg.ms-l) 1.67 ± 0.02 
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Characterisation of cardiac output measured with the ultrasonic flow probe 
Aortic flow, as measured with the ultrasonic probe showed a sinusoidal pattern which is 
different from what one would expect in vivo. The flow probe was vertically placed and 
connected in series to the aortic cannula. Cardiac output from the ejecting heart was 
recorded as positive flow during the ejection phase. When the aortic valve closed, flow in 
the aorta should decrease to zero until the next ejection phase when the aortic valve opened 
again. However, a negative flow was recorded in this working heart set-up. It could be due 
to (a) coronary arterial flow, (b) back-flow into the left ventricle due to aortic regurgitation, 
or both. In a few initial experiments where the aortic cannula was connected too close to the 
aortic valve causing aortic regurgitation, there was progressive dilatation of the left 
ventricle and deterioration of the preparation. The sinusoidal pattern with negative aortic 
flow was observed in all of the experiments where the hearts were stable and with no 
progressive dilatation of the left ventricle. Back-flow into the left ventricle was thought not 
to be the cause of the negative flow although the presence of minor aortic regurgitation 
could not be ruled out. A more probable explanation for the negative flow would be flow 
into the coronary arteries. 
Correlation between ultrasonic flow probe recordings with aortic flow and coronary 
effluent 
In order to investigate the components of the recordings from the ultrasonic flow probe, 
aortic flow and coronary effluent were collected over 30 s, during low and normal flow in 5 
experiments and correlated with the flow probe signals. The digitised flow probe signals 
were exported into a Microsoft Excel spreadsheet and mathematically integrated to give a 
positive and negative flow over 30 s. Figure 5.2 summarises the relationship between the 
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recorded and measured flow components. The Transonic Systems TI06 flow-meter gives an 
instantaneous electronic mean in addition to the phasic flow signals. The electronic mean 
was found to correlate well with the mean flow calculated from the digitised signals 
(positive minus negative flow) (r = 0.99, p < 0.001, Figure 5.2 A). This calculated mean 
flow was found to correlate well with the aortic flow collected (r = 0.998, p < 0.001, Figure 
5.2 B). It was found that the positive flow correlated well with the total amount of effluent 
collected over time (aortic flow plus coronary effluent) (r = 0.99, p < 0.002, Figure 5.2 C). 
There was also an association between the negative flow and the amount of coronary 
effluent collected over time ( r = 0.93, p < 0.05, Figure 5.2 D). 
The Pearson correlation coefficients between the pairs of variables suggested strong 
associations between them and the regression coefficients were close to unity suggesting 
that the individual variable within the pairs varied to the same extent in parallel with one 
another. These data showed that:- (a) the positive flow recorded by the flow probe 
represented the total cardiac output from the ejecting working heart; (b) the electronic mean 
flow produced by the Transonic flow-meter reflected the calculated mean flow which 
represented the proportion of the total cardiac output flowing through the working heart 
apparatus into the compliance and after-load chambers, measured as aortic flow by the 
analogue flow meter; and (c) the negative flow measured by the flow probe reflected the 
proportion of cardiac output flowing into the coronary arteries after the ejection phase and 
was close to the amount of coronary effluent collected - although coronary flow during 
. 
systole could not be accurately measured, this was likely to be small as there was little 
difference between the coronary effluent collected and the negative flow. 
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Correlation between flow signals recorded by the ultrasonic flow probe 
and measured flow in the working heart configuration in 5 experiments during low 
and high flow conditions. Panel A shows a plot of the electronic mean flow signal from 
the Transonic flow meter against the mean flow calculated by subtracting the negative 
flow from positive flow. Panel B shows a plot of the calculated mean flow against 
aortic flow collected over 30 s. Panel C shows a plot of the positive flow recorded by 
the flow probe against amount of aortic flow plus coronary effluent collected over 30 s. 
Panel D shows a plot of the negative flow recorded by the flow probe against the 
amount of coronary effluent collected over 30 s. Lines represent linear regression of 
the 2 parameters with the equation (shown in bold type), correlation coefficients (r) 
and significance levels (p) shown in the shadowed boxes. 
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Slow response to step increase in pre-load 
The effects of a step increase in pre-load, from a baseline level of 10 cmH20 (8 mmHg) to 
15 cmH20 (11 mmHg) above the level of the aorta, on the haemodynamic parameters over 
time were observed. Hearts were paced at a cycle length of 300 ms via the right atrium. 
Steady state was obtained prior to the load change and the effect of the change was 
observed with continuous recording of the parameters until a new steady state was reached. 
The results of a typical experiment are shown in Figure 5.3. The step increase in pre-load 
produced an immediate increase in left ventricular peak systolic pressure and aortic flow 
which was quickly followed by a decrease in the two parameters (phase I). These reached a 
minimal value before increasing slowly to a steady state over time (phase II). The results of 
the changes in the various haemodynamic parameters over time in the 5 normal hearts as a 
result of the step change in pre-load are summarised in Table 5.2. When pre-load was 
increased from 10 to 15 cmH20 (Le. 8 to 11 mmHg) above the level of the aorta, left 
ventricular peak systolic pressure rose initially to 107 ± 3 % whilst the cardiac output 
increased to 115 ± 5 %, followed by a fall in the 2 parameters to 102 ± 3 % and 110 ± 7 % 
respectively over 1.5 ± 0.2 min. There was also an immediate increase in both end-diastolic 
(to 101.8 ± 0.8 %) and end-systolic dimensions (to 100.9 ± OJ %) followed by a further rise 
in both parameters during this initial phase. End-diastolic pressure rose initially to 155 ± 13 
% reaching 156 ± 12 % at the end of phase 1. These results suggested that the increase in 
pre-load caused an increase in left ventricular inotropy as measured by the immediate 
changes in intraventricular pressure and cardiac output. The gradual fall in peak systolic 
pressure and cardiac output during phase I was accompanied by a gradual increase in 
systolic dimension and, to a lesser extent, diastolic dimension. Over the next 5.6 ± 0.4 min 
(phase II), left ventricular systolic pressure recovered to 105 ± 3 % and cardiac output to 
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113 ± 6 % but these changes were not associated with any significant change in left 
ventricular end-diastolic dimension which remained at 101.9 ± 0.7 %. Both left ventricular 
systolic pressure and cardiac output at the end of stage II were significantly different from 
those at the end of stage I (p < 0.01 and 0.02 respectively). These changes during phase II 
suggested that there was a slow increase in inotropy. This slow response to a step change in 
pre-load is better demonstrated in Figure 5.4 which was modified from Figure 5.3 with the 
peak systolic pressure and end-systolic dimension amplified to show the slow increase in 
inotropy with time. There was an average increase in peak systolic pressure of 2.9 ± 0.6 
mmHg and cardiac output of 5.3 ± 2.4 ml.min-1 during phase II. The data are graphically 
represented in Figure 5.5. 
There was no significant change in the coronary flow as measured by the negative flow in 
the ultrasonic flow probe over time after the step increase in pre-load. The mean coronary 
flow was 68.1 ± 1.7 ml.min-1 at a pre-load of lOcmH20 (8 mmHg) and 68.0 ± 1.7 ml.min-! 
at the end of phase II (p = NS). This suggests that coronary flow was not altered by a 
change in cardiac output as a result of change in pre-load. Previous work on this working 
heart set-up by Dr. Maurice Pye (1992) had suggested that the coronary arteries in the 
isolated heart were maximally vasodilated under these conditions. Coronary flow was thus 
not critically dependent on coronary vascular tone. Since coronary flow occurred 
predominantly during diastole and after-load was maintained at a constant level of 75 
cmH20 (55 mmHg) above the level of the aorta, coronary flow would be constant and 
would not be altered by changes in cardiac output as a result of changes in pre-load. The 
absence of change in coronary flow with an increase in pre-load further verified that the 
changes observed in systolic pressure and cardiac output were truly due to an increase in 
inotropy and not due to a change in coronary flow. Increase in coronary flow could cause an 
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increase in cardiac output and systolic pressure as a result of the garden-hose effect. The 
results showed that the slow response was not due to such an effect. 
With the coronary flow staying constant throughout the time course after the increase in 
pre-load, the changes in mean aortic flow reflected changes in the total cardiac output. As 
mentioned earlier, since the electronic mean produced by the Transonic flow-meter 
correlated well with the mean aortic flow, this was monitored over time and used to reflect 
changes in total cardiac output after step increases in pre-load in the following experiments 
examining the Frank-Starling relationship. 
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Figure 5.3 Effect of step change in pre-load on cardiac dimension (Dimension), 
cardiac output (Flow) and intraventricular pressure (Pressure) over time in the 
isolated ejecting working heart. Arrows show the point when pre-load was increased 
from a level of 10 cmH20 (8 mmHg) to 15 cmH20 (11 mmHg). Phases I and II arc 
shown as marked (see text). 
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Table 5.2 Response of haemodynamic parameters to step increase in pre-load in 5 
normal rabbit hearts in the working heart configuration. 
(%) 
After-load was kept at 75 cmH20 (55 mmHg) with right atrial pacing at a cycle 
length of 300 ms. Changes in the individual parameters are shown as percentage 
(%) relative to the baseline value at 10 cmH20. (C.O. = cardiac output, SysP = 
peak left ventricular systolic pressure, EDD = end-diastolic dimension, ESD = 
end-systolic dimension, LVEDP = left ventricular end-diastolic pressure) 
Preload 
10cmHp 
202±8 
Immediate change 
10 to 15 cmH20 
230±6 
lIS ± 5 
End of pbase r End ofpbase II 
221 ± 8 226 ±6 
IlO±7 113±6 
SysP (mmHg) 93 ± 5 100 ± 6 94 ±6 97± 6 
(%) 107± 3 lO2±3 105±3 
EDD (mm) 18.8 ± 1.0 19.1 ± 1.0 19.2 ± 1.0 19.2±1.0 
(%) 101.8 ± 0.8 I01.9±0.8 101.9 ± 0.7 
ESD(mm) 17.9 ± 0.9 18.0 ± 0.9 18.2 ± 0.9 18.2 ± 0.9 
(%) 100.9 ± 0.3 101.8 ± 0.6 101.7 ± 0.6 
L VEDP (mmHg) 5.7 ± 1.7 10.2 ± 1.6 10.5 ± 2.1 9.5 ± 1.6 
(%) 155 ± 13 156 ± 12 147 ± 13 
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Figure 5.4 Modification of Figure 5.3 showing the effect of step change in pre-load 
on end-systolic dimension and peak systolic pressure over time in the isolated ejecting 
working heart. Broken white lines are drawn at the level of both parameters after 
equilibration during phase I (see text), further illustrating the slow response during 
phase II (see text) with an increase in peak systolic pressure and decrease in end-
systolic dimension with time. 
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Figure 5.5 Graphical representation of the changes in left ventricular systolic 
pressure (SysP), end-diastolic pressure (EDP) and cardiac output in response to a step 
increase in pre-load from 10 cmH10 (8 mmHg) [marked "Pre" with arrowl to 15 
cmH10 (11 mmHg) over time in 5 normal stock rabbit hearts in the working heart 
configuration. 
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Frank-Starling mechanism 
The inotropic response of the 5 normal hearts on the working heart configuration was 
further studied by examining the form of the Frank-Starling relationship. The parameters 
were measured at steady state after a IS min equilibration period at each pre-load level and 
the results are summarised in Table 5.3 and in Figure 5.6. There was an increase in peak left 
ventricular systolic pressure and aortic flow on increasing the pre-load from 10 to IS 
cmH20 (Le. 8 to 11 mmHg) and then from 15 to 20 cmH20 (Le. 11 to 15 mmHg) with 
appropriate increases in left ventricular end-diastolic pressure, as would be expected by the 
Frank-Starling relationship. The increase in end-diastolic pressure in each of the 2 increases 
in pre-load was about 4 mmHg (equivalent to 5.4 cmH20) which was close to the 5 cmH20 
step change. However, on increasing pre-load from 20 to 25 cmH20 (Le. 15 to 18 mmHg), 
there was a much smaller increase in end-diastolic pressure (about 2 mmHg) and there was 
a decrease in systolic pressure and aortic flow instead. Lactate levels were collected from 
the coronary effluent at the end of each load-change for all the experiments but did not 
show any increase at high pre-loads, suggesting against the possibility that the decrease in 
systolic pressure and aortic flow was due to hypoxia. This apparent descending limb of the 
Frank-Starling curve may be due to the limitations of this working heart set-up, which will 
be considered in detail below in the Discussion section. 
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Table 5.3 Frank-Starling relationship in 5 isolated normal rabbit hearts in the 
working heart configuration. 
After-load was kept at 75 cmH20 (55 mmHg) with right atrial pacing at a cycle 
length of 300 ms. (Flow = aortic flow, SysP = peak left ventricular systolic 
pressure, LVEDP = left ventricular end-diastolic pressure) 
Preload (cmH2O) 
__ ". ____ ... ____ " .. __ • ____ .... M. ______ ._._ ... _ ... _ ............... __ " .... M •• _ ... "' ... 
10 15 20 25 
Flow (ml.min-I) 107 ± 14 133 ± 11 138 ± 12 133±17 
SysP(mmHg) 93 ±S 97±6 99±6 97± 8 
L VEDP (mmHg) 5.7 ± 1.7 9.5 ± 1.6 12.9 ± 1.1 14.7 ± 0.4 
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Figure 5.6 Graphical representation of the Frank-Starling relationship in S normal 
stock rabbit hearts in the working heart configuration with changes in left ventricular 
systolic pressure (SysP), end-diastolic pressure (EDP) and aortic flow in response to 
increases in pre-load from 10 cmH20 (8 mmHg) to 2S cmH20 (18 mmHg) in S cmH20 
steps. 
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Discussion 
The working heart configuration allowed the mechanical performance of the heart to be 
studied in vitro with the isolated heart functioning in a similar way as it would do in vivo. 
The loading conditions could be controlled and the heart could be studied without the 
influence of biological factors like autonomic nervous system and hormonal influence 
which may be difficult to control in vivo. Changes in left ventricular pressure, cardiac 
output and cardiac dimensions during the cardiac cycle could be measured. 
It was shown that a slow response to a step increase in pre-load was present in normal rabbit 
hearts. The increase in pre-load from 10 to 15 cmH20 (Le. 8 to 11 mmHg) produced a rise 
in left ventricular end-diastolic pressure from 5.7 to 9.5 mmHg which is within a 
physiological range. Although the magnitude of slow response was small (about 2 % 
increase in systolic pressure and cardiac output), the effect was evident and significant. The 
step increase in pre-load produced an increase in end-diastolic left ventricular dimension of 
about 2 % as opposed to an 8 to 10 % length change used in studies on papillary muscle 
strips which produced a much larger slow response (Parmley and Chuck, 1973; Lakatta and 
Jewell, 1977; Allen and Kurihara, 1982). 
An ascending limb of the Frank-Starling curve was produced by step increases in pre-load 
in the normal hearts showing the normal inotropic response to increased end-diastolic 
pressure / volume. At a high pre-load level (25 cmH20), an apparent descending limb was 
observed. This might have been a real effect or an artefact due to the working heart set-up. 
The pericardium had been removed from the isolated hearts prior to mounting onto the 
working heart apparatus and the apparent descending limb is unlikely to be due to 
inadequate ventricular filling as a result of pericardial constriction. A mean left ventricular 
end-diastolic pressure of 14.7 mmHg at 25 cmH20 (18 mmHg) pre-load, which is not 
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particularly high, suggested against a true descending limb. As mentioned above, this level 
of end-diastolic pressure was lower than would be expected for the level of pre-load. It was 
quite often observed in these experiments that at high pre-load levels, the left atrium of the 
working heart was significantly dilated or "ballooned". With the hearts being paced at a 
constant cycle length which was relatively fast, it would appear that left ventricular filling 
might not have been complete at high pre-load levels. This would cause left atrial dilatation 
and a left ventricular end-diastolic pressure which was lower than would be expected from 
the level of pre-load. The decrease in systolic pressure and aortic flow at high pre-load level 
is more difficult to explain. One possibility may be that the metabolic demands at high pre-
load and hence high workload outweighed the supply to the ejecting working heart. 
Oxygenation and coronary flow in the set-up could have been insufficient for the working 
heart at high pre-load levels. However, lactate levels measured from the coronary effluent 
collected at each pre-load change for all 5 experiments did not show any significant increase 
even at high pre-load levels. This suggested against the possibility that ischaemia or 
hypoxia was the cause for the apparent descending limb. Another possibility may be that at 
high pre-load levels, the hearts were dilated to the extent that mitral regurgitation occurred 
as a result of stretch of the valve annulus. This would cause part of the cardiac output to be 
pumped back into the left atrium during systole, causing left atrial dilatation (which was 
observed at high pre-load levels) and decrease in left ventricular systolic pressure and aortic 
flow. 
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RABBITS WITH HEART FAILURE 
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Introduction 
Increased heart size, elevated ventricular filling pressure and low cardiac output have been 
well-recognised hallmarks of the syndrome of heart failure for a long time. Hope (1832) 
was the first to put forward the concept of "backward failure" in which the overworked 
ventricle hypertrophies and then dilates. With the development of technology to measure 
ventricular pressures, it was found that end-diastolic pressure was raised in the failing heart 
chamber (Wiggers, 1952) and an elevated ventricular end-diastolic pressure was taken to 
signify the presence of heart failure (Braunwald and Ross, 1963). Mackenzie (1913), 
however, proposed the theory of "forward failure" and stated that the impairment of the 
blood supply from a failing heart was the main feature in heart failure. With the Law of the 
heart (Starling, 1918) came the awareness of the length-tension relationship or pressure-
volume relationship in the heart. Experiments by Spann et al. (1972) showed that contractile 
performance was depressed in failing cat ventricles with decreased peak developed tension 
and velocity of contraction under the same loading conditions as normal hearts. The main 
haemodynamic sequelae in the syndrome of heart failure were regarded to be the result of 
systolic dysfunction in the pump leading to poor cardiac output and raised filling pressure. 
More recently, Grossman et al. (1979) introduced the concept of diastolic dysfunction in 
heart failure. It was shown that in many patients with heart failure, the rate of ventricular 
relaxation was significantly decreased in failing hearts with decreased rate of ventricular 
pressure decline. Left ventricular diastolic distensibility or compliance was also decreased 
in failing hearts. This would fit with the pathophysiological observation that there was 
significant hypertrophy in the chronically overloaded failing heart. Hypertrophy in the heart 
itself would cause impaired relaxation and chamber stiffness. Additional factors involved in 
the structural remodelling and biochemical changes in the myocardium would contribute to 
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the abnormal diastolic function of the failing heart. Some patients may have symptoms of 
heart failure in the absence of abnormal systolic function (Dougherty et al. 1984) as a result 
of diastolic dysfunction. This has been termed diastolic heart failure and the importance of 
differentiating systolic from diastolic heart failure has been emphasised as the approach to 
therapy is different (Goldsmith and Dick, 1993). However, the majority of patients with 
chronic heart failure have systolic dysfunction with reduced pump efficiency, and diastolic 
dysfunction can also be demonstrated in many of them. 
As mentioned in Chapter 1, the depressed contractile performance of the failing heart is 
attributable to many factors ranging from intrinsic myocyte abnormality to geometrical 
inefficiency due to structural remodelling (Figueredo and Camacho, 1995; Wagoner and 
Walsh, 1996). Some of the mechanisms by which a normal heart can improve performance 
have been found to be impaired in the failing heart. Down regulation of p-adrenoceptors, as 
a result of chronic sympathetic over-activity, leads to blunted catecholamine responsiveness 
in the failing heart (Bristow et al. 1982). The ability of the myocardium or myocyte to 
improve contraction with stimulation rate via the force-frequency relationship (the 
Bowditch effect) is also impaired (Mulieri et al. 1992; Davies et al. 1995). There is, 
however, debate as to whether the Frank-Starling relationship is intact in the failing heart. 
Schwinger et al. (1994) reported that there was no increase in the force of contraction in 
skinned-fibre preparations of left ventricular papillary muscle strips from human failing 
hearts when stretched to 150 % of the resting length and Ca2+ sensitivity of the skinned 
fibres was insensitive to stretching. On the other hand, Holubarsch et al. (1996) examined 
the Frank-Starling mechanism in excised human whole left ventricles, isolated left 
ventricular muscle strips and skinned fibre preparations and found that it was well-
preserved in failing hearts but diastolic compliance was reduced. In chronic heart failure, 
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left ventricular dilatation and hypertrophy occur leading to a shift of the pressure-volume 
curve to the right and upwards (LeJemtel and Sonnenblick, 1993). The equilibrium volume 
is increased and chamber compliance is reduced. These may alter the Frank-Starling 
relationship in failing hearts but the mechanism may not be completely absent. As discussed 
in Chapter 5, there are slow changes following an immediate increase in inotropy in 
response to a step increase in pre-load or muscle length in the whole heart or myocardial 
tissue. This has not been investigated in the failing heart or failing myocardial tissue and its 
relevance in the Frank-Starling relationship in heart failure is unknoWn. 
In this Chapter, mechanical performance of the isolated heart from rabbits with heart failure 
was examined. Firstly, performance in the working heart configuration was studied in 
similar ways to those described in Chapter 5 for normal stock hearts. Secondly, the in vitro 
performance of these hearts in the working heart configuration was correlated with in vivo 
echocardiographic measurements. Thirdly, the performance of isolated hearts in the 
Langendorff mode, which was used for experiments on Ca2+ transient and Monophasic 
Action Potential measurements described in subsequent Chapters, was studied and 
correlated with in vivo measurements. 
Methods 
Cardiac performance of failing hearts in working heart configuration 
The mechanical performance of the hearts from rabbits with heart failure was studied in 
vitro using the working heart configuration. The hearts (n = 8) were isolated from rabbits 8 
weeks after the initial coronary artery ligation procedure as described in Chapter 3. Sham-
operated animals (n = 8) were used as controls. The hearts were studied on the working 
heart set-up, paced at a cycle length of 300 ms via the right atrium. After-load was kept at a 
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level of 75 cmH20 (55 mmHg) above the level of the aorta. Baseline parameters at a pre-
load level of 10 cmH20 (8 rnmHg) of the failing hearts and controls were compared. 
Changes during the different phases of the cardiac cycle were also analysed and compared. 
The effect of a step increase in pre-load from 10 to 15 cmH20 (i.e. 8 to 11 mmHg) was 
observed in the 2 groups to investigate the slow response as mentioned in Chapter 5. The 
Frank-Starling relationship in the heart failure group was also compared with that in 
controls by increasing the level of pre-load from 10 to 25 cmH20 (i.e. 8 to 18 mmHg) in 5 
. cmH20 steps. 
At the end of the working heart experiments, a modified Tyrode's solution containing 10 
mM K+ was used for perfusion in the Langendorff mode to inhibit cardiac contraction. The 
heart was relaxed and a latex balloon was inserted via the left atrium into the left ventricle 
to measure passive compliance. The latex balloon was connected via a 6F cannula to a 
water-filled syringe and a pressure transducer. Incremental 0.5 ml boluses of water were 
injected into the balloon whilst monitoring the pressure inside the balloon which 
represented the intraventricular pressure. The volume of the balloon used was about 5 ml 
when fully filled (but not stretched). This volume was chosen so that it was greater than the 
maximum expanded volume of the left ventricle in either group of hearts; there would be no 
tension generated by the balloon itself with the volume increments and the pressure 
measured would reflect intraventricular pressure alone. These results were used to describe 
the static pressure-volume relationship of the left ventricle. 
Correlation between in vitro working heart performance and in vivo 
echocardiographic measurements in heart failure 
In vivo cardiac performance was assessed in all the experimental animals 1 week prior to 
sacrifice as described in Chapters 3 and 4. Ejection fraction (EF) as measured on 
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echocardiography was used as an indicator of systolic function in vivo and this was 
correlated with in vitro parameters of contractile perfonnance, namely left ventricular 
systolic pressure and cardiac output in both experimental groups under baseline working 
heart conditions (pre-load of 10 cmH20 [8 mmHg] and after-load of75 cmH20 [55 mmHg]) 
at 37°C with right atrial pacing at 300 ms cycle length. 
Cardiac performance of Langendorff perfused hearts from rabbits with heart failure 
and correlation with in vivo measurements 
Subsequent Chapters will describe experiments measuring Ca2+ transients and Monophasic 
Action Potentials (MAPs) in isolated rabbit hearts from both the heart failure and sham-
operated groups. In these experiments, the isolated hearts were perfused in the Langendorff 
mode and a latex balloon was inserted into the left ventricle to monitor intraventricular 
pressure. Water was injected into the balloon to alter the volume thereby adjusting the end-
diastolic pressure to zero at the beginning of the experiments. This would standardise the 
loading conditions in both experimental groups and allow the comparison and analysis of in 
vitro cardiac perfonnance. The pressure profiles of 17 hearts from the heart failure group 
and 13 from the sham-operated group were analysed during right atrial pacing at 350 ms. 
This was then correlated with in vivo cardiac performance as measured by the ejection 
fraction on echocardiography. With Langendorff perfusion, it was found that the intrinsic 
cycle length of the beating heart was longer (and heart rate slower) than in the working 
heart configuration (380 to 400 ms vs. 330 to 350 ms - see "Methods" section in Chapter 
5). The slightly slower pacing rate with a cycle length of 350 ms (Le. about 170 beats.min- I ) 
was still close to the physiological heart rate of the rabbit (around 180 to 200 beats.min-1 in 
vivo) and still ensured a constant, paced rhythm during the experiments but allowed the time 
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course of the Ca2+ transients and MAP signals to be better analysed with greater resolution 
(see subsequent Chapters). 
Results 
Cardiac performance of failing hearts in working heart configuration 
Baseline haemodynamic parameters in heart failure 
The results of the baseline haemodynamic parameters measured on the working heart set-up 
in hearts from the heart failure group and controls are summarised in Table 6.1. At a 
baseline pre-load of 10 cmH20, left ventricular end-diastolic pressure was significantly 
higher (15.7 ± 1.0 vs. lOA ± 1.7 mmHg, p < 0.02) and left ventricular systolic pressure 
(87.1 ± 2.8 vs. 96.4 ± 2.8 mmHg, p < 0.05) and total cardiac output (175 ± 10 vs. 212 ± 7 
mmHg, p < 0.05) significantly lower in the heart failure group when compared to controls. 
There was no significant difference in coronary flow, as measured by the negative flow in 
the ultrasonic flow probe, between the two groups (75 ± 3 vs. 75 ± 3 ml.min- I , p = NS). This 
suggested that the coronary vascular tone was not significantly different on the working 
heart set-up in the 2 groups and that the difference observed in the haemodynamic 
parameters could not be explained by a difference in coronary arterial perfusion. 
Cardiac dimensions measured with the sonomicrometer crystals during diastole and systole 
were increased in the heart failure group when compared to controls (Table 6.1), in 
agreement with the echocardiographic findings in vivo and the tissue weights as mentioned 
in Chapter 4. 
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Table 6.1 Comparison of baseline haemodynamic parameters measured in the 
isolated ejecting working heart between rabbits with heart failure (HF) and 
controls (Sham). 
Measurements were made at a pre-load 10 cmH20 (8 mmHg) and after-load of 
75 cmH20 (55 mmHg) with right atrial pacing at a cycle length of 300 ms. 
(LVEDP = left ventricular end-diastolic pressure, SysP = left ventricular peak 
systolic pressure, C.O. = total cardiac output, EDD = end-diastolic dimension, 
ESD = end-systolic dimension) 
HF (n = 8) Sham (n = 8) P value 
LVEDP (mmHg) , 15.7 ± 1.0 10.4 ± 1.7 <0.02 
SysP (mmHg) 87.1 ± 2.8 96.4 ± 2.8 <0.05 
C.O. (ml.min·l) 175 ± 10 212±7 <0.05 
Coronary flow (ml.min·l) 75 ±3 75 ±3 NS 
EDD(mm) 22.0 ± 0.9 19.3±1.0 < 0.05 
ESD(mm) 20.6 ± 0.8 18.1 ± 1.0 <0.05 
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Baseline haemodynamic parameters in sham-operated group and normal stock hearts 
Most of the baseline haemodynamic parameters measured in the 8 hearts from the sham-
operated group at a pre-load of 10 cmH20 (8 mmHg) and after-load of 75 cmH20 (55 
mmHg) with right atrial pacing at 300 ms were comparable to those measured in the 5 
nonnal stock hearts described in Chapter 5 (Table 6.1 and Table 5.2). The peak left 
ventricular systolic pressure, cardiac output, end-diastolic dimension and end-systolic 
dimension were similar (p = NS). However, the left ventricular end-diastolic pressure was 
significantly higher in the sham-operated group when compared to normal stock hearts 
(10.4 ± 1.7 vs. 5.7 ± 1.7 mmHg, p < 0.05). 
Changes during the phases of the cardiac cycle 
The difference between the heart failure group and sham-operated group was also analysed 
by examining the changes during the different phases of the cardiac cycle. The 
intraventricular pressure signals were averaged in the 8 hearts in each group and compared. 
The 2 averaged traces are shown in Figure 6.1. It is evident that the mean left ventricular 
peak systolic pressure was lower and the mean left ventricular end-diastolic pressure higher 
in failing hearts than in controls. The data on the different phases of the cardiac cycle are 
summarised in Table 6.2. The parameters obtained from the 8 sham-operated hearts were 
comparable to those from the 5 stock rabbit hearts described in Chapter 5 (cf. Table 5.1). 
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Figure 6.1 Averaged tracings of left ventricular pressure in 8 hearts from the heart 
failure group (HF - red solid line) and 8 control hearts (Sham - blue solid line) in the 
working heart configuration, paced via the right atrium at 300 ms cycle length, at a 
baseline pre-load level of 10 cmH20 (8 mmHg) and after-load level of 75 cmH20 (55 
mmHg) - both marked with horizontal solid lines. Vertical broken lines represent the 
timing of (a) the beginning of systole, (b) aortic valve opening , (c) aortic valve closure 
and (d) mitral valve opening. Isovolumic contraction phase is represented by the 
interval (a - b), ejection phase by interval (b - c), isovolumic relaxation phase by (c - d) 
and ventricular filling phase by (d - a). 
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Table 6.2 Comparison of different phases of the cardiac cycle in the isolated ejecting 
working heart between rabbits with heart failure (HF) and controls (Sham) 
under baseline conditions. 
Measurements were made at a pre-load 10 cmH20 (8 mmHg) and after-load of 
75 cmH20 (55 mmHg) with right atrial pacing at a cycle length of 300 ms. 
(IVeT = isovolumic contraction time, dP.dr\max) = maximum rate of change of 
pressure, A V = aortic valve, MV = mitral valve, IVRT = isovolumic relaxation 
time) 
HF (n = 8) Sham (n = 8) p value 
Isovolumic Contraction Phase 
IVCT(ms) 31.6 ± 1.6 31.3 ± 2.3 NS 
1.99 ± 0.10 2.34 ± 0.14 <0.05 
Ejection Phase 
Ejection time (ms) 148.7 ± 5.9 153.7 ± 4.2 NS 
+ dP.dr\mlX) (mmHg.ms·J) 1.40±0.10 2.09±0.13 < 0.002 
_ dP.drl(mlX) (mmHg.ms·J) 1.43 ± 0.08 1.70 ± 0.06 <0.02 
Isovolumic Relaxation Phase 
AV closure time (ms) 180.2 ±4.8 185.0 ± 3.0 NS 
MY opening time (ms) 241.0 ± 7.9 228.4 ± 3.5 NS 
IVRT(ms) 60.7 ±3.8 43.3 ± 1.2 < 0.001 
_ dP.dr\mlX) (mmHg.ms·J) 1.44 ± 0.08 l.70 ± 0.06 < 0.02 
133 
Chapter 6 Cardiac performance of the failing heart 
Isovolumic contraction phase 
After ventricular filling, the sharp rise in left ventricular pressure marks the beginning of the 
isovolumic contraction phase. This phase ends with the opening of the aortic valve when 
intraventricular pressure exceeds the after-load. The working heart experiments were carried 
out under a constant after-load of75 cmH20 (55 mmHg). The isovolumic contraction phase 
was the time for the intraventricular pressure to reach that level after its initial sharp rise. 
When this phase was analysed in the 2 experimental groups, it was found that there was no 
difference in the time taken to reach an after-load of 55 mmHg. The isovolumic contraction 
time was 31.6 ± 1.6 ms in the heart failure group and 31.3 ± 2.3 ms in controls (p = NS). 
However, during this phase the maximum rate of pressure rise was decreased in the heart 
failure group when compared to controls (1.99 ± 0.10 vs. 2.34 ± 0.14 mmHg.ms·\, p < 0.05). 
Ejection phase 
When the left ventricular pressure exceeded the after-load of 55mmHg, the aortic valve 
opened and the ejection phase began. The maximum rate of pressure rise during this 
ejection phase was decreased in the heart failure group (l.40 ± 0.1 0 vs. 2.09 ± 0.13 
mmHg.ms·\, p < 0.002), reaching a lower peak systolic pressure than the control group as 
mentioned above. This, together with the abnormality during isovolumic contraction, 
suggested significant abnormal mechanical function of the failing hearts during systole. 
The maximum rate of pressure decline during the ejection phase was also decreased in the 
heart failure group when compared to controls (1.43 ± 0.08 vs. 1.70 ± 0.06 mmHg.ms·\, p < 
0.02). When the left ventricular pressure dropped below the after-load level of 55 mmHg, 
the aortic valve closed and this marked the end of the ejection phase. The total duration of 
the ejection phase was slightly shorter in the heart failure group (148.7 ± 5.9 vs. 153.7 ± 4.2 
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ms) but this did not reach statistical significance as the time of aortic valve closure was only 
slightly earlier in the heart failure group when compared to controls (180.2 ± 4.8 vs. 185.0 ± 
2.0 ms from the beginning of systole); this difference being again non-significant. 
Isovolumic relaxation phase 
The interval between aortic valve closure and mitral valve opening during the cardiac cycle 
is termed the isovolumic relaxation phase. In the working heart set-up, it was the time taken 
for the left ventricular pressure to fall from the after-load level of 55 nunHg (when the 
aortic valve closed) to the pre-load load of 8 mmHg (when the mitral valve opened). As 
mentioned above, the time of aortic valve closure was only slightly earlier in the heart 
failure group than controls. The time of mitral valve opening was slightly later in the heart 
failure group (241.0 ± 7.9 vs. 228.4 ± 3.5 ms from the beginning of systole) although this 
difference did not reach statistical significance. The interval between those two timings, i.e. 
the isovolumic relaxation time, was significant longer in the heart failure group when 
compared to controls (60.7 ± 3.8 vs. 43.3 ± 1.2 ms, p < 0.001) (see Figure 6.2). In addition, 
the maximum rate of pressure decay during this phase was significant lower in the heart 
failure group (1.44 ± 0.08 vs. 1.70 ± 0.06 mmHg.ms·1, p < 0.02). This suggested that there 
was significant diastolic abnormality in the failing hearts. 
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Figure 6.2 Modification of Figure 6.1 with the period during diastole expanded to 
show the isovolumic relaxation time in the heart failure (HF) group (interval marked 
by magenta lines) and in the control (Sham) group (interval marked by green lines). 
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Ventricular filling 
Left ventricular filling starts at the end of the isovolumic relaxation phase when the mitral 
valve opens. In the working heart set-up, the left ventricle started to fill when the left 
ventricular pressure fell below the pre-load level of 8 mmHg. The end of the filling phase 
was marked by the beginning of systole with the next cardiac cycle. In the heart failure 
group, ventricular filling, i.e. opening of the mitral valve, started slightly later than in 
controls (see above) although this difference was not significant. The ventricular filling 
period was slightly shorter in the heart failure group (67.2 ± 5.2 vs. 75.2 ± 3.7 ms) but again 
this difference was not significant. Despite the shorter filling time, the left ventricular 
pressure rose to a higher end-diastolic pressure in the heart failure group than in controls. 
This suggests that in addition to a relaxation abnormality, the failing hearts may have a 
reduced compliance which impaired ventricular filling during diastole. This possibility was 
investigated as described below. 
Passive compliance in the isolated heart 
The pressure-volume relationship in the K+ -arrested heart was studied with a latex balloon. 
When 0.5 ml boluses of water were injected into the balloon, there was a point (Vo) where 
pressure started to rise in an exponential manner. The pressure-volume data could be fitted 
to an exponential function with the equation: Pressure = A * (Volume) k where A and k are 
constants and Volume represents the volume above Yo' The mean values of A and k for the 
8 hearts in the heart failure group and 5 hearts in the control group are shown in Table 6.3. 
Sample data from one experiment from each group and the representative exponential 
curves for the mean values in both groups are shown in Figure 6.3. This showed that for a 
same level of pressure rise, there was a smaller increase in volume in the heart failure group 
137 
Chapter 6 Cardiac performance of the failing heart 
than in the sham-operated group indicating that failing hearts had a reduced compliance or 
increased stiffness when compared to controls. 
138 
Chapter 6 Cardiac performance of the failing heart 
Table 6.3 Comparison of left ventricular passive compliance between 8 failing hearts 
(HF) and 5 controls (Sham). 
A 
k 
Passive compliance was described by the Pressure - Volume relationship, 
Pressure = A * (Volume) k (see text). 
HF (n = 8) Sham (n = 5) p value 
22.2 ±4.0 2.1 ± 0.3 <0.005 
1.3 ± 0.1 2.5 ± 0.3 < 0.002 
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Figure 6.3 Comparison of passive compliance in IC arrested hearts as measured by 
the pressure - volume relationship (see text) between the heart failure group (shown in 
red, n = 8) and controls (shown in blue, n = 5). Dotted lines represent standard errors. 
Sample data from one failing heart (A ) and one control (e ) are shown. 
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Slow response to step increase in pre-load 
The effect of a step increase in pre-load from 10 to 15 cmH20 (Le. 8 to 11 mmHg) above 
the level of the aorta was examined over time in both the heart failure group and sham-
operated controls in the same way as described in Chapter 5 for stock hearts. The results are 
summarised in Table 6.4 and illustrated in Figure 6.4. All the haemodynamic parameters 
(cardiac output, left ventricular systolic and end-diastolic pressure) increased immediately 
as the pre-load was increased. This was followed by a decrease in these parameters to 
equilibrate at a level towards the end of phase lover 1.6 ± 0.3 min in the heart failure group 
and over 1.5 ± 0.2 min in controls (p = NS). Over the next 5.7 ± 0.5 min in the heart failure 
group and 5.6 ± OJ min in controls (p = NS), cardiac output and left ventricular systolic 
pressure increased over time to reach a steady state at the end of phase II. The left 
ventricular end-diastolic pressure stayed at the same level over the course of phase II in the 
heart failure group but decreased over time in controls. 
Coronary flow in the heart failure group at the end of phase II was 74 ± 3 ml.min·1 as 
compared to 75 ± 3 ml.min·1 prior to the step increase (p = NS). Similarly, there was again 
no significant difference in coronary flow as a result of the pre-load increase in the control 
group (74 ± 4 m1.min-1 after the load change as compared to 75 ± 3 ml.min·1 before, p = 
NS). 
The end-diastolic and end-systolic dimensions in both groups followed a similar pattern of 
change over time in response to the step increase in pre-load as the stock hearts described in 
Chapter 5. There was an initial increase in both parameters immediately following the pre-
load increase. End-diastolic dimension stayed the same throughout phase I and II in both 
experimental groups. There was a further increase in end-systolic dimensions in both groups 
during the course of phase I followed by a small decrease over the course of phase II. 
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There was an increase in left ventricular pressure by 3.5 ± 0.7 mmHg (p < 0.02) and cardiac 
output by 5.0 ± 0.9 m1.min-t (p < 0.005) during phase II in the sham-operated hearts with 
these 2 parameters at the end of stage II being significantly different from those at the end 
of stage I. These changes were similar to those observed in normal stock hearts and 
represent slow increase in inotropy. In the heart failure group, there was a mean change in 
left ventricular pressure of 0.4 ± 0.2 mmHg and that in cardiac output of 1.3 ± 0.7 ml.min-1 
during phase II. These values at the end of stage II were not significantly different from 
those at the end of stage I and suggest that the slow increase in inotropy was either small or 
non-existent. The slow increases in left ventricular pressure and cardiac output observed in 
sham-operated controls were significantly different from the change in the 2 parameters in 
failing hearts during phase II (p < 0.05 and p < 0.01 respectively). 
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Table 6.4 Response of haemodynamic parameters to step increase in pre-load in 8 
hearts in the heart failure group (HF) and 8 controls (Sham) in the working 
heart configuration. 
After-load was kept at 75 cmH20 (55 mmHg) with right atrial pacing at a cycle 
length of 300 ms. (C.O. = cardiac output, SysP = peak left ventricular systolic 
pressure, EDD = end-diastolic dimension, ESD = end-systolic dimension, 
LVEDP = left ventricular end-diastolic pressure) 
Pre-load Immediate change End of phase I End of phase II 
10cmH2O 10 to 15 cmH20 
C.O. (ml.min-
'
) 
HF 175 ± 10 183 ± 10 171 ± 10 172 ± 10 
Sham 212 ±7 227± 6 211 ± 6 215 ± 6 
SysP (mmHg) 
HF 87± 5 90 ±6 85 ±6 86 ±6 
Sham 96 ± 3 103 ± 3 95 ± 3 98 ±2 
EDD(mm) 
HF 22.0 ± 0.9 22.1 ± 1.0 22.1 ± 1.0 22.1 ± 1.0 
Sham 19.3 ± 1.0 19.5 ± 1.0 19.5±1.0 19.5 ± 1.0 
ESD(mm) 
HF 20.6 ± 0.8 20.7 ± 0.8 20.8 ± 0.8 20.7 ± 0.8 
Sham 18.1 ± 1.0 18.2 ± 1.0 18.4 ± 1.0 18.3±1.0 
L VEDP (mmHg) 
HF 15.7 ± 1.0 19.3 ± 0.9 18.8±1.0 18.8 ± 1.0 
Sham 10.4 ± 1.7 14.6 ± 2.1 14.1 ± 1.9 13.8 ± 2.0 
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Graphical representation of the changes in left ventricular systolic 
pressure (SysP), end-diastolic pressure (EDP) and cardiac output in response to a step 
increase in pre-load from 10 cmHzO (8 mmHg) [marked "Pre" with arrow] to 15 
cmHzO (11 mmHg) over time in 8 hearts from the heart failure group (data in closed 
symbols) and 8 from the sham-operated group (data in open symbols) in the working 
heart configuration. 
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Frank-Starling relationship 
The inotropic response of the isolated working hearts in the heart failure group and controls 
were examined further by studying the Frank-Starling relationship on increasing the pre-
load from 10 cmH20 (8 mmHg) to 25 cmH20 (18 mmHg) above the level of the aorta in 5 
cmH20 steps. The results are summarised in Table 6.5 and illustrated in Figure 6.5. 
In the sham-operated group, all 8 isolated working hearts were stable when the pre-load was 
increased from 10 through to 20 cmH20 (Le. 8 to 15 mmHg). Significant periods of 
arrhythmia developed in 2 experiments in the sham-operated group when the pre-load was 
increased from 20 to 25 cmH20 (i.e. 15 to 18 mmHg) when the hearts became unstable and 
the experiments had to be terminated. Thus data were available for all 8 control hearts up to 
20 cmH20 (15 mmHg) and for 6 at a pre-load of 25 cmH20 (18 mmHg). In the heart failure 
group, the 8 hearts were stable when the pre-load was increased from 10 to 15 cmHzO. Two 
of the 8 became unstable when the pre-load was increased from 15 to 20 cmH20 (i.e. 11 to 
15 mmHg) and another 2 of the remaining 6 developing ventricular fibrillation when the 
pre-load was increased to 25 cmH20 (18 mmHg). Thus data were available for all 8 failing 
hearts at pre-load 10 and 15 cmH20 (i.e. 8 and 11 mmHg), 6 of the 8 at pre-load 20 cmH20 
(15 mmHg) and 4 at 25 cmH20 (18 mmHg). Lactate levels of the coronary effluent were 
checked at the various pre-load levels in 2 hearts in the heart failure group and 3 in the 
control group which showed no significant change with the pre-load increase. 
End-diastolic pressure in both experimental groups increased with increased pre-load with 
the pressure being higher in the heart failure group at all pre-load levels. As observed in 
nonnal stock hearts on the working heart configuration mentioned in Chapter 5, the increase 
in end-diastolic pressure did not follow a linear relationship with the increase in pre-load 
especially at high pre-load levels. This was observed in both experimental groups. Left 
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ventricular systolic pressure and aortic flow increased when the pre-load was raised from 10 
to 15 cmH20 (Le. 8 to 11 nunHg) and from 15 to 20 cmH20 (Le. 11 to 15 mmHg) in the 
sham-operated group indicating a positive inotropic response to pre-load increase as 
described by an ascending limb of the Frank-Starling relationship. This was not observed in 
the heart failure group. At the equivalent levels of pre-load increase, both haemodynamic 
parameters remained the same suggesting a flattened Frank-Starling curve at these pre-load 
levels. When the pre-load was raised from 20 to 25 cmH20, the left ventricular systolic 
pressure and aortic flow decreased in both experimental groups. 
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Table 6.5 Frank-Starling relationship in isolated hearts from the heart failure group 
(HF, n = 8) and controls (Sham, n = 8) in the working heart configuration. 
HF 
Sham 
SysP (mmHg) 
HF 
Sham 
After-load was kept at 75 cmH20 (55 mmHg) with right atrial pacing at a cycle 
length of 300 ms. (Flow = aortic flow, SysP = peak left ventricular systolic 
pressure, LVEDP = left ventricular end-diastolic pressure) 
Pre-load (cmHzO) 
10 15 20 25 
89±7 87± 6 87 ±6 72 ± I 
128 ±9 138 ± 9 139 ± 10 120 ± 5 
87 ± 5 86 ± 6 87 ± 3 83 ±3 
96 ±3 98 ±2 99 ±2 92±2 
L VEOP (mmHg) 
HF 15.7 ± 1.0 18.8 ± 1.0 20.1 ± 1.0 21.0 ± 1.0 
Sham 10.4 ± 1.7 13.8 ± 2.0 15.9 ± 1.6 16.7 ± 1.7 
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Figure 6.5 Graphical representation of the Frank-Starling relationship in 8 hearts 
from the heart failure group (data in closed symbols) and 8 from the sham-operated 
group (data in open symbols) in the working heart configuration with changes in left 
ventricular systolic pressure (SysP), end-diastolic pressure (EDP) and aortic flow in 
response to increases in pre-load from 10 cmH20 (8 mmHg) to 25 cmH20 (18 mmHg) 
in 5 cmH20 steps. Numbers in brackets shown on the right hand panel for changes in 
aortic flow represent the number of hearts within each group from which data was 
available at each pre-load level where a steady stable state was achieved. 
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Correlation between in vitro working heart performance and in vivo 
echocardiographic measurements in heart failure 
The ejection fraction (EF) measured on echocardiography in the 8 rabbits from the heart 
failure group was significantly lower than that measured in the 8 sham-operated controls 
(46 ± 3 % vs. 67 ± 1 %, p < 0.001). This shows that there was significant contractile 
dysfunction demonstrated in vivo in the heart failure group. Cardiac performance 
measurements in vitro in the working heart configuration were consistent with the in vivo 
findings. Under baseline working heart conditions (pre-load of 10 cmH20 [8 mmHg] and 
after-load of 75 cmH20 [55 mmHg]) at 37°C with right atrial pacing at 300 ms cycle 
length, both left ventricular systolic pressure and cardiac output were significantly lower in 
the heart failure group than in controls (Table 6.1). Figure 6.6 shows that there was a 
significant correlation between in vivo ejection fraction and these 2 in vitro parameters ( r = 
0.50, p < 0.05 for left ventricular systolic pressure and r = 0.62, p < 0.02 for cardiac output). 
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Figure 6.6 Plot of (A) peak systolic left ventricular pressure (SysP) and (B) cardiac 
output (C.O.) measured in vitro in isolated working hearts under baseline loading 
conditions against in vivo ejection fraction (EF) from sham-operated (0) and heart 
failure (e) groups. The solid lines represent linear regression of the pairs of 
parameters with the correlation coefficients (r) and significance values (p) shown in 
the shaded boxes. 
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Cardiac performance of Langendorff perfused hearts from rabbits with heart failure 
and correlation with in vivo measurements 
The left ventricular pressure profiles of 17 Langendorff perfused hearts from the heart 
failure group and 13 from the sham-operated group as measured with the intraventricular 
balloon, adjusted to give zero end-diastolic pressure, were analysed during right atrial 
pacing at 350 ms and the data are summarised in Table 6.6. The peak left ventricular 
systolic pressure was significantly lower in the heart failure group when compared to 
controls (26.2 ± 3.7 mmHg vs. 49.0 ± 2.6 mmHg, p < 0.001). Both the maximum rate of 
pressure rise and the maximum rate of pressure decay were slower in failing hearts. These 
data again showed that there was significant systolic and diastolic dysfunction in the failing 
hearts demonstrated in the Langendorff perfusion mode as in the working heart 
configuration mentioned in previous sections. In vivo cardiac performance was also 
impaired in the failing hearts when compared to controls as shown by the significantly 
lower ejection fraction (41.3 ± 104 % vs. 73.8 ± 1.9 %, P < 0.001). When the in vitro and in 
vivo parameters were considered together, it was shown that left ventricular peak systolic 
pressure was significantly correlated with ejection fraction (r = 0.73, P < 0.001, see Figure 
6.7). 
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Table 6.6 Comparison of in vitro and in vivo cardiac performance parameters 
measured in the isolated Langendorff perfused heart between rabbits with 
heart failure (HF) and controls (Sham). 
SysP (mmHg) 
In vitro measurements were made during right atrial pacing at 350 ms cycle 
length. (SysP = left ventricular peak systolic pressure, dP .dt-\max) = maximum 
rate of pressure change, EF = ejection fraction) 
HF (n = 17) Sham (n = 13) p value 
26.2 ± 3.7 49.0 ±2.6 < 0.001 
+ dP.dr'<mlX) (mmHg.rns·J) 0.50 ±O.OS 0.96 ±0.07 < 0.001 
- dP.dr\max) (mmHg.rns· l ) 0.32 ± 0.04 0.66 ± 0.05 < 0.001 
EF(%) 41.3 ± 1.4 73.8 ± 1.9 < 0.001 
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Figure 6.7 Plot of peak systolic left ventricular pressure (SysP) measured in vitro in 
isolated Langendorff perfused hearts against in vivo ejection fraction (EF) from sham-
operated (0) and heart failure (e) groups. The solid line is a linear regression of the 
two parameters with the correlation coefficient (r) and significance value (p) shown in 
the shaded box. 
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Discussion 
Significant mechanical dysfunction was demonstrated in vitro in the heart failure group 
under baseline working heart conditions. Left ventricular end-diastolic pressure was 
increased and peak systolic pressure and cardiac output were decreased when compared to 
controls. These are similar to changes seen in human heart failure. Coronary flow was not 
different between the heart failure group and controls suggesting that the abnormality in 
baseline haemodynamic parameters in the failing hearts cannot be due to a difference in 
coronary vascular tone. 
The baseline haemodynamic parameters in the sham-operated group were comparable to 
those measured in normal stock hearts described in Chapter 5 apart from a higher left 
ventricular end-diastolic pressure in the sham-operated group. The sham-operated group 
had undergone thoracic surgery with a tie applied to the left ventricular apex, the 
pericardium opened and with the heart manipulated in the same way as the heart failure 
group apart from the coronary artery ligation procedure. This was done so that the changes 
seen in the heart failure group when compared to the sham-operated controls would only be 
subsequent to the effect of coronary artery ligation and the production of the myocardial 
infarct. The higher left ventricular end-diastolic pressure in the sham-operated group when 
compared to the normal stock hearts may be due to the effect of the thoracic surgery 
described or it could be due to a difference in age as the experiments were carried out 8 
weeks after thoracic surgery in the sham-operated group (to be comparable with the 8 weeks 
in the coronary artery ligation group to develop heart failure) whilst those in the normal 
stock rabbits were carried out very close to their arrival from the suppliers. Nevertheless, 
comparison of the haemodynamic parameters between the heart failure and sham-operated 
groups showed that there was significant mechanical dysfunction in the failing hearts. 
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Further scrutiny of the left ventricular pressure demonstrated that the mechanical 
dysfunction in the heart failure group was evident at the various phases of the cardiac cycle 
and that there was significant systolic and diastolic dysfunction. The rate of pressure rise 
was slower during the isovolumic contraction phase and ejection phase when compared to 
controls. Rate of pressure decline was slower during the ejection phase and the isovolumic 
relaxation phase. Isovolumic relaxation time, which is used clinically as a measure of 
diastolic function, was significantly prolonged in the heart failure group. 
Left ventricular diastolic compliance is determined by the level of operating pressure and 
the diastolic pressure-volume relation (Gaasch et al. 1976). The relation is curvilinear and 
chamber stiffness (or its reciprocal, chamber compliance) is described by this relation which 
is best fitted with a power law function (Mirsky, 1984). When the pressure-volume 
relationship was studied with a latex balloon in the K+ -arrested hearts, it was shown that the 
passive compliance was decreased in the failing hearts. The increased stiffness in the failing 
hearts would significantly impair ventricular filling during diastole. This could be the result 
of myocardial and non-myocardial changes. Compensatory hypertrophy of the surviving 
myocardium in response to increased wall stress as a result of the myocardial infarct would 
lead to a reduced compliance (Francis and Chu, 1994). Changes in the extracellular matrix 
with fibrosis would further reduce the compliance of the failing heart. 
A slow response to a step increase in pre-load from 10 to 15 cmHzO (i.e. 8 to 11 mmHg) 
was observed in sham-operated hearts similar to that described in Chapter 5 for normal 
stock hearts. There was a slow increase in cardiac output and left ventricular systolic 
pressure with time during phase II with the end-diastolic dimension remaining constant and 
the left ventricular end-diastolic pressure decreasing during that phase. These changes are 
consistent with a slow increase in inotropy in response to the initial increase in pre-load. 
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This step increase in pre-load from 10 to 15 cmH20 (Le. 8 to 11 mmHg) caused a similar 
rise in left ventricular end-diastolic pressure (about 3 mmHg) in the heart failure group as 
that in sham-operated hearts but produced a much smaller increase in cardiac output and left 
ventricular systolic pressure over time during phase II. The step increase in pre-load 
actually produced a small decrease in these parameters in the heart failure group at 15 
cmHzO (11 mmHg) when compared to a pre-load of 10 cmH20 (8 mmHg). This suggests 
that despite an apparently adequate stimulus with the step increase in pre-load producing a 
corresponding increase in left ventricular end-diastolic pressure, there was a much 
attenuated slow response in the failing hearts. 
When the Frank-Starling relationship was studied in the 2 experimental groups, it was 
shown that the inotropic response to pre-load increase was much attenuated in the failing 
hearts. The peak systolic pressure and aortic flow increased in the control group following 
an ascending limb of the Frank-Starling curve up to a pre-load of 20 cmH20 (15 mmHg) 
whilst these parameters remained relatively constant (or with a small decrease) in the heart 
failure group. When pre-load was increased from 20 to 25 cmH20 (Le. 15 to 18 mmHg), 
both parameters decreased in both experimental groups similar to the response of normal 
stock hearts on the working heart configuration described in Chapter 5. As discussed in 
Chapter 5, this may be due to the relatively fast pacing rate leading to incomplete left 
ventricular filling during diastole, left atrial compliance with left atrial "ballooning" or it 
may be due to mitral regurgitation as a result of annular dilatation. The similar response in 
the sham-operated and heart failure groups at the high pre-load level suggested that the 
blunted Frank-Starling curve observed in failing hearts at a lower pre-load was not due to 
the fact that the failing hearts were dilated or were working at a higher end-diastolic 
pressure implying that they were working at a different part of the same Frank-Starling 
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curve as the sham-operated hearts. Rather, the results suggested that the failing hearts and 
the control hearts were functioning on different Frank-Starling curves due to intrinsic 
differences in their mechanical performance. 
The results on the working heart configuration suggested that the hearts isolated from 
rabbits with heart failure produced by the coronary artery ligation model had significantly 
impaired mechanical performance with systolic and diastolic dysfunction. Passive 
compliance was reduced in the failing hearts and the Frank-Starling relationship was 
attenuated, which may be caused by the lack of a slow response to step increase in pre-load. 
The cellular basis for the slow response is not well understood. It has been suggested that 
the slow response may be mediated via cyclic AMP (Kentish et al. 1992). Down-regulation 
of p-adrenoceptors is a well-recognised feature in human heart failure (Bristow et al. 1982) 
and preliminary data from a rabbit coronary artery ligation model (Maurice et al. 1997) 
have shown decreased ~-adrenoceptor density in failing rabbit hearts. One may speculate 
that the attenuated slow response observed in the failing hearts in the current study may be 
associated with changes in p-adrenoceptor activity which can directly affect cyclic AMP 
activity. 
In vitro measurements in the Langendorff perfused hearts also showed significant systolic 
and diastolic dysfunction in the heart failure group. There was significant correlation 
between in vivo measurements of cardiac performance by echocardiography and in vitro 
parameters in the working heart configuration and with Langendorff perfusion. These 
studies suggest that the in vitro contractile behaviour of the isolated failing heart reflects in 
vivo contractile dysfunction in heart failure. 
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Introduction 
Different methods have been developed in measuring intracellular [Ca2+] in the whole heart 
including the use of bioluminescent dyes, fluorescent indicators and Nuclear Magnetic 
Resonance (NMR) spectroscopy (Bentivegna et al. 1991). The use of the bioluminsecent 
dye, aequorin involves injection into a region of the myocardium and hence Ca2+ transients 
can only be obtained from one localised area (Kihara et al. 1989). NMR spectroscopy has 
the problem of significant buffering and not being able to detect alterations in Ca2+ handling 
on a beat·to·beat basis (Marban et al. 1990). Fluorescent indicators have the advantage of 
ester·loading via perfusion which means that [Ca2+] can theoretically be measured from 
myocardium anywhere in the heart. The ability of fluorescent indicators to measure 
intracellular [Ca2+] depends on its binding with free Ca2+ in the cytosol. Compared to the 
earlier indicators, the second generation dyes have lower affinity and higher quantum yield, 
thus requiring lower concentration of the indicators. Ca2+ -buffering is not a major problem 
and contractile function is not adversely affected. However, loading the preparations using 
the AM ester of the indicator is not without its problems (Table 7.1):-
(a) unhydrolysed AM ester. After getting into the cytosol, the AM ester may not be 
completely cleaved to give the Ca2+-sensitive indicator. The ester is fluorescent, although 
not Ca2+ -sensitive. The presence of unhydrolysed AM ester means that part of the 
fluorescence collected is not due to Ca2+. MnCl2 quenches fluorescence due to the 
hydrolysed Ca2+ -sensitive indicator alone. By perfusing the indicator-loaded heart with 
MnCl2 solution, Brandes et al. (1993b) reported that levels ofunhydrolysed AM ester was 
negligible whilst others (Lee et al. 1988; Field et al. 1994) showed a small but significant 
(11 - 30 %) proportion of the fluorescence was not quenched, indicating presence of 
unhydrolysed AM ester. This discrepancy may be caused by different loading methods or 
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different concentration of indicator used. In the study by Lee et al. (1988), Mn2+-quench 
studies were also performed in tissue homogenates which showed that the majority of the 
unhydrolysed indo-II AM ester was associated with organelles especially mitochondria. 
(b) mitochondrial loading. Once inside the cell, the indicator may go into organelles either 
unhydrolysed, giving Ca2+ -insensitive fluorescence or hydrolysed, giving Ca2+ -sensitive 
fluorescence that is unrelated to cytosolic [Ca2+]. In the study by Lee et al. (1988), tissue 
homogenisation was used, with Mn2+ -quenching, to identify areas of localisation of the 
indicator within the cell. It was shown that 72.2 % of the total Ca2+-specific fluorescence 
was in the cytosol, 3.6 % was in mitochondria, 3.4 % in microsomal fraction and 20.8 % in 
the nuclear portion. This contrasts with the findings by Field et al. (1994) where localisation 
of Fura-2 in the mitochondria was found to account for 43.9 % of the fluorescence 
measured from the surface of Fura .. 2 loaded rat hearts. Using calculations of cytosolic [Ca2+] 
based on mitochondrial free [Ca2+] (Miyata et al. 1991), Brandes et af. (1993 b) inferred that 
mitochondrial loading of indo- I is not a major factor. It would appear that the majority of 
evidence suggests that most of the Ca2+ -sensitive indicator is contained within the 
cytoplasm whilst the Ca2+-insensitive AM ester is localised in intracellular organelles with 
the whole heart ester perfusion technique. 
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Table 7.1 Potential artefacts in [Ca1+] measurements in the whole heart using 
fluorescent indicators. 
Proportions of measured fluorescence that are not due to Ca2+ ·sensitive indicator 
in the cytosol are shown as percentages. (Mitochon = mitochondrial) 
First Year Indicator Loading Species Unhydro- Mitochon Endothelial 
author Conc lysed AM hydrolysed 
Lee 1988 Indo· 1 2.5 J.LM Rabbit 30% 3.6% 
Lorell 1990 Indo-l Rabbit portion 
Brandes 1993 Indo-l Rat negligible probably low < 18 % 
Field 1994 Fura-2 Rat 11.2 % 43.9% 33.6 % max 
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(c) Endothelial loading. A non-myocyte contribution to the overall fluorescence can arise 
from the loading of fluorescent indicator into vascular endothelial cells. Bradykinin 
increases endothelial cell [Ca2+] which triggers the release of autacoids including 
endothelium-derived relaxing factor and prostacyclins that promote vasodilation of 
underlying vascular smooth muscle. Luckhoff (1986) showed that fluorescence obtained 
from indo-l loaded endothelial cells increased with the application of bradykinin. Lorell et 
al. (1990) showed the same effect when indo-l loaded rabbit hearts were perfused with 10 
IlM bradykinin together with a slight fall in coronary perfusion pressure consistent with 
mild coronary vasodilation. This led the authors to conclude that a component of Ca2+-
sensitive fluorescence in the indo-l loaded hearts is contributed by endothelial cells. 
Brandes et al. (1993b) and Field et al. (1994) later attempted to quantify this endothelial 
contribution to the overall fluorescence in rat hearts loaded with indo-l and fura-2 
respectively. There was a maximal increase of 18 % in the indo-l fluorescence ratio with 10 
J.tM bradykinin in the study by Brandes et aI., with a difference of 60 nM in the estimated 
systolic [Ca2+] but no change in diastolic [Ca2+] with and without correcting for endothelial 
cell loading - leading the authors to suggest that the endothelial loading may be neglected. 
On the other hand, Field et al. used 3 JlM bradykinin and found that the maximal 
endothelial fura-2 fluorescence ratio constituted about 34 % of the maximal myocardial 
fura-2 ratio. Despite the potential contribution of Ca2+ -sensitive endothelial fluorescence to 
the overall myocardial fluorescence, it was shown that bradykinin did not have any effect 
on the time-course of the Ca2+ transients (Lorell et al. 1990; Field et al. 1994) as the 
endothelial fluorescence did not vary on a beat-to-beat basis. 
The above-mentioned limitations in loading the whole heart with the fluorescent indicator 
in the AM ester form preclude direct translation of the measured fluorescence ratio into 
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myocardial cytosolic [Ca2+]. Another factor which contributes to the measured fluorescence 
but is not related to myocardial [Ca2+] is tissue autofluorescence. Fralix et al. (1990) have 
shown that this "background" fluorescence is mainly due to the reduced pyridine 
nucleotide, NAD(P)H and the fluorescence increases during hypoxia. All these factors will 
have to be taken into account and their contribution subtracted from the measured 
fluorescence before quantifying the myocardial [Ca2+] (Brandes et al. 1993a). However, 
quantification of myocardial cytosolic [Ca2+] from measured fluorescence is not easy, as 
there are limitations with calibration techniques and problems with determining the Kd in 
vivo (Brandes et al. 1993b; Bassani et al. 1995). Different methods have been used to 
determine diastolic and systolic [Ca2+] in various physiological preparations but a wide 
range of values have been obtained (Mohabir et al. 1991; Wikman-Coffelt et al. 1991 b; 
Brandes et al. 1993a; Bassani et al. 1995). 
In addition to the above-mentioned considerations, measuring [Ca2+] in the whole heart 
using fluorescent indicators is also difficult because of movement of the beating heart. This 
may cause motion artefacts in the fluorescence signals obtained and give rise to erroneous 
estimation of [Ca2+]. The use of ratio metric dyes is an advantage, as opposed to fluorescent 
indicators in which the emission or excitation spectra do not shift. Motion artefacts should 
affect both of the emission or excitation wavelengths and the effects would be cancelled out 
in the ratio. It has been shown that the effect of motion artefacts on the fluorescence ratio is 
indeed small in indo-1 perfused hearts (Brandes et al. 1992; Brandes et al. 1993a). 
This Chapter describes the use of the system developed to measure intracellular [Ca2+] from 
the epicardial surface of isolated rabbit hearts using a single-core light guide with the 
fluorescent indicator indo-I. The loading technique and fluorescence measurements are 
characterised in both hearts from rabbits with heart failure and controls. 
163 
Chapter 7 [Ca2+ J measurements in the isolated rabbit heart 
Methods 
[Ca2+] measurements were made in isolated hearts from sham-operated rabbits and from the 
heart failure group using indo-I. The loading procedure and the fluorescence measurement 
system have been described in Chapter 3. After harvesting from the sacrificed animal, the 
heart was perfused in a constant flow Langendorff mode. It was then perfused with indo-I 
AM to load the myocardium with the Ca2+-sensitive dye. Fluorescence was measured with a 
single-core liquid light guide used both to transmit the incident excitation light to and 
collect the emitted fluorescence from the left ventricular epicardial surface of the beating 
heart. 
Indo-l loading characteristics 
The characteristics of the indo-l loading procedure was studied in the 17 hearts from the 
heart failure group and 13 sham-operated controls with the light guide held at the same 
position (site I, Figure 3.5) throughout the loading procedure. Fluorescence (F) was 
collected at wavelengths of 405 run and 495 nm and the ratio of the fluorescence at both 
wavelengths (F 405 / F 495) was also measured. The initial background fluorescence was 
measured and the increase in fluorescence due to indo-l loading was observed by 
intermittently illuminating the preparation for lOs at regular intervals during the 1 hr 
loading period. 
Measurement of intracellular Ca1+ transient 
After the loading procedure, the heart was perfused with nonnal Tyrode's solution and 
paced via the right atrium at a cycle length of 350 ms with the temperature being 
maintained at 37°C. Fluorescence signals collected from the left ventricular epicardial 
surface were analysed. As mentioned in the "Methods" section in Chapter 6, a pacing cycle 
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length of 350 ms was chosen for the [Ca2+] and Monophasic Action Potential measurement 
experiments in the Langendorff perfused hearts as opposed to 300 ms in the working heart 
experiments as the intrinsic heart rate of the isolated heart during Langendorff perfusion 
was found to be slower than in the working heart configuration. The slightly slower pacing 
rate with a cycle length of 350 ms (Le. about 170 beats.min-I) was still close to the 
physiological heart rate of the rabbit (around 180 to 200 beats.min-! in vivo) and still 
ensured a constant, paced rhythm during the experiments but allowed the time course of the 
Ca2+ transients and MAP signals to be better analysed with greater resolution (see later). 
Measuring fluorescence from the left ventricular epicardial surface of the beating heart with 
a single-core light guide was a novel technique. It was important that the character of the 
signals obtained be examined and that any potential artefacts be excluded so that the 
fluorescence signals and the ratio obtained truly reflected changes in the intracellular [Ca2+] 
_ the Ca2+ transient - in the region measured in the beating heart. A number of control 
experiments were therefore carried out for that purpose. 
Depth of myocardium sampled with the single-core light guide 
It is known that action potential duration is longer in sub-endocardial than sub-epicardial 
myocytes (Fedida and Giles, 1991). This may have a direct effect on the Ca2+ transient 
duration in sub-endocardial and sub-epicardial myocytes. Data on such difference are scarce 
in the rabbit but Figueredo et al. (1993) reported that such difference exists in the rat. lfthe 
Ca2+ transients from sub-endocardial myocytes were also sampled with the single-core light 
guide whilst recording from the left ventricular epicardial surface, this may lead to an 
average Ca2+ transient composed of characteristics of both sub-epicardial and sub-
endocardial myocytes. The Ca2+ transient would vary in duration depending on the number 
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of myocytes sampled of each kind. The effect of depth of myocardium sampled with the 
single-core light guide on the Ca2+ transient signal was investigated in two ways:-
Endocardial freezing 
The possibility that Ca2+ signals from sub-endocardial myocytes were also recorded by the 
single-core light guide from the epicardial surface was examined by freezing the inside of 3 
normal stock hearts using a technique described by Allessie et a1. (1989). A small glass test 
tube was inserted in the left ventricle of the isolated, Langendorff perfused, indo-l loaded 
heart via the left atrium. The size of the glass test tube allowed firm contact with the 
endocardial surface of the beating heart. Liquid nitrogen was poured into the test tube via a 
silicone tubing connected to a funnel. The heart was continuously perfused with warm 
Tyrode's solution with overflow via the coronary effluent over the left ventricular epicardial 
surface to protect the sub-epicardial layer from damage. Fluorescence signal was obtained 
from the same left ventricular epicardial site during the freezing and the time course of the 
Ca2+ transient was analysed. 
Varying excitation light intensity 
Another way of examining the effect of depth of myocardium sampled with the single-core 
light guide on the Ca2+ transient signal was to reduce the intensity of the excitation light. 
With the light guide being kept on the same left ventricular epicardial site to record the Ca2+ 
transient signal, the effect of reducing the light intensity by a factor of 10 or 100 using 
neutral density filters was examined in 3 normal stock hearts. 
Effect of altered intraventricular conduction 
Fluorescence was recorded from the left ventricular epicardial surface using a light guide of 
3 mm diameter. Therefore, the signal represents the average Ca2+ transient from cells within 
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an area of approximately 7 mm2• If the activation of the myocytes within this region were 
not completely synchronous, the time course of the average Ca2+ transient may be affected 
by altered patterns of excitation of the myocardium. The time course of the average Ca2+ 
transient measured with the light guide may be abnormal even though the Ca2+ transient at 
the individual myocytes in the sampled region may be nonna!. This probability was 
investigated by comparing the time course of the Ca2+ transient obtained during atrial pacing 
with that obtained at the same site during direct ventricular pacing. The direct stimulation 
of the ventricle will generate a different excitation pattern with delay in ventricular 
activation when compared to atrial pacing which uses the His-Purkinje system (Rosenqvist 
et al. 1996). At the same pacing cycle length of 350 ms, the fluorescence signal obtained at 
one site was recorded when pacing was switched from the right atrium to the right ventricle 
in 8 hearts from the sham-operated group and 8 from the heart failure group. 
Endothelial contribution to indo-l fluorescence signals 
Studies in isolated hearts using fluorescence dyes with acetoxymethyl ester loading via 
coronary perfusion (Lorell et al. 1990; Brandes et al. 1993b; Field et af. 1994) suggested 
that a substantial proportion of the fluorescence signal was due to loading of vascular 
endothelial cells. Bradykinin increases endothelial [Ca2+]i which triggers the relaxation of 
vascular smooth muscle causing vasodilatation. The possibility that this vascular 
endothelial component of the fluorescence signal may affect the time course of the Ca2+ 
transient was examined by perfusing the heart with Tyrode's solution containing 10 f.1M 
bradykinin whilst recording the fluorescence signal from the left ventricular epicardial 
surface in 3 nonnal stock rabbit hearts. 
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Results 
Indo-! loading characteristics 
The characteristics of the indo-l loading procedure were examined in the 17 hearts in the 
heart failure group and the 13 sham-operated controls. Figure 7.1 shows the time course of 
the rise in fluorescence at 405 nm (F 405) and 495 nm (F 495) above background level together 
with the F 40sIF 49S signal in a typical experiment. Fluorescence started to rise around 1.5 to 2 
. min after perfusion with the indo-1 AM containing solution, which was the time taken for 
the solution to arrive at the heart. The rise in fluorescence routinely reached a plateau after 
about 45 min with the ratio signal reaching a steady state at the same time. Typically, indo-
1 loading increased the F40S by 1.37 ± 0.05 times background level while an increase of 3.08 
± 0.24 times background level was seen at F495 • Phasic changes in the F40SIF49S ratio were 
discernible after 10 min loading and the signal to noise ratio improved as loading 
progressed. There was no change in the amplitude or slowing of the time course of the 
intraventricular pressure during the loading period indicating that there was no significant 
buffering of intracellular Ca2+ by indo-I. 
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Figure 7.1 Measurements of fluorescence at 405 nm (F 405 - .) and 495 nm (F 495 - .) 
expressed in terms of photomultiplier current (A) measured at one epicardial site 
during the perfusion of an isolated rabbit heart with Tyrode's solution containing 10 
J.lM Indo-! AM. Total fluorescence ratio (F40S/F495 Ratio - Y') is also shown on the same 
plot (right-hand side scale). 
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The fluorescence due to indo-! loading alone could be obtained at site 1 by subtracting the 
background fluorescence for each wavelength to generate results illustrated in Figure 7.2. 
The time courses of the rise in F40s and F49s were fitted to an exponential curve and the time 
to halfmaximal fluorescence noted for individual wavelengths. As illustrated in Figure 7.2, 
an exponential time course describes the increase in fluorescence satisfactorily, with 
approximately the same half-time for each wavelength. This analysis allowed the loading 
characteristics of failing and sham hearts to be compared. These results are summarised in 
Table 7.2 and show that background fluorescence at site 1 and the extent of loading with 
indo-! were similar in the 2 groups. The values for the half-times indicate that indo-l 
loading occurred with a slightly faster time course in the control group when compared to 
failing hearts, but this difference did not reach statistical significance. 
170 
Chapter 7 [Ca2+ J measurements in the isolated rabbit heart 
1.2 
1.0 
<,0.8 
- • ~ 
c 
• • ~ 0.6 fIJ • ~ 
• 0 :::J 0.4 u:: 
• 
• F405 0.2 
• F495 
0.0 
0 10 20 30 40 50 60 70 
Time (min) 
Figure 7.2 Indo-1 fluorescence expressed as photomultiplier current (A) at 405 nm 
(.) and 495 nm (e) obtained by subtraction of background fluorescence. Solid lines 
describe the best fit curves to the points using the equation F = A * (1 - e ollk). For 
fluorescence at 405 nm, A = 0.62 and k = 19.6 min; for fluorescence at 495 nm, A = 
1.22 and k = 20.4 min. 
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Table 7.2 Comparison of Indo-l loading characteristics between failing (HF) and 
control (Sham) hearts. 
Background Fluorescence Increase in Fluorescence Half-time of loading 
(A) (A) (min) 
____ M .. __ '_M_.M .... ____ , ___ .. _ ._ 
405nm 495nm 405nm 495nm 405nm 495nm 
HF (n = 17) 1.32 ± 0.05 0.39 ± 0.02 0.48 ± 0.09 0.77 ± 0.11 19.9 ± 2.4 16.6 ± 1.3 
Sham (n = 13) 1.31 ± 0.03 0.35 ± 0.01 0.46 ± 0.08 0.74 ± 0.13 13.l± 2.4 13.1 ± 1.0 
P value NS NS NS NS 0.08 0.09 
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Measurement of intracellular Caz+ transient 
Figure 7.3 illustrates the individual fluorescence signals (F40S and F49s ) measured from site 1 
on the surface of the left ventricle and the simultaneously recorded isovolumic pressure 
record in a typical experiment. The fluorescence records prior to loading with indo-l 
showed no phasic changes and the fluorescence ratio was constant with a value of 
approximately 4. These recordings illustrate that this particular optical arrangement did not 
generate significant movement artefact in the fluorescence signal from the contracting 
myocardium below the light guide. After the loading procedure, the fluorescence of the 
epicardial surface had increased significantly at both wavelengths and as indicated in Fig 
7.3 A, phasic signals were evident at both 405 run and 495 run. The value of the 
fluorescence ratio was now approximately 2, due to the relatively greater increase in 
fluorescence at 495 nm. In addition to this, the signal contained a significant phasic 
component as shown on an expanded scale in Figure 7.3 B. The fluorescence ratio 
increased rapidly to a peak and fell gradually to steady level and represents the time course 
of the changes of intracellular [Ca2+] within the myocardium at site 1. 
Conventionally, the fluorescence ratio is calculated after the subtraction of background 
fluorescence, and the values of maximum and minimum fluorescence ratio represent the 
systolic and diastolic intracellular [Ca2+] respectively. However, in this study the 
subtraction of background fluorescence for allIS sites was not feasible for two reasons:- (a) 
Precise background fluorescence measurements would have to be made at the 15 sites, 
either prior to indo-I loading or after quenching the Ca2+-sensitive signal at the end of the 
experiment. Due to the optical system used in these experiments, the magnitude of 
background fluorescence was approximately the same as that of the indo-l fluorescence. 
Imprecise positioning of the light guide would generate errors in the estimation of 
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background fluorescence leading to large errors in the estimation of the indo-l fluorescence 
ratio values. This was confirmed by preliminary measurements of indo-! fluorescence ratio 
which showed large variations in value when comparing a number of sites over the 
epicardial surface of one heart or the same site over a number of individual hearts within 
one experimental group. (b) As shown in Figure 7.3 A, fluorescence signals at 405 nm and 
495 nm consisted of small variations of photomultiplier current on top of substantial 
baseline values. Background subtraction at 15 sites would have to be performed off-line on 
digitised data. The resolution of the A I D converter (12 bit) limits the precision of the 
measurements of small signals on top of a large base line value and therefore substantially 
degrades the computed ratio signal. For these two reasons, the fluorescence ratio 
measurements quoted in this study represent the ratio of the total fluorescence signals 
provided by an analogue divider circuit. These measurements preclude comparisons of 
diastolic and systolic [Ca2+] values across the epicardial surface. However, the time course 
of the transient changes in signal can be used to examine the duration of the intracellular 
[Ca2+] signal. To illustrate the similarities in the time course of the two fluorescence ratio 
signals, the calculated indo-} fluorescence ratio is plotted (as individual points) 
superimposed on the continuous analogue signal of total fluorescence ratio in Figure 7.3 B. 
It is clear that both fluorescence ratio values, although different in magnitude, have similar 
time courses. 
174 
A 
Foos (A) 
F 09s (A) 
Chapter 7 [Ca2+} measurements in the isolated rabbit heart 
before Indo-1 after Indo-1 ~~--------------------
~l ______ -------------
B 
2.01] _r--.... __ ~~_-r-___ _ 
1.96 
1.00] 
0.95 
210]~~r02 
2.00 a..; 0.94 
7:~H~)] J\N JW ] A /\f\ 
L..-.I " 
350ms 350ms 
Figure 7.3 Panel A, records of fluorescence at 405 run (F40S), 495 run (F495) , 
fluorescence ratio (F4os/F49S) and left ventricular isovolumic pressure (Pressure) from 
an isolated Langendorff perfused rabbit heart at 37 -C, paced via the right atrium at a 
cycle length of 350 ms. Records are shown before and after Indo-l loading procedure. 
Each trace is an average of 30 recordings. Panel B shows sections of the above traces 
after Indo-l loading on an expanded vertical and horizontal scale. The individual 
points (0) superimposed on the F4osIF49S Ratio record are the calculated Indo-l 
fluorescence ratio values (right-hand side axis, see text). 
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Measurement ofCa2+ transient duration 
The Ca2+ transients described here and in subsequent Chapters were averaged over 30 
sweeps (equivalent of about 30 s recording) prior to analysis. The time course of the Ca2+ 
transient described in this Chapter was measured from the beginning of the upstroke of the 
transient to the point of 50 % decay of the signal. This was taken as the duration of the Ca2+ 
transient at the left ventricular epicardial site measured. 
Depth of myocardium sampled with the Single-core light guide 
The depth of myocardium sampled with the single-core light guide was estimated in 3 
normal stock rabbit hearts by destroying the endocardial and intramural layers of the 
beating, indo-l loaded hearts with liquid nitrogen. After this procedure, only a 0.5 - 0.7 mm 
thick epicardial layer remained viable, as judged by the colour change in the myocardium 
when the left ventricle was opened and examined after the experiment. The Ca2+ transient 
signal obtained at the same left ventricular epicardial site showed no change in the 
amplitude or time course before and after the freezing procedure (results not shown). This 
suggests that the epicardial Ca2+ transients were recorded from a layer not more than 0.7 
mmdeep. 
Another method was used to investigate the effect of depth of myocardium sampled by the 
single-core light guide on the indo-} fluorescence signals in 3 normal stock rabbit hearts. 
Figure 7.4 shows the effects on fluorescence signals when the light intensity of the 
ultraviolet light source was reduced by a factor of 10 and } 00 with neutral density filters 
(ND 1.0 and ND 2.0 respectively). When the light intensity of the excitation light was 
reduced using ND 1.0 filter, the emitted fluorescence collected at 405 nm and at 495 nm 
decreased. There was a greater decrease in F 405 than in F 495 leading to a fall in the F 405 / F 495 
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ratio. A decrease in the amplitude of the Ca2+ transient was also observed in the ratio signal 
with no obvious change in the left ventricular pressure tracing. In addition, there was an 
increase in the noise to signal ratio. When the excitation light intensity was reduced using 
ND 2.0 filter, similar changes were observed:- (a) F40S and F49S were reduced, (b) F405 / F495 
ratio decreased, (c) amplitude of the Ca2+ transient was smaller, (d) signal to noise ratio 
declined but (e) no change in the left ventricular pressure signal was observed. The time 
course of the Ca2+ transients at the different excitation light intensities were analysed and no 
difference was observed. Figure 7.5 shows the Ca2+ transient signals obtained at the 3 
different excitation light intensities. When the normalised signals were superimposed, it was 
evident that there was no significant difference in the time course of the Ca2+ transients 
obtained at the different excitation light intensities. 
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Figure 7.4 Records of fluorescence at 405 run (F40S)' 495 run (F .. 9s)' and fluorescence 
ratio (F4osIF49s) recorded at one epicardial site and left ventricular isovolumic pressure 
(Pressure) from an isolated Langendorff perfused rabbit heart at 37 - C, paced via the 
right atrium at a cycle length of 350 ms. Traces shown were recorded at the same 
epicardial site either with no neutral density filter, an ND 1.0 filter or an ND 2.0 filter 
in front of the excitation source. 
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Figure 7.5 Records of fluorescence ratio (F4os/F49s) at one epicardial site from an 
isolated LangendorfT perfused rabbit heart at 37°C, paced via the right atrium at a 
cycle length of 350 ms, with different excitation light intensities - no neutral density 
filter, an ND 1.0 filter (data shown in blue) or an ND 2.0 filter (data shown in red) in 
front of the excitation source as in Figure 7.4. The Ca2+ transient signals obtained at 
the different excitation light intensities are aligned at the baseline in the upper panel 
and are normalised and superimposed at the bottom panel. 
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Effiet of altered intraventricular conduction 
The effect of change of pacing from the right atrium to the right ventricle on Ca2+ transient 
duration was studied in 8 hearts from the heart failure group and 8 controls. Figure 7.6 A 
shows the Ca2+ transients and left ventricular pressure recordings in a sham-operated heart 
during atrial and ventricular pacing. Figure 7.6 B shows the superimposed Ca2+ transient 
recordings during atrial and ventricular pacing showing that there was no significant 
difference in the time course of the Ca2+ transient. When the Ca2+ transient duration (time 
from the beginning to 50 % decay of the transient) was measured. there was a change of 0.9 
± 0.6 % on changing from atrial to ventricular pacing in the heart failure group and 0.7 ± 
0.3 % in the controls. This change was not statistically significant in either of the 
experimental group. There was a small decrease in left ventricular peak systolic pressure on 
ventricular pacing. This would be discussed in greater detail in Chapter 11. 
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Atrial pacing Ventricular pacing 
350 ms 
Figure 7.6 Panel A shows fluorescence ratio records (F4osiF495) recorded from one 
epicardial site and isovolumic left ventricular pressure (Pressure) in an isolated 
LangendorfT perfused rabbit heart at 37°C paced at a cycle length of 350 ms via 
electrodes either on the right atrium (data shown in red) or on the right ventricle (data 
shown in blue). The horizontal broken line shows the level of peak left ventricular 
systolic pressure during atrial pacing. Panel B shows the fluorescence ratio records 
su perim posed. 
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Endothelial contribution to indo-l fluorescence signals 
The contribution of fluorescence from endothelial cells loaded with indo-l and the potential 
effect on the time course of the Ca2+ transient measured were studied by perfusion with 10 
J.l.M bradykinin. In the 3 normal stock rabbit hearts loaded with indo-I, perfusion with 
bradykinin caused a reversible increase in the fluorescence signals. An example is shown in 
Figure 7.7. With bradykinin, fluorescence measured at 405 nm increased slightly and that at 
495 run decreased to a relatively greater extent. This led to a slight increase in the ratio 
signal. In addition, there was a small decrease in the perfusion pressure signal (not shown) 
with a small increase in left ventricular peak systolic pressure. This is consistent with 
vasodilatation caused by bradykinin mediated through an increase in endothelial [Ca2+], 
possibly leading to a "garden-hose effect" on left ventricular pressure. When the time 
course of the Ca2+ transients before and during bradykinin perfusion were analysed, no 
difference was observed. This is illustrated in Figure 7.7 B showing the superimposed, 
nonnalised signals. 
182 
Chapter 7 [Cct+] measurements in the isolated rabbit heart 
A pre - Bradykinin Bradykinin 
F405 (A) 
1.85] 
1.75 ... .. ....... .... .... ..... .... .......... .... ... ... ... .... .. ... .... .. ....... ............. ........ ..... .... ....... ... ..... . 
F.95 (A) 
1.50] 
1.40 ....... .... ...... .......... ..... ...... ... ..... .. ... ... .... ...... ..... ....... .. .......... ... ............ ...... ... .... ... . 
F~05/F~95 
1.26] 
Ratio 1.21 ...... .... . 
B 
Pressure 
(mmHg) 
Normalised 
ratio 
Figure 7.7 
350ms 
Panel A shows fluorescence at 405 nm (F405) , 495 nm (F495), and 
fluorescence ratio (F40siF49S) recorded from one epicardial site and left ventricular 
isovolumic pressure (Pressure) of an isolated LangendorfT perfused rabbit heart at 37 
°C paced at a cycle length of 350 ms via the right atrium, before (shown in red) and 
during (shown in blue) perfusion with 10 JlM bradykinin. Panel B shows the 
normalised fluorescence ratio records superimposed. 
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Discussion 
Indo-l loading characteristics 
Fluorescence monitored at site 1 increased while the isolated hearts were perfused with the 
indo-l AM containing Tyrode's solution. The initial rise was probably due to the 
fluorescence of indo-} AM, firstly in the perfusate in the coronary vasculature, then 
crossing the sarcolemma into the myocytes with progressive build-up inside the cytosol. 
After about } 0 min perfusion, phasic signals were discernible. Although the signal to noise 
ratio was low in these first signals, the characteristics followed what one would expect and 
what was observed after fun loading to be representative of the intracellular Ca2+ transient. 
These signals, therefore, represented signals from the Ca2+ -sensitive indo-l which had been 
cleaved by intracellular esterases. The increase in fluorescence at both 405 nm and 495 nm 
followed an exponential time course and reached a plateau at around 45 min. By that time 
of loading, an equilibrium had been reached between the perfusate in the coronary 
vasculature and the cytosol. Subsequent Ca2+ transient measurements were made after a 15 
min washout period with normal Tyrode's solution. There was no obvious decrease in the 
measured fluorescence after washout suggesting that at the end of the loading period, the 
fluorescence measured with the light guide was exclusively from intracellular indo-I. The 
absence of any changes in the amplitude and time course of intraventricular pressure during 
the loading procedure suggested that significant Ca2+ -buffering by indo-! was not a feature 
of this loading. 
With the indo-I loading procedure described here using the single-core light guide, there 
was an increase in fluorescence intensity at both wavelengths by a factor of 1.4 to 3.1. This 
is in contrast to other studies using bifurcated light guides for measuring intracellular [Ca2+] 
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in intact hearts using indo-l where a much higher (up to 20-fold) increase in fluorescence 
intensity above original tissue autofluorescence was observed (Lee et al. 1987; Lorell et al. 
1990; Mohabir et al. 1991). One explanation may be that the background fluorescence 
measured with the optical arrangement described here using a single light guide was higher 
than in other studies leading to a lower relative increase in fluorescence intensity with indo-
1 loading. A number of preliminary experiments (n = 3) were performed using a bifurcated 
liquid light guide in a modified set-up using the same indo-! loading protocol. This showed 
a much lower background fluorescence and a 10-15 fold increase in fluorescence intensity 
with indo-! loading. Although the reason for this difference in background fluorescence 
obtained with the two methods is unknown, results of these experiments would suggest that 
the contribution of epicardial fluorescence to the background fluorescence was less using a 
bifurcated light guide. Despite a higher background fluorescence using a single light guide, 
measurements could be made in a smaller, more discrete area of myocardium and signals 
were less prone to movement artefacts than signals recorded using a bifurcated light guide. 
These features are of particular importance in the experiments described in subsequent 
Chapters for the measurement of fluorescence signals from multiple sites over the epicardial 
surface of the left ventricle. 
Comparison o/indo-lloading between/ailing hearts and controls 
Background fluorescence at both wavelengths prior to indo-l loading were similar in both 
the control and heart failure groups. Fralix et al. (1990) showed that the majority of this 
tissue autofluorescence is due to intracellular metabolite, NAD(P)H. This would suggest 
that there was no significant difference in the resting metabolic state at the myocardium 
sampled with the light guide between failing hearts and controls. 
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The indo-l loading characteristics were similar in the failing hearts and controls with both 
groups achieving the same level of fluorescence increase above background. However, the 
half-time in fluorescence increase in the failing hearts was slightly longer (although not 
statistically significant) suggesting a lower esterase activity in these hearts when compared 
to controls. 
Measurement of intracellular Ca1+ transient 
After indo-! loading, the analogue ratio of the total fluorescence at 405 and 495 nm 
revealed phasic changes with the time course and features characteristic of the intracellular 
Ca2+ signal. While the peak systolic and diastolic values of this signal do not simply reflect 
systolic and diastolic [Ca2+], the time course of the fluorescence change reflects the time 
course of intracellular [Ca2+] change. This assertion was verified by calculating the indo-l 
fluorescence ratio change (after background subtraction) at site 1 which followed the time 
course of the analogue ratio accurately. This shows that the time course of the total 
fluorescence ratio change is not sensitive to the level of the background fluorescence. 
However, the amplitude of the calculated indo-l fluorescence ratio was much less than 
expected on the basis of the indo-l spectrum published by Grynkiewicz et al. (1985). There 
are a number of possible reasons for this:- (a) The dichroic mirror (385 nm long-pass) will 
reduce the fluorescence collected by the 405 nm photomultiplier. (b) The indo-! spectrum 
may be shifted significantly within the myocyte (Hove-Madsen and Bers, 1992; Brandes et 
af. 1993a). (c) Several studies have shown that there is a non-cytosolic component to the 
Ca2+ -sensitive fluorescence due to loading of dye into organelles such as mitochondria and 
sarcoplasmic reticulum (Lee et al. 1988; Brandes et al. 1993b; Field et al. 1994). Miyata et 
al. (1991) showed that fluorescence from indo-! located in mitochondria did not affect the 
beat-to-beat variation of the total fluorescence signal. (d) There may be a component of 
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unhydrolysed indo-l AM in the signal but there is debate about the importance of its 
contribution to the total fluorescence (Lee et al. 1988; Brandes et al. 1993b). (e) Lorell et 
al. (1990) suggested that a substantial proportion of the fluorescence signal was due to indo-
1 loading of vascular endothelial cells but this was shown not to affect the time course of 
the ratio signal which is consistent with the controls experiments performed in this study 
with bradykinin. 
All the above-mentioned factors may affect the intensity of the fluorescence signals at the 
individual wavelengths and make the quantitation of cytosolic [Ca2+] in intact hearts 
difficult. Different techniques (Mohabir et al. 1991; Wikman-Coffelt et al. 1991 b; Brandes 
et al. 1993a) have been used which yielded different normal ranges for systolic and diastolic 
[Ca2+]. Calibration measurements of the intracellular [Ca2+] were not made in view of the 
potential limitations. Since it was planned to sample 15 sites over the left ventricular 
epicardial surface, measurement of background fluorescence prior to indo-l loading at the 
exact 15 positions would be required for the quantitation of [Ca2+] at all sites. The main 
objective was to examine the time course of the Ca2+ transients from different sites over the 
left ventricular epicardial surface rather than the absolute value of [Ca2+] at each site. The 
factors described above which affect the intensity of the fluorescence signals and hinder the 
quantitation of [Ca2+] have been shown not to affect the time course of the ratio signal. 
There are other factors which may potentially influence the time course of the recorded 
fluorescence signal and these were considered in this study and are discussed below:-
(a) Conduction delay over epicardial surface. The absence of difference between the time 
course of Ca2+ transients on atrial and ventricular pacing showed that conduction delay over 
the epicardial surface studied with the light guide would not account for any change in Ca2+ 
transient duration. 
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(b) Depth of tissue sampled with light guide. Previous studies suggested that fluorescence 
was typically detected from within the first millimeter of the epicardium (Stewart, 1985; 
Turvey and Allen, 1994). Attempts were made to examine this in two ways in this study:-
(i) The left ventricle of Langendorff perfused hearts were progressively frozen from the 
endocardial surface towards the epicardium while monitoring the epicardial Ca2+ transient. 
These measurements suggested that the majority of the signal was recorded from within 0.7 
mm of the epicardial surface. (ii) As described in Figure 7.5, there was no change in the 
time course of the Ca2+ transient when the intensity of the excited light was reduced by 10-
and 100-fold. Since decreasing the intensity of excitation light will lead to reduction in the 
layer of tissue illuminated, this procedure examines Ca2+ transients from differing thickness 
of myocardium. Despite the fact that the time course of the ratio signal was unchanged, 
there was a difference in the degree to which the emitted fluorescence collected at the 2 
wavelengths was decreased, when the excitation light intensity was reduced. This suggests 
that thickness of myocardial tissue and hence the distance travelled by the emitted light may 
affect the intensity of individual emission wavelengths differently. This may due to 
different tissue absorbance of the 2 wavelengths. Nevertheless, the time course of the ratio 
signal appeared to be insensitive to this optical difference. 
(c) Movement artefacts. The application of the 3 mm-diameter light guide to the surface of 
the beating heart appeared not to incur significant movement artefact in either background 
or indo-l fluorescence signals. Moreover, the use of the ratio of fluorescence at the two 
emission wavelengths would cancel out any potential artefact (Brandes et al. 1992; Brandes 
et al. 1993a). 
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Introduction 
Ca2+ plays a central role in the excitation-contraction process in cardiac muscle. Since the 
development of fluorescence techniques in measuring intracellular [Ca2+], researchers have 
been applying these to investigate the possibility that the abnormal contractile function in 
heart failure may be related to defects in the Ca2+ -handling processes. Gwathmey et aZ. 
(1987) used the bioluminescent indicator, aequorin, and showed that Ca2+ transients were 
prolonged in ventricular trabeculae isolated from patients with heart failure. It was also 
shown that Ca2+ transients were prolonged in myocytes from patients with heart failure later 
by Beuckelmann et al. (1992) using fura-2. However, the measurements were made at 
abnormally low stimulus rates (and temperatures) in these studies. In the study by 
Gwathmey et al., the trabeculae were paced at 3 s intervals at 30°C whilst the myocytes in 
the study by Beuckelmann et aZ. were paced at 0.5 Hz at 35°C. It is difficult to extrapolate 
from these results to predict the behaviour of the intracellular [Ca2+] and its impact on 
mechanical function under more physiological conditions. 
Regional differences in Ca2+ handling in the heart have not received much attention 
although one early study (Saari and Johnson, 1980) reported differences in the Ca2+ content 
and uptake rate for different segments from normal rabbit hearts. A recent study (Mubagwa 
et al. 1998) suggests that the decrease in Ca2+ uptake is not homogeneous in the failing 
human heart with previous myocardial infarction. It was shown that Ca2+ uptake was 
reduced in the region close to the infarcted area as compared to regions remote from the 
infarct. 
In this Chapter, the time course and regional characteristics of intracellular Ca2+ transients 
measured with indo-l from the left ventricular epicardial surface of isolated hearts from 
rabbits with heart failure are investigated. 
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Methods 
Isolated hearts from the heart failure (n = 17) and sham-operated groups (n = 13) were 
loaded with indo-l as described in Chapters 3 and 7. Ca2+ transients were measured at the 
15 left ventricular epicardial sites according to a map illustrated in Figure 3.5. The durations 
of the Ca2+ transients were measured and compared between 2 groups. Variation of the Ca2+ 
transient durations at different sites within each heart was analysed and this variation was 
also compared between the 2 groups. 
Effect of altered extracellular [Ca1+1 on intracellular Ca1+ transient duration in control 
hearts 
In a separate set of experiments, Ca2+ transients were monitored from the same site on the 
epicardial surface of 4 isolated Langendorff perfused hearts from the sham-operated group 
while the extracellular [Ca2+] was decreased from 1.8mM to 0.8mM, or increased to 3.6 mM 
by perfusion with Tyrode's solution containing the different [Ca2+]. The Ca2+ transients were 
recorded and the duration was measured during right atrial pacing at 350 ms cycle length 
and at 37°C. Intraventricular pressure was monitored throughout the experiments using a 
latex balloon. 
Results 
Figure 8.1 illustrates the range of signals measured at 15 epicardial sites from an isolated 
heart from the sham-operated group (panel A) and from the heart failure group (panel B). It 
is clear that the duration of the Ca2+ transient varies to a limited extent in sham-operated 
hearts, the shortest duration was observed at site 7, while the longest duration was observed 
at site 1 for the heart illustrated in Figure 8.1 A. The recordings from a heart with a 
significant infarct had several unusual features. Firstly, records made from within the infarct 
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zone showed no transient changes confirming that this region did not contain significant 
amounts of viable myocardium. Secondly, the remaining sites showed transient signals 
with a wide range of time courses, the shortest transient being recorded from site 3, while 
transients with a particularly long duration were obvious at sites 2 and 8 for the heart 
illustrated in Figure 8.1 B. 
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Figure 8.1 Panel A shows a schematic diagram of an isolated rabbit heart with 
right ventricle outflow tract (RVOT), left atrium (LA) and right atrium (RA) marked 
as shown. The marginal branch of the left circumflex artery is represented by a 
vertical line on the left ventricle. The numbers on the left ventricle are the standard set 
of 15 sites from which epicardial fluorescence measurements were made. The Ca2+ 
transients recorded at each site from a sham-operated heart are shown beside the 
appropriate site number. Traces are the average of 30 recordings. Panel B shows 
parallel recordings made from a heart from the heart failure group with an apical 
infarct shown as a non-shaded area at the apex of the left ventricle (with the 
approximate position of the ligature indicated). The Ca2+ transients recorded at each 
site are shown beside the appropriate site number. Traces are the average of 30 
recordings. 
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Measurement of the time course of Ca2+ transients 
The Ca2+ transients were analysed in all 15 sites obtained from sham-operated hearts. In 
failing hearts, since recordings from sites within the infarct zone gave no transient signal, 
analysis only included recordings from the remaining surviving myocardium with transient 
signals, the number of viable sites ranging from 7 to 12 (mean of9). 
The time course of the Ca2+ transients recorded from both groups were analysed from the 
beginning of the transient signals at each measured site to the various points of the signals 
(Figure 8.2). The upstroke of the Ca2+ transient was measured as the time between the 
beginning of the signal to 50 % of the peak. The time intervals between the beginning of the 
signal to the peak, to 25 % decay, to 50 % decay, to 75 % decay and to 90 % decay were 
similarly measured for each of the epicardial sites. A mean value was obtained from each 
heart for the upstroke, time to peak (CaD-Peak), time to 25 % decay (CaD-25), time to 50 % 
decay (CaD-50), time to 75 % decay (CaD-75) and time to 90 % decay (CaD-90). The 
values obtained from failing hearts were compared with those from controls and are 
summarised in Table 8.1 and illustrated in Figure 8.3 A. It was shown that there was no 
difference between the initial upstroke of the Ca2+ transients (time to 50 % peak) observed 
in heart failure and in controls (10.0 ± 0.5 ms vs. 9.5 ± 0.3 ms, p = NS). There was a 
significant delay in the time to peak Ca2+ transient in the heart failure group compared to 
controls with a difference of 18.9 ms between the mean values in the 2 groups. This 
difference increased progressively at subsequent points of the time course of the Ca2+ 
transient to 31.7 ms between the mean values in the 2 groups at time to 75 % decay. The 
difference at time to 90 % decay narrowed slightly to 29.6 ms between the mean values in 
the 2 groups, but the mean Ca2+ transient duration was significantly longer in failing hearts 
than in controls throughout the whole decay phase of the transient. 
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Figure 8.2 Representative tracing of Ca2+ transients recorded from the left 
ventricular epicardial surface of an isolated Langendorff perfused heart, paced via the 
right atrium at 350 ms cycle length. Arrows mark the beginning of the transients, the 
point from where the duration of each signal was measured (see text). The trace 
represents an average of 30 recordings. 
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Table 8.1 Comparison of the time course of Ca1+ transients over the left 
ventricular epicardial surface of isolated hearts from rabbits with heart failure (HF) 
and controls (Sham). 
Measurements were made from the beginning of the Ca2+- transient signal at 
each measured site to the various points of the signal, at a pacing cycle length of 
350 ms. The differences between the mean values obtained for the 2 groups at 
the various points of the Ca2+ transient are also shown. 
HF Sham p value Difference (ms) 
Time to 50 % Peak (ms) - Upstroke 10.0 ± 0.5 9.5 ± OJ NS 0.5 
Time to Peak (ms) - CaD-Peak 50.4 ± 3.8 31.5 ± 1.2 <0.001 18.9 
Time to 25 % decay (ms) - CaD-25 107.2 ± 3.7 81.7±1.8 < 0.001 25.5 
Time to 50 % decay (ms) - CaD-50 156.2 ± 3.2 124.9 ±2.6 < 0.001 31.3 
Time to 75 % decay (ms) - CaD-75 213.2 ± 3.5 181.5 ± 4.4 < 0.001 31.7 
Time to 90 % decay (ms) - CaD-90 268.5 ± 3.3 238.9 ± 7.0 <0.001 29.6 
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Time course of ci· transients 
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Figure 8.3 Comparison of (A) the time course of Ca2+ transients and (B) adjusted 
dispersion time (see text) at the various points of the Ca2+ transient time course, over 
the left ventricular epicardial surface of isolated hearts from rabbits with heart failure 
(HF) and controls (Sham) at a cycle length of 350 ms during right atrial pacing. 
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Correlation between Ca1+ transient duration and site location 
Several methods of analysis were carried out to correlate the Ca2+ transient duration with the 
location of the site measured to see if any particular epicardial sites had consistently long or 
consistently short Ca2+ transient durations in either of the experimental groups. Ca2+ 
transient duration was measured from the beginning of the signal to 50 % decay at each 
measured site. The mean Ca2+ transient duration at each measured site for both experimental 
groupS are shown in Table 8.2. The difference between the 2 experimental groups at each 
measured site in relation to the variation in Ca2+ transient duration will be discussed in a 
later section "Dispersion of Ca2+ transient duration". The analyses described here were 
carried out to examine the relationship between the epicardial site and Ca2+ transient 
duration measured within each of the experimental groups. 
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Table 8.2 Comparison of mean Ca1+ transient durations (as measured by the 
beginning of the transient to 50 % decay) at the individual left ventricular 
epicardial sites in isolated hearts from rabbits with heart failure (HF) and 
controls (Sham). 
Site No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Numbers in brackets represent the number of hearts in each group where Ca2+ 
transients were measurable at each site. 
Ca2+ transient duration (ms) p value 
HF (n = 17) Sham (n = 13) 
158.5 ± 8.5 134.4 ± 5.6 <0.05 
(17) (13) 
140.6 ± 6.4 123.1 ±9.1 0.12 
(17) (13) 
160.1 ± 10.7 141.3 ± 8.1 0.25 
(17) (13) 
154.3 ± 6.6 126.9 ± 5.0 <0.005 
(17) (13) 
150.6 ± 14.1 125.3 ± 9.0 0.13 
(7) (13) 
153.7 ± 7.9 128.6 ± 6.7 0.09 
(3) (13) 
149.2 ± 9.1 119.8 ± 8.2 <0.05 
(17) (13) 
163.8 ± 9.9 136.3 ± 5.8 <0.05 
(17) (13) 
141.5 ± 8.7 114.6 ± 8.1 <0.05 
(15) (13) 
151.1 ± 7.3 120.3 ± 7.9 < 0.01 
(16) (13) 
184.5 ± 9.3 125.7 ± 8.4 < 0.005 
(4) (13) 
144.7 ± 10.1 123.2 ± 8.0 0.12 
(9) (13) 
132.8 ± 11.9 N/A 
(13) 
129.2 ± 10.5 N/A 
(13) 
136.4 ± 5.2 N/A 
(13) 
199 
Chapter 8 Ca2+ transients in the/ailing rabbit heart 
Analysis o/Variance 
Single-factor Analysis of Variance (ANOVA) was carried out with the data in the sham-
operated and heart failure groups. In the sham-operated group, an F statistic value of 0.81 
was obtained with a non-significant p-value of 0.65 (F - critical value = 1.77 for p < 0.05). 
In the heart failure group, the F statistic value was 1.01, again giving a non-significant p-
value of 0.44 (F - critical value = 1.87 for p < 0.05). These data suggest that there was no 
significant trend where a particular epicardial site had a consistently. prolonged or brief Ca2+ 
transient duration in either of the experimental groups. 
Multiple comparison test (!'ukey test) 
Single-factor ANOV A is helpful in identifying whether one particular epicardial site had 
Ca2+ transient duration different from the rest of the sites within each experimental group. In 
order to study the difference between pairs of measured sites, a different method has to be 
used. Two-sample t-tests are not appropriate as the calculated test statistic, t, and the critical 
values are designed to test whether the 2 samples are likely to have come from the same 
population and are therefore not applicable to multiple samples (measured sites). Multiple 
comparison tests are used for tackling such problems (Zar, 1996). A commonly-used Tukey 
test was employed to study the relationship between the Ca2+ transient duration measured at 
the different epicardial sites within each experimental group. It was found that the 
calculated statistic ( q value) was below the critical value for significance in both the sham-
operated and heart failure groups. This shows that, within each experimental group, there 
was no correlation between the epicardial site and the Ca2+ transient duration measured. 
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Layer analysis 
Further regional analysis of Ca2+ transient variation was carried out by dividing the heart 
into layers according to the geographic locations of the measure sites (see Figure 3.5). Four 
layers were thus allocated with sites 1, 2, 7 and 8 belonging to the basal layer; sites 3, 4, 9 
and 10 to the upper cavity layer; sites 5, 6, 11 and 12 to the lower cavity layer and sites 13, 
14 and 15 to the apical layer. The mean Ca2+ transient durations for each layer in the 2 
experimental groups are summarised in Table 8.3. It is shown that the mean Ca2+ transient 
duration at the basal, upper cavity and lower cavity layers were significantly longer in the 
heart failure group than controls. The apical layer was where there was a consistent infarct 
in the heart failure group and thus no measurable Ca2+ transients were obtained. The 
individual layers were compared with each other within experimental groups using the 
above mentioned methods for individual epicardial sites. Neither single-factor ANOVA nor 
mUltiple comparison Tukey test identified any correlation between left ventricular layer and 
Ca2+ transient duration in either of the experimental groups. 
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Table 8.3 Comparison of mean Ca2+ transient durations (as measured by the 
beginning of the transient to 50 % decay) at the individual left ventricular 
layers in isolated hearts from rabbits with heart failure (HF) and controls 
(Sham). 
Layer 
Basal 
(sites 1,2, 7, 8) 
Upper cavity 
(sites 3, 4, 9, 10) 
Lower cavity 
(sites 5, 6, 11, 12) 
Apical 
(sites 13, 14, 15) 
Ca2+ transient duration (ms) 
HF (n= 17) Sham (n = 13) 
153.9 ± 4.5 128.1 ± 3.8 
155.5 ± 4.3 125.0 ± 3.8 
153.6 ± 7.0 125.8 ± 3.9 
132.8 ± 5.3 
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Dispersion of Ca1+ transient duration 
As mentioned above, there appeared to be a variation in the time course of Ca2+ transients 
obtained at the various sites within the same heart in both experimental groups and this 
variation appeared to be greater in failing hearts than in controls. This "dispersion" of Ca2+ 
transient duration was studied in greater detail within each experimental group and the 
results from the 2 groups were compared. Again, the Ca2+ transient duration was measured 
from the beginning of the signal to 50 % decay. 
Site by site analysis 
The mean Ca2+ transient duration at each measured epicardial site for the 2 experimental 
groups are summarised in Table 8.2. Firstly, these data showed that there was variation in 
the Ca2+ transient duration measured at different sites within the heart failure group and 
within the sham-operated hearts. Sites 13, 14 and 15 were within the region where there was 
a consistent infarct in the heart failure group and hence there was no measurable Ca2+ 
transient. When the 2 experimental groups were compared at each individual epicardial site, 
it was found that the Ca2+ transient duration was significantly prolonged at most of the left 
ventricular epicardial sites (1, 4, 7, 8, 9, 10 and 11) in failing hearts when compared to 
controls. Ca2+ transient duration was also more prolonged in the remaining sites in failing 
hearts (apart from the infarct zone) than in controls although the difference did not reach 
statistical significance. This suggests that in these remaining sites (2, 3, 5, 6 and 12), there 
were Ca2+ transients recorded in failing hearts which were of a similar duration as that 
observed in sham-operated hearts for those particular sites. If we consider the range of Ca2+ 
transient durations obtained in sham-operated hearts to be "physiological", there were some 
epicardial sites in the failing hearts which had Ca2+ transient durations within this "normal" 
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range and other sites that had much more prolonged Ca2+ transient durations. The 
significance of this increased variation in heart failure was studied by analysing the 
variation of Ca2+ transient duration within each heart in both experimental groups. 
Heart by heart analysis - range of values, standard deviation, dispersion 
The Ca2+ transient durations at all the measured sites within each heart were analysed. The 
maximum value, minimum value and standard deviation of the Ca2+ transient durations for 
each heart were obtained in the 2 experimental groups. Dispersion was measured as the 
difference between the maximum and minimum value in each heart. The mean value of 
these parameters in the heart failure and sham-operated groups are summarised in Table 8.4 
and illustrated in Figure 8.4. 
Figure 8.4 A uses a box and whiskers plot to compare the average standard deviation and 
range of the Ca2+ transient duration in each experimental group. This figure shows that the 
range of Ca2+ transient durations was increased in the heart failure group and this was 
mainly due to the higher maximum value, with a smaller increase in the minimum value 
when compared with the control group. The standard deviation of the Ca2+ transient 
duration in each heart was significantly increased in the heart failure group when compared 
to controls (29.0 ± 2.0 ms vs. 21.9 ± 1.8 ms, p < 0.02). 
An alternative method of analysis is to measure the dispersion of the Ca2+ transient duration 
in each heart by the difference between the longest and the shortest duration. Figure 8.4 B 
shows that dispersion of the Ca2+ transient duration was significantly greater in the heart 
failure group. 
204 
Chapter 8 Ca2+ transients in the/ailing rabbit heart 
Table 8.4 Comparison of variation in Ca1+ transient durations (as measured by the 
beginning of the transient to 50 % decay) within each heart in the heart 
failure group (HF) and controls (Sham). (See text for discussion) 
HF Sham p value 
(n = 17) (n == 13) 
Maximum value (ms) 201.2 ±4.0 155.0 ± 5.0 < 0.001 
Minimum value (ms) 115.1 ± 5.0 90.6 ± 4.3 <0.002 
Standard deviation (ms) 29.0 ± 2.0 21.9 ± 1.8 <0.02 
Dispersion (ms) 86.1 ± 6.6 64.4 ± 5.3 <0.05 
Adjusted dispersion (ms) 31.2 ± 2.4 20.1 ± 1.8 < 0.002 
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Figure 8.4 Panel A shows a box and whiskers plot illustrating the range of Ca2+ 
transient duration values (CaD-50) measured from control (Sham) and heart failure 
(HF) groups. Lines denote the range of CaD-50 values, the upper and lower edges of 
the box denote the standard deviation, and the middle line denotes the mean value of 
the CaD-50. Panel B shows a histogram of the mean dispersion of Ca2+ transient 
duration (maximum CaD-50 value - minimum CaD-50 value in each heart) in both 
control (Sham) and heart failure (HF) groups. Error bars denote standard error. ( * 
indicates a significant difference, p < 0.05) 
206 
Chapter 8 Ca2+ transients in the/ailing rabbit heart 
Adjusted dispersion ojCa2+ transient duration 
Ca2+ transients could be measured from all 15 sites in the control hearts but were not 
available in the infarcted areas in the failing hearts. The infarcted areas could have 
contained a particularly long or short Ca2+ transient duration. Simply taking the difference 
between the longest and shortest measured durations in each heart could have 
underestimated the variation in the failing hearts although this did show a significant 
difference between the 2 groups. The variation of the Ca2+ transient duration appeared to be 
greater in the heart failure group despite the fact that there were fewer sites sampled. An 
attempt was made therefore to correct the Ca2+ transient dispersion for the number of 
measured sites in the each heart. This was done using a simple method employed clinically 
for correcting QT dispersion for the number of ECG leads where the QT interval can be 
confidently measured (Statters et al. 1994). In a study by Day et al. (1991), it was found 
that QT dispersion increased in proportion to the square root of the number of leads 
measurable and could be "adjusted" by dividing the dispersion by the square root of the 
number of leads measured. Using this method, adjusted dispersion of the Ca2+ transient 
duration was obtained by dividing the difference between the longest and shortest duration 
by the square root of the number of measured sites in each heart. It was found that the 
adjusted dispersion of Ca2+ transient duration (measured at 50 % decay) was significantly 
increased in the heart failure group when compared to controls (31.2 ± 2.4 ms vs. 20.1 ± 1.8 
ms, p < 0.002, Table 8.4). 
As mentioned above, Ca2+ transient duration was measured at other points of the time 
course of the Ca2+ transients. The mean duration at the various points during the time course 
of the Ca2+ transients are summarised in Table 8.1 and Figure 8.3 illustrates the comparison 
between the 2 groups with regard to the mean duration and the adjusted dispersion of the 
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duration at the various points during the time course of the transients. It shows that the 
mean Ca2+ transient duration in the heart failure group was significantly prolonged at all 
points during the decay phase of the time course of the Ca2+ transient when compared to 
controls. Adjusted dispersion of the Ca2+ transient duration was also increased in the heart 
failure group when the Ca2+ transients were compared at the peak, 25 % - and 50 % - decay 
of the transients (see Figure 8.3 B). This difference became non-significant during the later 
part of the cardiac cycle at 75 % - and 90 % - decay of the Ca2+ transient signal. This may be 
due to the fact that the hearts were paced at a near-physiological cycle length of 350 ms; 
any difference in the tenninal part of the Ca2+ transient would be difficult to resolve when 
the transients from different parts of the heart would have decayed to near-diastolic levels. 
The significant differences in adjusted dispersion of the Ca2+ transient duration at the peak, 
25 % - and 50 % - decay of the transients between the 2 groups suggest that there was 
increased variation in the Ca2+ transient duration in the heart failure group. 
Effect of altered extracellular [CaH ] on intracellular Ca1+ transient duration in control 
hearts 
The effects of altered extracellular [Ca2+] on intracellular Ca2+ transient and intraventricular 
pressure were studied in 4 sham-operated hearts. Extracellular [Ca2+] was decreased from 
1.8mM to 0.8mM, and increased to 3.6 mM with the hearts being paced at 350 ms cycle 
length from the right atrium. The steady state Ca2+ transients are shown in Figure 8.5 for 
one of the experiments. Lowering the extracellular [Ca2+] reduced both the peak systolic and 
end-diastolic fluorescence ratio. However the duration of the Ca2+ transient was prolonged 
when compared to that measured in nonnal extracellular [Ca2+]. Conversely, raising 
extracellular [Ca2+] increased the peak systolic and end-diastolic fluorescence ratio, while 
the duration of the Ca2+ transient was shorter than nonnal. The results are summarised in 
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Table 8.5 accompanied by the mean peak systolic pressure and maximum rate of pressure 
decay. The intraventricular pressure profile of the isolated Langendorffperfused hearts from 
the heart failure group and the sham-operated group are summarised again in Table 8.6 
together with the mean Ca2+ transient durations in the 2 groups as measured by the CaD-50 
for comparison. 
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A 
0.8 mM (e) 1.8 mM 3.6mM(+) 
1.50 
1.48 
F40/ F495 
Ratio 
1.46 
1.44 
350 ms 
B (i) (ii) 
350 ms 350 ms 
Figure 8.5 Panel A shows records of fluorescence ratio (F4os/F~9S) from one site on 
the epicardial surface of an isolated Langendorff perfused rabbit heart from the 
control group during right atrial pacing at a cycle length of 350 ms. Traces represent 
the average of 30 records sampled in the presence of 0.8 mM (e), 1.8 mM (normal) 
and 3.6 mM (+) extracellular [CaH ]. Panel B shows (i) the traces superimposed on a 
common baseline and (ii) normalised traces superimposed and aligned at the upstroke. 
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Table 8.5 Effect of altered extracellular [Ca1+] on peak systolic pressure, maximum 
rate of pressure decay and Ca1+ transient duration in 4 isolated sham-
operated hearts. 
SysPCmmHg) 
(SysP = left ventricular peak systolic pressure, -dP.dr\max) = maximum rate of 
pressure decay, CaD-50 = mean Ca2+ transient duration measured from the 
beginning of the transient to 50 % decay) 
0.8 mM [Ca2+] 1.8 roM [Ca2+] 3.6 roM [Ca2+] 
28.3 ± 2.1 42.6 ±2.2 54.5 ± 1.3 
-dP.dr1(max) (mmHg.ros·1) 0.32 ± 0.04 0.55 ± 0.05 0.64 ± 0.04 
CaD-50 (ms) 139.5 ± 8.8 126.0 ± 9.5 109.0 ± 9.6 
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Table 8.6 Comparison of left ventricular pressure profile and mean Ca2+ transient 
duration in the isolated Langendorff perfused heart between rabbits with 
heart failure (HF) and controls (Sham). 
SysP(mmHg) 
(SysP = left ventricular peak systolic pressure, dP .dr\max) = maximum rate of 
pressure change, CaD-50 = mean Ca2+ transient duration as measured by the 
beginning of the transient to 50 % decay) 
HF (n = 17) Sham (n = 13) p value 
26.2 ±3.7 49.0 ±2.6 < 0.001 
- dP.dr\max) (mmHg.ms·1) 0.32 ± 0.04 0.66 ± 0.05 < 0.001 
CaD-50 (ms) 156.2 ± 3.2 124.9 ± 2.6 < 0.001 
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Discussion 
Prolonged Ca2+ transient duration in failing hearts 
It was shown in this Chapter that Ca2+ transients recorded from the left ventricular 
epicardial surface of hearts from rabbits with heart failure had a significantly more 
prolonged time course than those obtained from the sham-operated group. There was no 
significant difference in the initial upstroke of the Ca2+ transient (time to 50 % peak) 
between the 2 groups. However, the mean value of the time to peak Ca2+ transient was more 
prolonged in the failing hearts than in controls. There is therefore a longer delay for the Ca2+ 
transient to rise from 50 % peak to its peak level in the failing hearts. This can result either 
from a decrease in sarcoplasmic reticulum (SR) Ca2+ release in the failing hearts (with a 
slow rise to peak [Ca2+]) or from an increase in SR Ca2+-reuptake (attempting to restore 
cytosolic [Ca2+] to baseline before the Ca2+ transient has reached its peak). An increase in 
SR Ca2+ -reuptake in the failing hearts is unlikely when the rest of the Ca2+ transient time 
course was analysed in the 2 groups. In fact, a decrease in SR Ca2+ -reuptake is suggested by 
the fact that there was a progressive delay in the Ca2+ transient duration throughout the 
decay phase of the Ca2+ transient (up to 90 % decay) in the heart failure group when 
compared to controls (Table 8.1). If there was no difference in SR Ca2+ reuptake between 
the 2 groups, one would expect that the difference in the time to peak Ca2+ transient between 
the 2 groups be maintained throughout the decay phase of the transient. The progressive 
increase in the difference in the mean values between the 2 groups at the various time points 
throughout the decay phase (up to 90 % decay) suggests that SR Ca2+ reuptake is reduced in 
the failing hearts compared to controls. The slightly smaller difference between the 2 groups 
at 90 % decay may be due to the fact that the hearts were paced rather fast at a cycle length 
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of 350 ms and the Ca2+ transients were returning to diastolic levels at that point before the 
next cardiac cycle. These results suggest that possibly both SR Ca2+-release and SR Ca2+_ 
reuptake are reduced in the heart failure group when compared to controls. 
Regional variation in the time course of Ca2+ transients 
In addition to a prolongation in Ca2+ transient durations in the failing hearts, it was also 
shown in this Chapter that there was increased variation of the Ca2+ transient durations 
within each heart in the heart failure group when compared to controls. 
Individual hearts from the sham-operated control group exhibited Ca2+ transients with a 
limited range of durations. The cause of this variation is unknown, regional differences in 
excitation pattern are not thought to be a factor since Ca2+ transients of identical time course 
were obtained on atrial or ventricular stimulation at the same site recorded with the single 
light guide. A physiological dispersion of repolarisation is recognised (Brutsaert, 1987) and 
this may be related to the regional variation in Ca2+ transient duration observed in the 
control hearts. Variation in Ca2+ transient durations was also observed within failing hearts 
but this variation was greater in magnitude than in controls. 
There was no consistent relationship between site position and the Ca2+ transient duration in 
either of the experimental groups. No difference was observed when the Ca2+ transients 
obtained from the basal portion of the left ventricle were compared with those from the 
apex. Some studies have suggested an apex to base difference in cardiac action potential 
duration (Cohen et al. 1976; Watanabe et al. 1983). Action potential duration can be 
affected by mechanical load as a result of mechano-electric feedback (Lab, 1982). It is 
conceivable that difference in action potential duration between different regions of the 
heart may be the result of differences in wall tension although it may also be due to 
differences in intrinsic properties of the myocytes in those regions. Regional differences in 
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Ca2+ handling in the heart have not been fully investigated although one early study (Saari 
and Johnson, 1980) reported differences in the Ca2+ content and uptake rate for different 
heart segments. Muscle length changes have been shown to affect Ca2+ transient duration 
(Allen and Kurihara, 1982; Allen et ai. 1988). Differences in regional wall tension in the 
whole heart can result in different resting sarcomere lengths and different muscle length 
changes during the cardiac cycle, giving rise to different Ca2+ transient durations at various 
regions of the heart even if the different regions have similar intrinsic properties. In 
addition, electrical heterogeneity would directly affect Ca2+ homeostasis and hence Ca2+ 
transient durations. Mechanical changes which affect the action potential may also cause 
similar effects on Ca2+ handling (Lab et ai. 1984). 
Regional wall tension was not assessed in the experiments described. Another reservation of 
this study is that the hearts were perfused in the Langendorff mode. The performance of the 
beating heart is quite different when it is perfused in the Langendorff mode from during 
anterograde perfusion in the working heart configuration or in vivo. Thus the regional wall 
tension in the Langendorff perfused heart may not represent the conditions in vivo. An 
effort was made to compare the 2 experimental groups at similar loading conditions, i.e. 
similar sarcomere lengths by inflating the intraventricular balloons to give zero end-
diastolic pressure in each heart. Although this cannot ensure that the regional wall tension is 
similar to the situation in vivo or when the heart is ejecting isotonically, the difference in 
Ca2+ transients observed between the heart failure group and the sham-operated group is not 
due to different loading conditions. 
Dispersion of Ca1+ transient duration 
Further scrutiny of Ca2+ signals from the heart failure group reveals that the longer mean 
duration was a result of abnormally prolonged Ca2+ transients in a number of sites in each 
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heart. Despite recordings being available from fewer sites due to the presence of an apical 
infarct when compared to controls, the variation of Ca2+ transient duration was greater in 
each heart from the heart failure group. This is obvious from measurements of the range of 
values (Figure 8.4 A) or from the measure of the dispersion of Ca2+ transient duration 
(Figure 8.4 B). This was also true when the dispersion of Ca2+ transient duration was 
adjusted for the number of sites measured (Table 8.4). Therefore, changes in the 
myocardium in this model of heart failure in the rabbit appear heterogeneous. Some regions 
showed pronounced prolongation of the Ca2+ transient while the duration of the transients in 
others were close to normal. As with the normal myocardium in control hearts, there 
appeared to be no consistent relationship between site position and the duration of the Ca2+ 
transient. In particular, prolonged Ca2+ transients were not specifically located at the border 
between normal and infarcted myocardium suggesting that the remodelling process in heart 
failure may be a heterogeneous one. A recent study (Mubagwa et al. 1998) also suggests 
that the abnormality in Ca2+ handling is not homogeneous in the failing heart with previous 
myocardial infarct, but it was reported that Ca2+ uptake was reduced in the surviving 
myocardium close to the infarcted area as compared to regions remote from the infarct. 
Systolic dysfunction and Ca2+ handling 
The smaller systolic pressures observed in failing hearts were naturally associated with 
slower maximum rates of relaxation (see Table 8.6). The limitations of the optical 
techniques used to measure Ca2+ transients prevented the systolic and diastolic intracellular 
[Ca2+] being measured as discussed in Chapter 7 but it would not be unreasonable to assume 
that the slower rates of decay of the Ca2+ transients in failure hearts were accompanied by a 
reduced peak systolic [Ca2+]. A number of investigators have demonstrated a reduced peak 
systolic [Ca2+] in isolated myocardial preparations or myocytes from failing hearts 
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(Beuckelmann et al. 1992; Capasso et al. 1993). These studies also demonstrated a marked 
prolongation of the Ca2+ transient. Changes in Ca2+ transient duration as a result of inotropic 
changes have been extensively studied in multicellular (Allen and Kurihara, 1980; Endoh 
and Blinks, 1988) and single cell preparations (Frampton et al. 1991; Bers and Berlin, 
1995). It was found that the rate of [Ca2+] decline during diastole in cardiac myocytes 
depends on peak systolic [Ca2+] with a low systolic [Ca2+] being associated with a slowed 
diastolic [Ca2+] decline. The basis for the effect on time course is thought to be a slowed 
rate of Ca2+ uptake by the sarcoplasmic reticulum. 
The possibility that prolongation of Ca2+ transient duration observed in failing hearts was a 
result of reduced peak systolic [Ca2+] was studied by examining the effect of altering the 
extracellular [Ca2+] on the Ca2+ transient duration in the control hearts. When the reduced 
peak systolic force was mimicked in control hearts by reducing the extracellular [Ca2+] to 
0.8 mM, this was accompanied by a prolongation of the Ca2+ transient measured at one site 
on the epicardial surface. In contrast to this, increasing extracellular [Ca2+] to 3.6 mM 
caused an increased peak systolic pressure and a shortening of the duration of the Ca2+ 
transient. The contractile performance of control hearts perfused with 0.8 mM extracellular 
Ca2+ appeared to be very similar to the average contractile performance of the heart failure 
group in terms of peak systolic pressure and maximum rate of pressure decay. However, 
the Ca2+ transient duration under conditions of low extracellular [Ca2+] in control hearts was 
not prolonged to the same extent as that seen in heart failure (see Tables 8.5 & 8.6). The 
fact that the measurement of Ca2+ transient was performed at only one site, weakens this 
comparison but it would be expected that the effects of lowering extracellular [Ca2+] would 
have uniform effects on the intracellular [Ca2+] across the ventricle. These results suggest 
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that the abnormally long Ca2+ transients observed in heart failure may be partly explained 
by a reduced peak systolic intracellular [Ca2+]. 
The trigger for sarcoplasmic reticulum Ca2+ release, namely Ca2+ entry via the voltage-
sensitive L-type channels is believed to be unchanged in heart failure by many investigators 
(Beuckelmann et aZ. 1991; Mewes and Ravens, 1994; Kaab et al. 1996; Qiu et aZ. 1996; 
Rozanski et al. 1997) although there are reports to the contrary (Rossner, 1991; Hatem et al. 
1994; Ming et al. 1994). In the absence of altered Ca2+ trigger influx, a reduced systolic 
[Ca2+] would result from abnormality of the sarcoplasmic reticulum Ca2+ release 
mechanism. There are reports that the expression, level and function of the sarcoplasmic 
reticulum Ca2+ -release channel are decreased in heart failure (Brillantes et al. 1992; 
D'Agnolo et aZ. 1992; Arai et al. 1993; Lachnit et aZ. 1994; Go et aZ. 1995) although these 
results are not universal (Finkel et aZ. 1992; Sapp and Howlett, 1994; Meyer et al. 1995). 
There is also recent evidence (Gomez et al. 1997) that the architectural coupling of the 
sarcolemmal L-type channel and the sarcoplasmic reticulum Ca2+ -release channel is altered 
so that Ca2+ influx is not as effective in evoking Ca2+ release. However, the effect that such a 
decrease in the sensitivity of Ca2+ -induced Ca2+ release may have on steady state systolic 
[Ca2+] is debatable. It has been shown that tetracaine (an agent which inhibits Ca2+ -induced 
Ca2+ release) only transiently inhibits contraction (and Ca2+ transients) in cardiac myocytes 
and contraction returns to normal when the myocyte gains Ca2+ by reducing efflux (via a 
reduced Na+ / Ca2+ exchanger tail current) until a balance is reached with influx again 
(overend et al. 1997a; Overend et al. 1997b). 
Depressed sarcoplasmic reticulum function is consistent with the results described in this 
Chapter since the abnonnally long Ca2+ transients recorded are probably the result of 
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reduced sarcoplasmic reticulum Ca2+ release and / or reuptake in heart failure. The increased 
variation in Ca2+ transient duration over the epicardial surface in failing hearts suggests that 
the alteration in excitation-contraction coupling may be a heterogeneous process in the 
whole heart. 
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LEFT VENTRICULAR EPICARDIAL MONOPHASIC 
ACTION POTENTIALS IN HEART FAILURE 
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Introduction 
As mentioned in Chapter 1, action potential prolongation is a consistent finding in studies 
on the failing myocardium and delayed repolarisation is associated with changes in ion 
channel activity. A prolonged action potential has been shown in myocytes (Beuckelmann 
et al. 1993; Kaab et al. 1996; Qiu et al. 1996) and muscle preparations (Rossner and Sachs, 
1978; Gwathmey et al. 1987) isolated from failing hearts but has not been demonstrated 
under more physiological conditions. Recent studies (Barr et al. 1994; Fu et ai. 1997) have 
shown an increased dispersion of repolarisation, as suggested by increased QT dispersion 
on EeG, in patients with heart failure and they ruso showed that this was a prognostic 
marker for sudden cardiac death in these patients. Monophasic Action Potential (MAP) is 
an extracellularly recorded signal that reflects changes in the intracellular action potential 
(Franz, 1991). MAPs have been used in the whole heart to study repolarisation and the 
effects of drugs, ischaemia, heart mechanics, etc. in normal and diseased myocardium 
(Franz et ai. 1984; Lab, 1991; Yuan et ai. 1994) and have also been used to examine 
dispersion of repolarisation in the isolated heart as a result of volume / load changes (Reiter 
ef al. 1988; Zabel et al. 1996). 
This Chapter describes the measurements of MAP signals from the left ventricular 
epicardial surface of isolated hearts from rabbits with heart failure and the time course and 
regional characteristics of the signals are analysed. 
Methods 
MAPs were measured using suction electrodes, as described in Chapter 3, from the 
epicardial surface of 9 isolated hearts from the heart failure and 5 from the sham-operated 
group after the Ca2+ measurement experiments described in Chapter 8 .. MAPs were 
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measured from the same 15 left ventricular epicardial sites where the Ca2+ transients were 
measured, according to the arbitrary map illustrated in Figure 3.5. The isolated hearts were 
paced at a cycle length of 350 ms via the right atrium and recordings were made at 37°C. 
The duration of the MAP signals were measured and compared between 2 groups. Variation 
of the MAP duration at different sites within each heart was analysed and this variation was 
also compared between the 2 groups. 
Results 
A representative tracing of the MAP signals is shown in Figure 9.1. The MAP signals 
showed a "spike and dome" appearance. There was an initial sharp upstroke ending in a 
spike followed by a small downward deflection before the dome-shaped repolarisation 
phase. The small spikes between the MAP signals shown in Figure 9.1 are pacing artefacts 
as the recordings were made with right atrial pacing at a cycle length of 350 ms. 
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Figure 9.1 Representative tracing of Monophasic Action Potential (MAP) signals 
recorded from the left ventricular epicardial surface of an isolated Langendorff 
perfused heart, paced via the right atrium at 350 ms cycle length. The MAP signals 
are composed of a spike and dome appearance. Arrows mark the beginning of the 
upstroke of the signal, the point from where the duration of each signal was measured. 
The small spikes between the MAP signals are pacing artefacts. The trace represents 
an average of 10 recordings. 
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Measurement of the time course of MAP signals 
The MAP signals were recorded from the same epicardial sites where the Ca2+ transients 
were measured in the 9 failing hearts and 5 controls. As with Ca2+ transients, the MAP 
signals were analysed in all 15 sites obtained from sham-operated hearts. In failing hearts, 
since recordings from sites within the infarct zone gave no MAP signal, analysis only 
included recordings from the remaining surviving myocardium with transient signals, the 
number of viable sites ranging from 7 to 12 (mean of 9). 
The time course of the MAP signals measured at each left ventricular epicardial site was 
analysed in a similar way as that described for Ca2+ transient duration in Chapter 8. The 
MAP signals were analysed from the beginning of the sharp upstroke to the various points 
of the signals. The time intervals between the beginning of the upstroke to the peak, to 25 % 
decay, to 50 % decay, to 75 % decay and to 90 % decay were measured for each of the 
epicardial sites. The peak of the signal referred to here represents the peak of the dome 
component of the signal. In some MAP signals, the spike of the upstroke was of a greater 
amplitude than the following dome component. The time intervals were all measured from 
the beginning of the upstroke to the various points with reference to the amplitude of the 
peak of the dome component (and not the peak of the upstroke). A mean value was obtained 
for each heart of the time to peak (MAPD-Peak), time to 25 % decay (MAPD-25), time to 
SO % decay (MAPD-50), time to 75 % decay (MAPD-75) and time to 90 % decay (MAPD-
90). The values obtained from failing hearts were compared with those from controls and 
are summarised in Table 9.1 and illustrated in Figure 9.2. There was a significant delay in 
the time to peak (MAPD-Peak) in the failing hearts compared to controls with a difference 
of 21.4 ms between the mean values in the 2 groups. This difference remained about the 
same with some variation (18.7 to 23.9 ms) for the rest of the decay phase of the MAP 
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signal. The mean MAP duration was significantly longer in failing hearts than in controls 
throughout the MAP signal. 
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Table 9.1 Comparison of the time course of Monophasic Action Potentials (MAPs) 
over the left ventricular epicardial surface of isolated hearts from rabbits 
with heart failure (HF, n = 9) and controls (Sham, n = 5). 
Measurements were made from the beginning of the upstroke at each measured 
site to the various points of the signal at a pacing cycle length of 350 ms. The 
differences between the mean values obtained for the 2 groups at the various 
points of the MAP signal are also shown. 
HF Sham p value Difference (ms) 
Time to Peak (ms) - MAPD-Peak 56.3 ±4.1 34.9 ± 1.8 < 0.005 21.4 
Time to 25 % decay (ms) - MAPD-25 106.7 ±3.3 82.8 ± 2.1 < 0.001 23.9 
Time to 50 % decay (ms) - MAPD-50 132.4 ±2.8 110.2 ± 3.3 < 0.001 22.2 
Time to 75 % decay (ms) - MAPD-75 152.3 ±2.4 133.6 ± 4.0 < 0.002 18.7 
Time to 90 % decay (ms) - MAPD-90 179.1 ±4.0 157.2 ± 5.2 < 0.01 21.9 
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TIme course of MAP signals 
o to Peak 0 to 25%0 0 to 50%0 0 to 75%0 0 to 90%0 
Adjusted Dispersion I~HF I rc=:g Sham 
o to Peak 0 to 25%0 0 to 50%0 0 to 75%0 0 to 90%0 
Figure 9.2 Comparison of (A) the time course of Monophasic Action Potential 
(MAP) signals and (B) adjusted dispersion time (see text) at the various points of the 
MAP signal time course, over the left ventricular epicardial surface of isolated hearts 
from rabbits with heart failure (HF) and controls (Sham) at a cycle length of 350 ms 
during right atrial pacing. 
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Correlation between MAP duration and site location 
As with the Ca2+ transient duration described in Chapter 8, several methods of analysis were 
carried out to correlate the MAP duration with the location of the site measured to see if any 
particular epicardial sites had consistently long or consistently short MAP durations in 
either of the experimental groups. MAP duration was measured from the beginning of the 
signal to 50 % decay at each measured site. The mean MAP duration at each measured site 
for both experimental groups are shown in Table 9.2. The difference between the 2 
experimental groups at each measured site in relation to the variation in MAP duration will 
be discussed in a later section "Dispersion of MAP duration ". The analyses described here 
were carried out to examine the relationship between the epicardial site and MAP duration 
measured within each of the experimental groups. 
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Table 9.2 Comparison of mean Monophasic Action Potential (MAP) duration (as 
measured by the beginning of the upstroke to SO % decay) at the individual 
left ventricular epicardial sites in isolated hearts from rabbits with heart 
failure (HF) and controls (Sham). 
Numbers in brackets represent the number of hearts in each group where MAPs 
were measurable at each site. 
Site No. MAP duration fms) p value 
HF (n = 9) Sham (n = 5) 
140.4 ± 6.1 109.0 ± 2.9 < 0.01 
(9) (5) 
2 128.5 ± 3.5 109.8 ± 6.3 < 0.05 
(9) (5) 
3 142.2 ± 6.0 112.3 ± 3.8 <0.02 
(9) (5) 
4 131.6 ± 5.1 112.8 ± 5.3 <0.05 
(9) (5) 
5 140.3 ± 10.3 119.0 ± 4.5 0.08 
(4) (5) 
6 127.0 ± 18.0 110.0 ± 4.3 0.28 
(2) (5) 
7 137.6 ± 4.0 10l.0 ± 3.9 < 0.001 
(9) (5) 
8 124.6 ± 9.9 ]06.4 ± 6.6 < 0.20 
(9) (5) 
9 127.7 ± 6.l 102.0 ± 5.3 <0.02 
(9) (5) 
10 133.3 ± 4.4 113.8 ± 5.4 <0.02 
(9) (5) 
11 124.5 ± 6.5 109.0 ± 7.8 0.28 
(4) (5) 
12 138.7 ± 3.9 119.4 ± 4.4 < 0.05 
(9) (5) 
13 103.6 ± 3.4 N/A 
(5) 
14 116.4 ± 4.6 N/A 
(5) 
15 106.0 ± 2.5 N/A 
(5) 
229 
Chapter 9 MAP signals in the failing rabbit heart 
Analysis of Variance 
Single-factor Analysis of Variance (ANOVA) was carried out with the data in the sham-
operated and heart failure groups. In the sham-operated group, an F statistic value of 1.39 
was obtained with a non-significant p-value of 0.19 ( F - critical value = 1.88 for p < 0.05). 
In the heart failure group, the F statistic value was 0.84, again giving a non-significant p-
value of 0.60 (F - critical value = 1.95 for p < 0.05). These data suggest that there was no 
significant trend where a particular epicardial site had consistently prolonged or brief MAP 
duration within either of the experimental groups. 
Multiple comparison test (Tukey test) 
Single-factor ANOVA is helpful in identifying whether one particular epicardial site had 
MAP duration different from the rest of the sites within each experimental group. In order 
to study the difference between pairs of measured sites, a mUltiple comparison test, the 
Tukey test, was employed to study the relationship between the MAP duration measured at 
the different epicardial sites within each experimental group. It was found that the 
calculated statistic ( q value) was below the critical value for significance in both the sham-
operated and heart failure groups. This shows that, within each experimental group, there 
was no correlation ,between the epicardial site and the MAP duration measured. 
Layer analysis 
Further regional analysis of MAP variation was carried out by dividing the heart into layers 
according to the geographic locations of the measure sites (see Figure 3.5). Four layers were 
thus allocated with sites 1, 2, 7 and 8 belonging to the basal layer; sites 3, 4, 9 and 10 to the 
upper cavity layer; sites 5, 6, 11 and 12 to the lower cavity layer and sites 13, 14 and 15 to 
the apical layer. The mean MAP durations for each layer in the 2 experimental groups are 
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summarised in Table 9.3. It is shown that the mean MAP duration at the basal, upper cavity 
and lower cavity layers were significantly longer in the heart failure group than controls. 
The apical layer was where there was a consistent infarct in the heart failure group and thus 
no measurable MAP signals were obtained. The individual layers were compared with each 
other within experimental groups using the above mentioned methods for individual 
epicardial sites. Neither single-factor ANOV A nor multiple comparison Tukey test 
identified any correlation between left ventricular layer and MAP duration in either of the 
experimental groups. 
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Table 9.3 Comparison of mean Monophasic Action Potential (MAP) duration (as 
measured by the beginning of the upstroke to 50 % decay) at the individual 
left ventricular layers in isolated hearts from rabbits with heart failure 
(HF) and controls (Sham). 
Layer 
Basal 
(sites 1,2,7,8) 
Upper cavity 
(sites 3, 4, 9, 10) 
Lower cavity 
(sites 5, 6, 11, 12) 
Apical 
(sites 13, 14, IS) 
MAP duration (ms) 
HF (n = 9) Sham (n= 5) 
131.9 ± 3.1 106.2 ±2.S 
132.4 ±2.S 109.8 ±2.7 
134.0 ± S.O 114.6 ± 2.6 
108.9 ± 2.6 
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< 0.001 
< 0.001 
< 0.001 
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Dispersion of MAP duration 
As mentioned above, there appeared to be a variation in the time course of the MAP signals 
obtained at the various sites within the same heart in both experimental groups and this 
variation appeared to be greater in failing hearts than in controls. This "dispersion" of MAP 
duration was studied in greater detail within each experimental group and the results from 
the 2 groups were compared. Again, the MAP duration was measured from the beginning of 
the upstroke to 50 % decay. 
Site by site analysis 
The mean MAP duration at each measured epicardial site for the 2 experimental groups are 
summarised in Table 9.2. Firstly, these data showed that there was variation in MAP 
duration measured at different sites within the heart failure group and within the sham-
operated hearts. Sites 13, 14 and 15 were within the region where there was a consistent 
infarct in the heart failure group and hence there was no measurable MAP signal. When the 
2 experimental groups were compared at each of the remaining individual epicardial sites, it 
was found that the MAP duration was significantly prolonged at all but 3 of the left 
ventricular epicardial sites in failing hearts when compared to controls. The MAP duration 
at sites 5, 6 and 11 were longer in the heart failure group than controls but this difference 
did not reach statistical significance. These 3 sites were frequently involved in the 
myocardial infarct depending on the level of coronary ligation and the size of the infarct. 
Thus, viable tissue was only present and MAP signals were only recordable in 4 of the 9 
failing hearts at site S, 2 at site 6 and 4 at site 11. The lack of statistical significance in the 
MAP duration at these sites between failing hearts and controls may be attributable to the 
smaller sample at these sites. Another possibility is that these sites contained myocardium 
233 
Chapter 9 MAP signals in the failing rabbit heart 
with MAP durations that were close to the nonnal range. The data obtained from the other 
epicardial sites suggested that MAP signals obtained from most of the left ventricular 
epicardial surface were prolonged compared to controls. The variations in MAP duration 
within each heart in both experimental groups were analysed using methods similar to those 
described in Chapter 8 for Ca2+ transient duration. 
Heart by heart analysis - range of values, standard deviation, dispersion 
The MAP durations at all the measured sites within each heart were analysed. The 
maximum value, minimum value and standard deviation of the Ca2+ transient durations for 
each heart were obtained in the 2 experimental groups. Dispersion was measured as the 
difference between the maximum and minimum value in each heart. The mean value of 
these parameters in the heart failure and sham-operated groups are summarised in Table 9.4 
and illustrated in Figure 9.3. 
Figure 9.3 A uses a box and whiskers plot to compare the average standard deviation and 
range of the MAP duration in each experimental group. This figure shows that the range of 
MAP durations was increased in the heart failure group and this was mainly due to a 
significantly higher maximum value. The minimum value was also slightly increased in the 
heart failure group but this difference did not reach statistical significance (p = 0.07) when 
compared with the control group. The standard deviation of the MAP duration in each heart 
was significantly increased in the heart failure group when compared to controls (13.6 ± 1.8 
ms vs. 9.1 ± 1.0 ms, p < 0.05). 
Dispersion of MAP duration in each heart was analysed by calculating the difference 
between the longest and the shortest duration. Figure 9.3 B shows that dispersion of the 
MAP duration was greater in the heart failure group than controls but this difference did not 
reach statistical significance (38.6 ± 5.3 ms vs. 27.6 ± 2.5 ms, p = 0.08). 
234 
Chapter 9 MAP signals in the Jailing rabbit heart 
Table 9.4 Comparison of variation in Monophasic Action Potential (MAP) durations 
(as measured by the beginning of the upstroke to 50 % decay) within each 
heart in the heart failure group (HF) and controls (Sham). (See text for 
discussion) 
HF (n =9) Sham (n = 5) p value 
Maximum value (ms) 147.4 ± 3.2 124.8 ± 2.9 < 0.001 
Minimum value (ms) 108.9 ± 4.8 97.6 ± 3.7 0.07 
Standard deviation (ms) 13.6 ± 1.8 9.1 ± 1.0 <0.05 
Dispersion (ms) 38.6 ± 5.3 27.6 ±2.5 0.08 
Adjusted dispersion (ms) 13.5 ± 1.9 7.4 ± 0.7 < 0.02 
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Figure 9.3 Panel A shows a box and whiskers plot illustrating the range of 
Monophasic Action Potential duration values (MAPD-50) measured from control 
(Sham) and heart failure (HF) groups. Lines denote the range of MAPD-50 values, the 
upper and lower edges of the box denote the standard deviation, and the middle line 
denotes the mean value of the MAPD-SO. Panel B shows a histogram of the mean 
dispersion of MAP duration (maximum MAPD-50 value - minimum MAPD-50 value 
in each heart) in both control (Sham) and heart failure (HF) groups. E rror bars 
denote standard error. 
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Adjusted dispersion of MAP duration 
As discussed in Chapter 8 with dispersion of Ca2+ transient duration, simply taking the 
difference between the longest and shortest durations as a measure of dispersion is probably 
an over-simplification. The dispersion of MAP duration was corrected for the number of 
measured sites in the each heart by dividing the difference between the longest and shortest 
duration by the square root of the number of measured sites in each heart. It was found that 
the adjusted dispersion of MAP duration (measured at 50 % decay) was significantly 
increased in the heart failure group when compared to controls (13.5 ± 1.9 ms vs. 7.4 ± 0.7 
ms, p < 0.02, Table 9.4). 
As mentioned above, MAP duration was measured at other points of the time course of the 
MAP signals. The mean duration at the various points during the time course of the MAP 
signals are summarised in Table 9.1 and Figure 9.2 illustrates the comparison between the 2 
groups with regard to the mean duration and the adjusted dispersion of the duration at the 
various points during the time course of the signals. It shows that the mean MAP duration 
in the heart failure group was significantly prolonged at all points during the decay phase of 
the time course of the MAP signals when compared to controls. Adjusted dispersion of 
MAP duration was also significantly increased in the heart failure group at the various 
points during the decay phase of the MAP signals except at 75 % - decay where the 
difference was not statistically different. 
Discussion 
It was shown in this Chapter that the MAP signals obtained from the left ventricular 
epicardial surface of Langendorff perfused hearts isolated from rabbits with heart failure 
followed a similar trend of abnormality as that seen in Ca2+ transients. The MAP duration 
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was prolonged in the failing hearts when compared to sham-operated controls and there was 
increased variation of the durations with each heart in the heart failure group than in 
controls. 
Prolonged MAP duration in failing hearts 
The time to peak of the dome component of the MAP signal (MAPD-Peak) was 
significantly delayed in the failing hearts when compared to controls, with a difference of 
about 20 ms in the mean values in the 2 groups (Table 9.1). This difference was maintained 
at around the same magnitude throughout the rest of the decay phase of the MAP signal. 
This shows that the prolongation of MAP duration in the failing heart occurs predominantly 
during the early part of the MAP signal. It is difficult to infer which ionic currents are 
responsible for this observation as the MAP signal is only an indirect assessment of the 
transmembrane action potential. However, these results suggest that ionic currents active 
during the early repolarisation phase of the action potential may be involved and the 
prolongation of MAP duration in the failing hearts could have resulted from a reduced 
outward current, increased inward current, or both. 
Regional variation in the time course of MAP signals 
Individual hearts from the sham-operated control group exhibited MAP signals with a 
limited range of durations. Non-uniform recovery of excitability with a physiological 
dispersion of repolarisation is well-recognised (Han and Moe, 1963; Brutsaert, 1987) and 
this may be related to the regional variation in MAP duration observed in the control hearts. 
Variation in MAP durations was also observed within failing hearts but this variation was 
greater in magnitude than in controls. 
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There was no consistent relationship between the site position and the MAP duration in 
either of the experimental groups. No difference was observed when the MAP signals 
obtained from the basal portion of the left ventricle were compared with those from the 
apex. Some studies have suggested an apex to base difference in action potential duration 
(Cohen et al. 1976; Watanabe et al. 1983). Action potential duration is affected by 
mechanica1load as a result of mechano-electric feedback (Lab, 1982). It is conceivable that 
difference in action potential duration between different regions of the heart may be the 
result of difference in wall tension although it may be due to differences in intrinsic 
properties of the myocytes in those regions. Regional wall tension was not assessed in the 
experiments described. Another reservation of this study is that the hearts were perfused in 
the Langendorff mode. The contractile performance of the beating heart is quite different 
when it is perfused in the Langendorff mode than when it is anterogradely perfused in the 
working heart configuration, not to mention when in vivo. Thus the regional wall tension in 
the Langendorff perfused heart may not represent the conditions in vivo. An effort was 
made to compare the 2 experimental groups at similar loading conditions by inflating the 
intraventricular balloons to give zero end-diastolic pressure in each heart. Although this 
cannot ensure that the regional wall tension is similar to the situation in vivo or when the 
heart is ejecting isotonically, the difference in MAP signals observed between the heart 
failure group and the sham-operated group should not be due to different loading 
conditions. 
Dispersion of MAP duration 
Further scrutiny of MAP signals from the heart failure group reveals that the longer mean 
duration was a result of abnormally prolonged MAP durations in a majority of sites in each 
heart. The variation of MAP duration was greater in each heart from the heart failure group 
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as measured by the standard deviation and adjusted dispersion of the MAP durations. The 
fact that there was only a small non-significant increase in the shortest MAP duration in 
each heart in the heart failure group when compared to controls suggests that there were 
regions in the failing hearts that had MAP durations close to the normal range. Indeed when 
the MAP durations were compared between the 2 experimental groups at each measured 
site, there were 3 sites (5,6 and 11) in the heart failure group which contained MAP signals 
with prolonged durations that were not statistically different from controls. There may be 
several reasons for this observation:- (1) As already discussed, the apparent lack of 
difference could be the result of a smaller sample of measurements at these sites in the heart 
failure group due to the fact that these sites were frequently involved in the infarct. (2) 
These regions could have contained myocardium with MAP durations that were close to the 
normal range. This possibility has been discussed in Chapter 8 as Ca2+ transients were found 
to be significantly prolonged in some of the epicardial sites in the failing hearts whilst in 
others (sites 2, 3, 5, 6, 12), there was a non-significant prolongation when compared to 
controls. (3) The fact that these regions were close to the infarct zone (where the ventricular 
wall was thin) could have made these sites more prone to the effect of stretch or increased 
wall tension. MAP durations at these sites could be affected by mechano-electric feedback 
to a greater extent as a result. 
The increased variation of the MAP signals with an overall increase in the MAP durations 
in the heart failure group suggests that changes in the myocardium in this model of heart 
failure in the rabbit are non-uniform as seen in the results of Ca2+ transients described in 
Chapter 8. The electrical remodelling process in heart failure may well be a heterogeneous 
one. 
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CA2+ HANDLING AND VENTRICULAR REPOLARISATION 
IN HEART FAILURE 
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Introduction 
In this Chapter, the mechanical function, Ca2+ handling and ventricular repolarisation data 
in the isolated Langendorff perfused hearts from both heart failure and sham-operated 
groups are correlated. 
Methods 
Mechanical function and Ca1+ handling in heart failure 
The pressure profiles of the isolated hearts were compared with the mean duration of Ca2+ 
transients obtained in each heart in the 2 experimental groups. 
Cardiac remodelling and Ca1+ handling in heart failure 
As described in Chapter 4, it was shown that there was significant cardiac remodelling 
produced by the heart failure model as demonstrated by the increased chamber dimensions 
on echocardiography and increased tissue weight in the failing hearts. Left ventricular dry 
weight was correlated with the mean duration of Ca2+ transients obtained in the 
corresponding heart. 
Ventricular repolarisation and Ca1+ handling in heart failure 
In 9 hearts from the heart failure group and 5 from the sham-operated group, Monophasic 
Action Potentials (MAPs) were measured at the same left ventricular epicardial sites where 
Ca2+ transients were measured. The Ca2+ transient and MAP data were compared and 
correlated in the 2 experimental groups. 
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Results 
Mechanical function and Ca1+ handling in heart failure 
It was shown in Chapter 6 that the rabbit coronary artery ligation model produced heart 
failure with significant systolic and diastolic dysfunction. This was demonstrated in the 
haemodynamic parameters in the working heart configuration and also in the left ventricular 
pressure profile in the Langendorff perfused hearts where Ca2+ measurements were made. 
The intraventricular pressure profile of the isolated Langendorff perfused hearts from the 17 
hearts from the heart failure group and 13 from the sham-operated group are summarised 
again in Table 10.1 together with the mean Ca2+ transient durations in the 2 groups as 
measured by the CaD-50 (from the beginning of the transient to 50 % - decay, see Chapter 
8). The peak systolic pressure in the heart failure group was decreased compared to 
controls. The maximum rate of pressure decay during diastole was also decreased in the 
failing hearts (0.32 ± 0.04 mmHg.ms·\ vs. 0.66 ± 0.05 mmHg.ms·\ in controls, p < 0.001) 
whilst the mean Ca2+ transient duration was prolonged (156.2 ± 3.2 ms vs. 124.9 ± 2.6 ms in 
controls, p < 0.001). These 2 latter parameters were considered together in both 
experimental groups and Figure 10.1 shows that there was a significant correlation between 
the mean Ca2+ transient duration in each heart and the corresponding maximum rate of 
pressure decay (r = - 0.63, P < 0.001). This suggests that impaired relaxation in the failing 
heart was associated with a prolonged Ca2+ transient duration. 
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Table 10.1 Comparison of left ventricular pressure profile and mean Ca2+ transient 
duration in the isolated Langendorff perfused heart between rabbits with 
heart failure (HF) and controls (Sham). 
SysP(mmHg) 
(SysP = left ventricular peak systolic pressure, dP .dr\max) = maximum rate of 
pressure change, CaD-50 = mean Ca2+ transient duration as measured by the 
beginning of the transient to 50 % decay) 
HF(n = 17) Sham (n = 13) P value 
26.2 ± 3.7 49.0 ±2.6 < 0.001 
- dP.dr\mlX) (mmHg.ms· l ) 0.32 ± 0.04 0.66 ± 0.05 < 0.001 
CaD-50 (ms) 156.2 ± 3.2 124.9 ± 2.6 < 0.001 
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Figure 10.1 Plot of the mean Ca1+ transient duration (CaD-50) in each heart against 
the corresponding maximum rate of pressure decay [-dP.dr\mu)] for both control (0) 
and heart failure (.) groups. The solid line is the linear regression of the two 
variables with the correlation coefficient (r) and significance value (p) shown in the 
shaded box. 
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Cardiac remodelling and Ca2+ handling in heart failure 
Structural changes in the heart as a result of the coronary artery ligation procedure were 
described in Chapter 4. Significant cardiac remodelling and compensatory hypertrophy 
were demonstrated in the remaining surviving myocardium in the failing hearts as a result 
of the myocardial infarct. Left ventricular dry weight in the 17 hearts from the heart failure 
group where Ca2+ transients were measured, corrected for body weight, was 0.38 ± 0.02 
g.kg-). This was significantly greater than the corrected left ventricular dry weight in the 13 
hearts from the sham-operated group (0.31 ± 0.01 g.kg-1, P < 0.02). When the corrected left 
ventricular dry weight was considered together with the corresponding mean Ca2+ transient 
duration in each heart from the 2 experimental groups, it was found that there was a 
significant correlation between these 2 parameters (r = 0.41, P < 0.05, see Figure 10.2). This 
suggests that compensatory hypertrophy in the failing heart was associated with a prolonged 
Ca2+ transient duration. 
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Figure 10.2 Plot of the mean Ca2+ transient duration (CaD-50) in each heart against 
tbe corresponding corrected left ventricular dry weight (LV dry weightc) for both 
control (0) and heart failure (.) groups. The solid line is the linear regression of the 
two variables with the correlation coefficient (r) and significance value (p) shown in 
the shaded box. 
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Ventricular repolarisation and Cal + handling in heart failure 
In 9 hearts from the heart failure group and 5 from the sham-operated group, data were 
available for the Ca2+ transient durations measured at the various left ventricular epicardial 
sites together with the Monophasic Action Potential (MAP) durations at the corresponding 
sites. It was shown in Chapter 8 that the mean Ca2;" transient duration was significantly 
prolonged in failing hearts when compared to controls and likewise the mean MAP duration 
was shown in Chapter 9 to be significantly prolonged in failing hearts. CaH transient and 
MAP durations were considered together and the Hotelling's 2-sample r-test was employed 
to compare the 2 experimental groups. Equal covariance matrices were verified in the 2 
parameters with the Box's m-test and the Hotelling's test showed that the 2 experimental 
groups were significantly different with the heart failure group having significantly 
prolonged Ca2+ transient and MAP durations (F statistic = 40.6, critical value = 3.07 for p < 
0.05). 
A relationship between Ca2-+- transient duration and MAP duration was then sought by 
correlating the Ca2+ transient at each measured site in both experimental groups with the 
corresponding MAP duration at that site. The results are plotted in Figure 10.3. It was 
evident that the mean durations of both Ca2;" transients and MAP signals were prolonged in 
the heart failure group with greater variation in the 2 parameters in the heart failure group 
than controls. There was a weak but significant association between the Ca2+ transient 
duration obtained at each left ventricular epicardial site and the corresponding MAP 
duration recorded at the site in the 2 experimental groups (r = 0.32, p < 0.001). These data 
suggest that epicardial sites in failing hearts which had prolonged Ca2+ transient durations 
also tended to have prolonged MAP durations. 
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Figure 10.3 Plot of the mean Ca1+ transient duration (CaD-SO) at each measured 
epicardial site against the corresponding Monophasic Action Potential duration 
(MAPD-SO) for both control (0) and heart failure (e) groups. Rectangular boxes 
denote limits of the measured parameters in the heart failure group (solid line) and 
controls (broken lines). The oblique solid line is the linear regression of the two 
variables with the correlation coefficient (r) and significance value (p) shown in the 
sbaded box. 
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Discussion 
In the study by Gwathmey et al. (1987), ventricular trabeculae isolated from patients with 
heart failure showed a significant prolongation in tension development with a marked delay 
in relaxation. Corresponding Ca2+ transients were prolonged and action potentials recorded 
from these trabeculae were also reported to be prolonged. Beuckelmann et al. (1992) 
showed similar fmdings in ventricular myocytes isolated from patients with heart failure 
with significant prolongation in both action potentials and Ca2+ transients in the failing 
myocytes. These experiments were, however, carried out under low pacing rates and 
temperatures. There are no data on such changes under more physiological conditions in the 
literature. 
As discussed in Chapter 1, it would not be unreasonable to suggest that the mechanical 
abnormalities seen in the failing myocardium are related to changes in Ca2+ handling since 
Ca2+ is central in the excitation-contraction coupling process. The data on action potentials 
and Ca2+ transients in heart failure tend to suggest that the abnormalities in Ca2+ handling 
may be associated with electrophysiological abnormalities in the failing myocardium. These 
abnormalities may have a causal relationship i.e. with abnormal Ca2+ handling causing 
abnormal electrophysiological changes and vice versa. Or, these abnormalities may have 
been caused by a common stimulus that underlies the whole remodelling process in the 
failing heart. 
An attempt was made in this Chapter to relate the different abnormalities demonstrated in 
the rabbit coronary artery ligation model of heart failure with each other. Since 
measurements of mechanical function, Ca2+ handling and ventricular repolarisation were 
made in the same hearts, abnormalities in these parameters could be compared and 
correlated. 
250 
Chapter 10 Mechanicalfunction. Ca2+ transients and MAP signals 
Diastolic dysfunction, hypertrophy and Cal + handling 
It has been shown in earlier Chapters that the rabbit heart failure model described produced 
significant mechanical abnormalities in the heart demonstrated both in vivo and in vitro. 
There was significant systolic and diastolic dysfunction. In the isolated Langendorff 
perfused heart, a causal link. between the duration of the Ca2+ transient and mechanical 
function was suggested by the significant correlation between the CaD-50 value and the 
maximum rate of left ventricular pressure decay (Figure 10.1). It was shown that pressure 
decay during diastole was slowed in heart failure and this was associated with a 
prolongation in the Ca2+ transient duration. In addition, failing hearts with prolonged Ca2+ 
transient durations were also found to have increased left ventricular dry weights indicative 
of significant compensatory hypertrophy. Hypertrophy per se is associated with abnormal 
mechanical profile and Ca2+ handling (Gwathmey et al. 1993). It is conceivable that 
hypertrophied myocardium would have an abnormal relaxation profile and that reduced 
sarcoplasmic reticulum Ca2+ uptake during diastole with higher cytosolic [Ca2+] would lead 
to slowed relaxation. However, the sequence of events that lead to the consequent 
pathological state in heart failure is unknown. It may be possible that the initial mechanical 
dysfunction with impaired systolic function increases the stress within the myocardium 
which then starts off a cascade of changes including those mediated by trophic factors 
leading to compensatory hypertrophy and structural remodelling and those leading to 
sarcoplasmic reticulum abnormalities. 
Cal + handling and ventricular repolarisation 
Data from the isolated Langendorff perfused hearts where both Ca2+ transients and MAP 
signals were measured suggested an association between the 2 parameters. It was shown 
that both the Ca2+ transient and MAP durations were significantly prolonged in the heart 
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failure group and there was increased dispersion in both parameters in failing hearts. The 
significant correlation between the 2 parameters at each measured site in the 2 experimental 
groups suggest that regions with prolonged Ca2+ transients also tended to have prolonged 
MAP durations. These data demonstrated that there was nonuniform prolongation of both 
Ca2+ transient and MAP durations in the failing hearts. 
The results in this Chapter suggest that there are regions in hearts from the heart failure 
group with compensatory hypertrophy associated with abnormal mechanical profile, altered 
Ca2+ handling and prolonged ventricular repolarisation. This suggests that there is 
significant remodelling in the failing heart of structural architecture, sarcoplasmic reticulum 
function and electrical events and that the remodelling process is a patchy and 
heterogeneous one. These changes can produce not only the reduced pump efficiency seen 
in heart failure but also an ideal milieu for the induction and propagation of malignant 
ventricular arrhythmias which are so often seen in heart failure. 
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Introduction 
The efficiency of the heart as a pump is dependent on its ability to propel effectively. A 
brisk contraction from the three-dimensional structure demands co-ordinated movement in 
the various regions. Since contraction is intimately linked with excitation, the electrical 
activation pattern of the heart should direct this co-ordinated movement. Thus, any 
alteration or abnormality in the activation pattern of the heart may directly affect the overall 
mechanical function of the pump. This Chapter investigates the potential contribution of 
altered electrical activity and uncoordinated contraction to the overall contractile 
dysfunction in heart failure. 
Normal ventricular activation 
The sino-atrial node is the normal electrical pacemaker of the heart and is the seat of the 
origin of the electrical impulse which propagates through the rest of the heart causing 
contraction. The fibrous mitral and tricuspid valve rings are devoid of myocardial tissue and 
act as electrical barrier to the propagation of electrical activity from the atria to the 
ventricles. The atrioventricular node acts as the flag-station which allows such propagation 
after a short delay. Investigators in the 19tb century like Purkinje, Tawara, Keith, James and 
His (Acierno, 1994) discovered the presence of a specialised system of tissues in the 
ventricles using light microscopy. The anatomy of the His-Purkinje system was defined. 
But it was not until the next century that the experiments of Sir Thomas Lewis 
demonstrated the importance of this system in the rapid conduction of electrical impulses 
through the ventricles. In his landmark paper published in 1915 (Lewis and Rothschild, 
1915), the wave of excitation in the dog's heart was shown to follow the pathway of the 
conduction system rather than the muscle fibres. These findings were later confirmed and 
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expanded by other studies. One elegant study by Durrer et al. (1970) demonstrated the 
nonnal excitation pattern of the isolated human heart using up to 870 intramural electrodes. 
By studying the activation times at the various electrode locations, isochronal maps were 
drawn and the pattern of spread of the excitation wavefronts was obtained. It was shown 
that the ventricles are excited first from the endocardial surface via the His-Purkinje system 
near the paraseptal region. The activation wave fronts then spread apically with the 
posterobasal parts of the ventricles being activated late. Epicardial activation of the 
ventricles reflects the movements of the intramural excitation wave with early epicardial 
"breakthroughs" at the paraseptal areas and late epicardial activation near the posterobasal 
regions. 
Abnormal ventricular activation and cardiac performance 
It has been the belief of many that the different regions of the ventricle would have to 
contract almost synchronously in order to generate a sufficiently powerful impulse to propel 
blood out of its cavity (Rushmer, 1964). Indeed, the total ventricular activation time is 
normally short (Durrer et ai. 1970). There is, however, a sequential pattern of excitation and 
hence activation. This pattern is thought to improve ejection of blood out of the chamber 
and any alteration to this pattern would lead to suboptimal mechanical function. 
Furthennore, if the total activation time is prolonged, due to either defects in the specialised 
conducting system or in the myocardial intercellular coupling, cardiac performance would 
also be jeopardised. 
studies have shown that conducting system disturbances like left bundle branch block can 
lead to impaired ventricular performance (Baragan et ai. 1968). The effect of abnormal 
ventricular activation on cardiac performance has been investigated especially in patients 
with implanted permanent pacemakers (Rosenqvist et al. 1991; Chirife, 1994). Patients who 
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require ventricular pacing for conducting system disease usually have the ventricular pacing 
wire positioned at the right ventricular apex. Right ventricular pacing causes delayed 
intraventricular conduction and produces an altered ventricular activation pattern similar to 
that in intrinsic left bundle branch block (Vassallo et al. 1986). Rosenqvist et al. (1991) 
demonstrated in patients with intact atrioventricular conduction who were implanted with 
dual chamber pacemaker system that cardiac performance was impaired when the right 
atrium and right ventricle were sequentially paced as compared with right atrial pacing only. 
Normal ventricular activation pattern can be mimicked by pacing from the proximal septum 
in the right ventricle and it has been shown in dogs that the ventricular activation time can 
be shortened and cardiac performance improved by proximal septal pacing as opposed to 
apical pacing (Rosenqvist et al. 1996). This further emphasises the importance of normal 
intraventricular conduction and ventricular activation for optimal cardiac performance. 
Other studies have also shown that ventricular diastolic function is also dependent on the 
activation pattern during systole (Xiao et al. 1991; Xiao and Gibson. 1994; Stojnic ef al. 
1996). There is a physiological non-uniformity in recovery of excitability (Han and Moe, 
1963; Brutsaert. 1987; Stevenson, 1995). The distribution of local recovery properties has 
been shown to be related to the normal excitation sequence (Burgess ef al. 1972). Thus, 
abnormal excitation of the ventricles could lead to alterations in regional repolarisation 
patterns which could directly affect relaxation and diastolic performance. 
The mechanisms underlying the contractile abnormality in heart failure are not fully 
understood. Asynchronous ventricular contraction as a result of impaired ventricular 
conduction and non-uniform ventricular activation could potentially playa part in causing 
systolic and diastolic dysfunction in the failing heart. Vassallo et al. (1986) showed that left 
ventricular activation time during right ventricular pacing was prolonged in patients with 
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previous anterior myocardial infarcts when compared to those with inferior infarcts 
although neither group had conducting system disease demonstrable during sinus rhythm. 
This suggests that delayed intraventricular conduction occurred within the post-infarct 
myocardium. Intercellular coupling within the myocardium may be impaired in the failing 
heart and cardiac remodelling and hypertrophy can provide changes which can further 
impair intraventricular conduction and ventricular activation. 
In this Chapter, the effect of abnormal intraventricular conduction on cardiac performance 
was studied in normal hearts and in hearts from the rabbit heart failure model. The potential 
contribution of altered ventricular activation in the mechanical dysfunction seen in the 
failing heart was investigated. 
Methods 
The effect of altered intraventricular conduction pattern on cardiac mechanical performance 
was studied in 7 hearts from the heart failure group and 5 from the sham-operated controls. 
Ca2+ transient and MAP signal measurements were made from the various left ventricular 
epicardial sites in the Langendorffperfused hearts as described in Chapters 3, 8 and 9 using 
the arbitrary IS-site map (Figure 3.S). At each measured site, the Ca2+ and MAP recordings 
were made during atrial pacing and ventricular pacing at the same cycle length of 350 ms. 
Pacing was carried out using pairs of platinum electrodes inserted into the right atrial 
appendage and the posterior aspect of the right ventricular apex for atrial and ventricular 
pacing respectively. The beginning of the MAP signal at each site represented the local 
electrical activation time and the beginning of the Ca2+ transient represented the timing of 
the local detectable Ca2+ event at that site for both atrial and ventricular pacing. As the 
recordings were triggered at the upstroke of the pacing stimulus, the local Ca2+ transient and 
MAP activation times at each measured site could be calculated relative to the timing of the 
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pacing stimulus. The dispersion of activation times with respect to Ca2+ transients and MAP 
signals at the different epicardial sites were used as an index of intraventricular conduction 
delay i.e. the time taken for the whole left ventricle to be activated during right atrial and 
right ventricular pacing. Adjusted dispersion was taken as the difference between the 
earliest and latest activation time in each heart divided by the square root of the number of 
measured sites - a method used for correcting the dispersion for the number of measured 
sites as described in Chapter 8. The intraventricular conduction delay was compared in the 2 
experimental groups during atrial and ventricular pacing. 
Mechanical function of the isolated heart was assessed by intraventricular pressure recorded 
using a latex balloon inserted into the left ventricle with the volume of the balloon adjusted 
to give zero end-diastolic pressure. At a constant pacing cycle length of 350 ms, the effect 
of transition from atrial to ventricular pacing on the pressure profile of the isolated heart 
was studied in both experimental groups. 
Results 
The intraventricular conduction pattern was studied first by examining the local activation 
times for Ca2+ transient and MAP signals in both the heart failure and sham-operated groups 
during atrial and ventricular pacing. The effects of atrial and ventricular pacing on the 
conduction delay through the left ventricle were analysed. Finally, the effect of different 
conduction patterns as a result of atrial or ventricular pacing on the mechanical performance 
of the heart was studied and compared between the 2 experimental groups. 
Activation pattern in the left ventricle 
Ca2+ transient and MAP signal recordings were made at the IS left ventricular epicardial 
sites using the pacing stimulus as the trigger. The local activation time for both Ca2+ and 
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MAP signals at each measured site could be easily calculated relative to the pacing 
stimulus. Analysis of the timing of the beginning of Ca2+ and MAP signals at the various 
epicardial sites was done to assess the pattern of activation of the left ventricle during atrial 
and ventricular pacing. This was carried out using similar methods as those described in 
Chapters 8 and 9 for analysing the variation of the time course of Ca2+ transient and MAP 
signals and for assessing the relationship between the epicardial site location and the time 
course of the signals measured at the site. As opposed to studying the time course of the 
signals, times between the stimulus and the upstroke of the MAP signals and Ca2+ transients 
were analysed here and the results are described below. 
Heart by heart analysis 
Firstly, the activation times for Ca2+ transients and MAP signals at all the measured sites in 
each heart were averaged to give a mean Ca2+ activation time (Ca-AT) and a mean MAP 
activation time (MAP-AT) for each heart during atrial and ventricular pacing. As mentioned 
in previous Chapters, there was no recordable Ca2+ transient or MAP signal in the infarcted 
area in failing hearts. Thus, measurements were available from between 7 to 12 sites (mean 
10) in the failing hearts and analysed whilst data were available for all 15 epicardial sites in 
controls. 
The mean MAP-AT during atrial pacing is the time interval between the atrial pacing 
stimulus to the mean ventricular electrical activation time. This represents the atrio-
ventricular conduction delay and is analogous to the PR interval on nonnal surface 
electrocardiogram. The mean MAP-AT during ventricular pacing is the time interval 
between the ventricular pacing stimulus to the mean ventricular electrical activation time. 
This represents the latency in mean ventricular electrical activation. Similarly for the Ca2+ 
transients, the mean Ca-A T during atrial pacing and during ventricular pacing are the mean 
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time intervals to Ca2+ events in the left ventricle from the atrial and ventricular pacing 
stimulus respectively. 
The mean Ca-AT and MAP-AT during atrial and ventricular pacing for both the heart 
failure and sham-operated groups are summarised in Table 11.1. The mean MAP-AT during 
atrial pacing was 107.5 ± 7.3 ms for the heart failure group and 102.1 ± 6.5 ms for controls. 
Although there was a small numerical difference, this did not reach statistical significance 
and suggests that atrioventricular conduction was not significantly impaired in the failing 
hearts. Latency to mean ventricular electrical activation by ventricular pacing was also 
slightly increased in failing hearts (39.3 ± 2.7 ms vs. 35.6 ± 2.1 ms in controls) but again 
this difference did not reach statistical significance. Mean Ca-AT during atrial and 
ventricular pacing were also slightly increased in the heart failure group but the differences 
were not statistically significant. 
From these mean data, it would appear that the difference between the MAP-AT and Ca-AT 
(i.e. the time delay between electrical and Ca2+ events) during atrial pacing or ventricular 
pacing was greater in the heart failure group than in the sham-operated group. The time 
intervals between the Ca-AT and MAP-AT were analysed at each epicardial site and these 
results and the relationship between the Ca-AT and MAP-AT in both experimental groups 
are described below. 
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Table 11.1 Comparison of mean Monophasic Action Potential activation time (MAP-
AT) and mean Ca%+ transient activation time (Ca-AT) (see text) in isolated 
hearts from rabbits with heart failure (HF) and controls (Sham) during 
atrial and ventricular pacing. 
HF (n = 7) Sham (n = 5) p value 
Atrial pacing 
MAP-AT (ms) 107.5 ± 7.3 102.1 ± 6.5 NS 
Ca-AT(ms) 116.7 ± 8,4 109.1 ±6.1 NS 
Ventricular pacing 
MAP-AT (ms) 39.3 ± 2.7 35.6 ± 2.1 NS 
Ca-AT(ms) 47.5 ± 2.6 40.5 ± 2.6 0.08 
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Site analysis 
(1) Atrial pacing 
In order to study the pattern of activation during atrial pacing and to investigate if there was 
anyone epicardial site that was activated consistently early or late with respect to the Ca2+ 
transient or MAP signals, the MAP-AT and Ca-AT were averaged in the 2 experimental 
groups at each epicardial site. The results are summarised in Table 11.2. 
Activation pattern 
During atrial pacing, site 5 had the earliest MAP-AT in the heart failure group followed by 
site 6 and site 3. Ca2+ transient activation followed a similar pattern with the earliest Ca-AT 
at site 5 but followed by site 3 and then site 2. These suggest that early electrical activation 
~d Ca2+ transients were recorded from the posterior area of the left ventricle in failing 
hearts. 
Data in the sham-operated group were different with the earliest MAP-AT at site 12 
followed by sites 10 and 15. Again the Ca2+ transient activation followed closely with the 
earliest Ca-AT at site 10 followed by sites 11 and 15. These suggest that early electrical 
activation and Ca2+ transients were recorded from the antero-septal portion of the left 
ventricle in control hearts. 
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Table 11.2 Comparison of Monophasic Action Potential and Ca1+ transient activation 
times (MAP-AT, Ca-AT) at the individual left ventricular epicardial sites 
in isolated hearts from rabbits with heart failure (HF) and controls (Sham) 
during atrial pacing. 
Nwnbers in brackets represent the number of hearts in each group where Ca2+ 
transients and MAPs were measurable at each site. 
Site HF (n = 7) Sham (n - S) P value 
MAP-AT (msl Ca-AT (ms) MAP-AT (ms) Ca-AT(ms) MAP-AT Ca-AT 
1 101.4 ± 9.4 123.9 ± 9.6 103.4 ± 3.4 116.8 ± 10.8 NS NS 
(7) (7) (5) (5) 
2 106.3 ± 5.2 116.3 ± 7.2 102.8 ± 5.7 118.6 ± 7.2 NS NS 
(7) (7) (5) (S) 
3 99.0 ± 11.9 112.1 ± 8.7 100.3 ± 4.5 113.3 ± 7.1 NS NS 
(7) (7) (5) (5) 
4 105.9 ± 14.1 117.7± 11.6 102.2 ±4.1 113.1 ± 8.5 NS NS 
(7) (7) (5) (5) 
5 84.6 ± 12.7 103.0 ± 5.0 104.6 ± 6.3 115.4 ± 8.0 NS NS 
(4) (4) (5) (S) 
6 91.3 ± 19.6 119.3±17.9 103.0 ± 4.4 116.8 ± 8.S NS NS 
(2) (2) (5) (5) 
7 104.0 ± 8.2 121.2 ± 12.1 107.3 ± 8.6 113.1 ± 8.5 NS NS 
(7) (7) (5) (S) 
8 101.2 ± 9.1 130.9 ± 11.7 102.2 ± 7.1 109.5 ± 6.3 NS NS 
(7) (7) (5) (5) 
9 109.5 ± 6.S 132.5 ± 13.8 108.4 ± 8.2 112.4 ± 11.1 NS NS 
(7) (7) (5) (5) 
10 103.1 ± 5.6 12S.7 ± 12.9 97.2 ± SA 101.2 ± 8.1 NS NS 
(7) (7) (5) (5) 
11 112.0 ±29.0 125.0 ± 17.5 100.5 ± 6.5 108.3 ± 7.3 NS NS 
(3) (3) (5) (5) 
12 104.6 ± 8.9 126.7 ± 13.7 92.7 ± 5.9 109.4 ± S.3 NS NS 
(6) (6) (5) (5) 
13 102.0 ± 6.4 113.6 ± 8.9 
(5) (5) 
14 101.2 ± 6.1 116.8 ± 8.8 
(5) (5) 
15 98.8 ± 10.7 108.6 ± 7.7 
(5) (5) 
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(b) (i) ANOVA and multiple comparison Tukey tests 
As shown in Table 11.2, there was no difference in the MAP-AT or the Ca-AT recorded at 
any of the epicardial sites between the heart failure group and controls. In order to 
investigate the possibility that one of the epicardial sites may have consistently early or late 
activation in either of the experimental groups, single-factor ANOVA test was used in a 
similar way as described in Chapters 8 and 9 for relating the time course of the Ca2+ 
transient or MAP signals recorded at each site with the site location. The MAP-AT was 
examined in the heart failure group and an F-statistic of 0.37 was obtained (p = NS) whilst 
an F-statistic of 0.59 (p = NS) was obtained for the Ca-AT indicating that there was no 
single epicardial site in the failing hearts that was consistently activated early or late. 
Multiple comparison Tukey tests were also performed on all the pairs of measured sites 
which confirmed no consistent relationship between the site location and the MAP 
activation time or Ca2+ transient activation time in the failing hearts. Similar analyses were 
performed in the sham-operated group. Single factor ANOV A test yielded an F -statistics of 
0.33 (p = NS) for MAP-AT and 0.34 (p = NS) for Ca-AT in the control hearts again 
indicating no consistent relationship between the site location and activation times. This 
was confirmed with Tukey tests. 
(ii) ANOVA and multiple comparison Tukey tests - adjusted activation times 
It was found that there was a wide variation in activation times between the different hearts 
during atrial pacing. Since the activation times were measured from the beginning of the 
atrial pacing stimulus to the beginning of the MAP signal or Ca2+ transient at the individual 
sites, the wide variation between hearts represents mainly the difference between atrio-
ventricular delays in the individual hearts. This wide variation in atrio-ventricular delay 
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would mask the small variation in the true ventricular activation time within each heart and 
make it difficult to identify a pattern of activation with the above-mentioned ANDV A and 
Tukey tests. An attempt was made thus to correct the MAP-AT and Ca-AT at each 
measured site in each heart for the atrio-ventricular delay. Since the electrocardiogram was 
not measured in the isolated hearts, atrio-ventricular delay was not estimated. Thus, the 
activation times at the measured sites in each heart were adjusted by subtracting the shortest 
(earliest) activation time in that heart. The adjusted MAP-AT and adjusted Ca-AT at the 
measured sites in both experimental groups were analysed using ANDV A and Tukey tests 
and the results are summarised in Table 11.3. 
It was shown by ANDV A and Tukey tests that there was no consistent relationship between 
the site location and the adjusted MAP-AT or adjusted Ca-AT in the failing hearts. The 
activation patterns in the individual failing heart may be different and hence produced no 
consistent trend in the group. However, when the adjusted activation times were analysed in 
the control group, a pattern was observed. ANDVA and Tukey tests on the adjusted MAP-
AT showed that site 12 was earlier than site 9. This suggests a consistent activation pattern 
in the control hearts during atrial pacing with the anteroseptal region being activated first 
and the basal portion last. The adjusted Ca-A T followed a similar trend with sites around 
the anteroseptal region (sites 10, 11, 12, 15) being activated earlier than the posterobasal 
region (sites 1,2,4). 
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Table 11.3 Results of single-factor analysis of variance (ANOV A) and multiple 
comparison Tukey test on adjusted Monophasic Action Potential and Cal + 
transient activation times (MAP-AT and Ca-AT, see text) recorded during 
atrial pacing at different epicardial sites in hearts from the heart failure 
group (HF, n = 7) and controls (Sham, n = 5). 
ANOVA Tukey test 
F • statistic site vs. site 
adjusted MAP-AT l.03 NS N/A NS 
adjusted Ca-A T 1.04 NS N/A NS 
Sham 
adjusted MAP-AT 1.93 <0.04 12 < 9 <0.05 
adjusted Ca-A T 4.24 < 0.001 10 < 1 <0.01 
10 <2 <0.05 
10 <4 <0.05 
11 < 1 <0.05 
12 < 1 < 0.01 
12 <2 < 0.01 
12 <4 <0.05 
12 <6 <0.05 
12 < 7 <0.05 
15 < 1 <0.05 
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(c) relationship between MAP-AT and Ca-AT 
It was suggested in the previous section on "Heart by heart analysis" that the difference 
between MAP-AT and Ca-AT (Le. the time delay between electrical and Ca2+ events) was 
greater in the heart failure group as shown in the mean values of the two parameters. This 
difference was examined at each of the epicardial sites. It was found that the difference 
between the local MAP activation time and Ca2+ transient activation time was greater in 
failing hearts than in controls (19.3 ± 1.9 ms vs. 10.7 ± 1.1 ms, p < 0.001). This suggests 
that there was greater delay between the electrical and Ca2+ events in the failing hearts. 
The MAP-AT and corresponding Ca-AT at each epicardial site were then compared and 
correlated for the 2 experimental groups. The results are illustrated in Figure 11.1 Linear 
regression lines were drawn and these showed that there was a strong association between 
the Ca-AT and MAP-AT in both experimental groups. The Ca-AT at each site followed the 
MAP-AT closely. It was also shown that there was a greater variation in MAP-AT and Ca-
AT values at the various epicardial sites in the heart failure group when compared to the 
sham-operated controls although the mean value appeared to be similar. The variation or 
dispersion of activation time as a measure of intraventricular conduction delay will be 
discussed later. 
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Figure 11.1 Plot of the mean Ca1+ transient activation time (ea-AT) at each 
epicardial site against the corresponding mean Monophasic Action Potential 
activation time (MAP-AT) during right atrial pacing at a cycle length of 350 ms for 
both control (0) and heart failure (e) groups. Linear regression lines of the two 
variables are shown for the heart failure group (solid line) and controls (broken line) 
with the correlation coefficient (r), significance value (p) and regression equation 
shown in boxes. 
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(2) Ventricular pacing 
Similar analyses as those performed for studying the activation pattern during atrial pacing 
were also carried out for ventricular pacing. The averaged MAP-AT and Ca-A T in the 2 
experimental groups at each epicardial site are summarised in Table 11.4. 
Activation pattern 
During ventricular pacing, site 5 had the earliest MAP-AT in the heart failure group 
followed by site 3 and site 6. Ca2+ transient activation followed a similar pattern with the 
earliest Ca-AT at site 5, followed by site 3 and then site 1. These suggest that early 
electrical activation and Ca2+ transients were recorded from the posterior area of the left 
ventricle in failing hearts. Sites 7 and 8 recorded late Ca2+ and MAP signals indicating late 
activation at the anterior and basal portions of the left ventricle. Ventricular pacing 
electrodes were placed at the posterior aspect of the right ventricular apex. This would be 
consistent with early activation at site 5 during ventricular pacing and late activation in sites 
7 and 8. The pattern of activation in the failing hearts during ventricular pacing was similar 
to that during atrial pacing with the earliest activation at the posterior area and late 
activation at the antero-basal area of the left ventricle. 
Data in the sham-operated group during ventricular pacing were similar to the heart failure 
group with the earliest MAP-AT at site 5 followed by sites 13 and 3. Again the Ca2+ 
transient activation followed closely. Late MAP-AT and Ca-AT were recorded at sites 7 and 
8. The pattern of activation during ventricular pacing was similar in controls to that in 
failing hearts with early activation at the postero-apical portion of the left ventricle, next to 
the pacing site, and late activation at the antero-basal portion of the left ventricle. This was 
distinctly different from the pattern of activation in the control hearts during atrial pacing. 
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The patterns of activation during atrial and ventricular pacing in the 2 experimental groups 
are illustrated in Figure 11.2 using colour coding for the mean MAP-AT at the measured 
sites. 
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Table 11.4 Comparison of Monophasic Action Potential and Ca1+ transient activation 
times (MAP-AT, Ca-AT) at the individual left ventricular epicardial sites 
in isolated hearts from rabbits with heart failure (HF) and controls (Sham) 
during ventricular pacing. 
Numbers in brackets represent the number of hearts in each group where Ca2+ 
transients and MAPs were measurable at each site. 
Site HF (n = 7) Sham (n - 5) P value 
MAP-AT (msl Ca-AT(msl MAP-AT (ms) Ca-AT (ms) MAP-AT Ca-AT 
1 32.8 ± 5.0 36.0 ±3.5 34.5 ± 4.3 35.3 ± 2.4 NS NS 
(7) (7) (5) (5) 
2 36.7 ± 5.3 42.4 ±4.7 38.0 ± 4.4 38.6 ± 3.4 NS NS 
(7) (7) (5) (5) 
3 23.0 ± 5.3 34.0 ± 5.1 28.0 ±4.5 29.4±2.8 NS NS 
(7) (7) (5) (5) 
4 34.0±7.1 42.3 ± 5.5 30.3 ±4.6 35.5 ± 3.7 NS NS 
(7) (7) (5) (5) 
5 20.0 ± 6.1 29.3 ± 8.1 22.0 ±2.9 26.9 ± 6.1 NS NS 
(4) (4) (5) (5) 
6 28.0 ± 7.9 59.0 ± 9.2 35.6 ± 4.9 36.7 ± 5.0 NS NS 
(2) (2) (5) (5) 
7 43.0 ±3.7 64.0 ± 5.8 46 ±4.0 59.7 ± 2.8 NS NS 
(7) (7) (5) (5) 
8 45.7 ± 3.3 61.0 ± 4.2 46.6 ± 1.7 52.5 ±4.8 NS NS 
(7) (7) (5) (5) 
9 45.3 ± 1.1 53.0 ± 3.5 44.3 ± 3.5 56.4 ± 8.2 NS NS 
(7) (7) (5) (5) 
10 38.8 ± 3.4 56.3 ± 7.1 43.0 ± 1.4 51.2 ± 5.5 NS NS 
(7) (7) (5) (5) 
11 34.0 ± 8.2 38.0 ± 8.5 37.4 ± 2.0 44.1 ± 2.4 NS NS 
(3) (3) (5) (5) 
12 34.3 ± 1.2 45.2 ± 3.0 34.2 ± 5.1 47.8 ± 1.8 NS NS 
(6) (6) (5) (5) 
13 26.6 ±4.7 28.5 ± 5.2 
(5) (5) 
14 30.3 ± 6.5 33.9 ± 5.5 
(5) (5) 
15 29.8 ± 1.3 39.0 ± 4.7 
(5) (5) 
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Figure 11.2 Panel A shows schematic diagrams of two rabbit hearts with right 
ventricle outflow tract (RVOT), left atrium (LA) and right atrium (RA) marked as 
shown - the heart on the right represents one from the heart failure group (HF) and 
the one on the left from the control group (Sham). The marginal branch of the left 
circumflex artery is represented by a vertical line on the left ventricle and the infarct 
in the HF heart is marked by the non-shaded area with site numbers 13, 14 and 15 
representing the sites with a consistent infarct. The mean Monophasic Action 
Potential activation time (MAP-AT) at all of the measured sites, during right atrial 
pacing at a cycle length of 350 ms, are coded according to the colour scale shown on 
the right and illustrated for the 2 groups. Panel B shows parallel data for MAP-AT 
during pacing near the right ventricular apex. 
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(b) ANOVA and multiple comparison Tukey tests 
As shown in Table 11.4, there was no difference in the MAP-AT or the Ca-AT recorded at 
any of the epicardial sites between the heart failure group and controls during ventricular 
pacing. In order to investigate the possibility that one of the epicardial sites may have 
consistently early or late activation in either of the experimental groups, single-factor 
ANDV A test and mUltiple comparison Tukey test were employed as for atrial pacing 
described above. The results are summarised in Table 11.5. 
The MAP-AT was examined in the heart failure group and an F-statistic of2.6 was obtained 
(p < 0.02) which indicated there were significant differences between the MAP-AT at 
certain sites. Tukey test was performed which showed that site 5 was significantly earlier 
than site 8. When the Ca-AT was examined in the heart failure group, an F-statistic of 5.6 (p 
< 0.001) was obtained for the Ca-AT indicating again that there were significant differences 
between the Ca-AT at certain sites. Tukey test showed that site 1 was significantly earlier 
than sites 7, 8 and 10; site 3 was significantly earlier than sites 7 and 8; and site 5 was 
significantly earlier than sites 7, 8 and 10. These results confirm the initial impression from 
the mean data above that the posterior portion of the left ventricle was activated early and 
the antero-basal portion activated late during ventricular pacing in the heart failure group. 
Similar analyses were performed in the sham-operated group. Single factor ANDV A test 
yielded an F-statistic of 3.6 (p < 0.001) for MAP-AT and 5.0 (p < 0.001) for Ca-AT in the 
control hearts which indicated there were significant differences between the activation 
times at certain sites. Tukey tests were then performed to examine pairs of sites. For MAp· 
AT, site 5 was significantly earlier than sites 7, 8, 9 and 10 and site 13 was significantly 
earlier than sites 7 and 8. For Ca-AT, both sites 3 and 5 were significantly earlier than sites 
7, 8,9, and 10; sites 6, 13 and 14 were significantly earlier than site 7; and in addition, site 
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13 was also significantly earlier than site 9. Again, these data supported the initial 
impression from the mean values of MAP-AT and Ca-AT at the different activation sites 
that early activation occurred at the postero-apical portion of the left ventricle with late 
activation at the antero-basal portion in control hearts during ventricular pacing. 
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Table 11.5 Results of single-factor analysis of variance (ANOV A) and multiple 
comparison Tukey test on Monophasic Action Potential and Ca1+ transient 
activation times (MAP-AT and Ca-AT) recorded during ventricular pacing 
at different epicardial sites in hearts from the heart failure group (HF, n = 
7) and controls (Sham, n = 5). 
ANOVA Tukey test 
F - statistic site vs. site 
HE 
MAP-AT 2.6 <0.02 5<8 < 0.05 
Ca-AT 5.6 < 0.001 1<7 < 0.01 
1<8 < 0.01 
1 < 10 < 0.05 
3<7 < 0.01 
3<8 < 0.05 
5<7 < 0.01 
5<8 < 0.01 
5 < 10 < 0.05 
Sham 
MAP-AT 3.6 < 0.001 5<7 < 0.01 
5<8 < 0.01 
5<9 < 0.05 
5 < 10 < 0.05 
13 <7 <0.05 
13 < 8 < 0.05 
Ca-AT 5.0 < 0.001 3<7 < 0.01 
3<8 < 0.05 
3<9 < 0.01 
3 < 10 <0.05 
5<7 < 0.001 
5<8 < 0.05 
5<9 < 0.01 
5 < 10 <0.05 
6<7 <0.05 
13 < 7 < 0.01 
13 <9 < 0.01 
14 < 7 <0.05 
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(e) relationship between MAP-AT and Ca-AT 
As with the data during atrial pacing, the difference between MAP-AT and Ca-AT was 
examined at each of the epicardial sites during ventricular pacing in the 2 experimental 
groups. It was found that the difference between the local MAP activation time and Ca2+ 
transient activation time was greater in failing hearts than in controls (12.1 ± 2.3 ms vs. 5.9 
± 1.2 ms, p < 0.02). This suggests again that there was greater delay between the electrical 
and Ca2+ events in the failing hearts during ventricular pacing as well as during atrial 
pacing. 
The MAP-AT and corresponding Ca-AT at each epicardial site were then compared and 
correlated for the 2 experimental groups. The results are illustrated in Figure 11.3. Linear 
regression lines were drawn and these showed that there was a strong association between 
the Ca-AT and MAP-AT in both experimental groups. The Ca-AT at each sites followed the 
MAP-AT closely as with atrial pacing. The data from the 2 experimental groups were very 
similar with similar mean values as demonstrated earlier. The variation in MAP-AT and Ca-
AT values at the various epicardial sites were not so different between the 2 groups as seen 
in the data during atrial pacing. This would appear that the pattern of ventricular activation 
and possibility conduction delay were similar in the 2 groups during ventricular pacing but 
different during atrial pacing. This will be discussed below especially examining the 
variation or dispersion of activation time as a measure of intraventricular conduction delay. 
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Figure 11.3 Plot of the mean Ca2+ transient activation time (Ca-A T) at each 
epicardial site against the corresponding mean Monophasic Action Potential 
activation time (MAP-AT) during right ventricular pacing at a cycle length of 350 ms 
for both control (0) and heart failure (.) groups. Linear regression lines of the two 
variables are shown for the heart failure group (solid line) and controls (broken line) 
with the correlation coefficient (r), significance value (p) and regression equation 
shown in boxes. 
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Intraventricular conduction delay 
As shown in the above sections on MAP and Ca2+ transient activation times, the pattern of 
activation was different during atrial pacing between the heart failure group and controls 
whilst the pattern of activation was similar on ventricular pacing. It was shown that the 
pattern of activation was different between atrial and ventricular pacing in the control group 
whilst it was quite similar between atrial and ventricular pacing in the heart failure group. 
This implies that there may be some abnormality in ventricular activation in failing hearts 
during atrial pacing. Normally, atrial pacing leads to ventricular activation via the 
specialised conducting tissues with almost synchronous activation of the whole ventricle 
whilst ventricular pacing usually leads to delayed ventricular conduction with the ventricle 
being activated sequentially from myocyte to myocyte not involving the specialised 
conducting system. Right ventricular pacing typically leads to a left bundle branch block 
pattern on the surface electrocardiogram. Thus, there may be abnormality in intraventricular 
conduction in the failing hearts during atrial pacing. This was investigated by examining the 
variation or dispersion of the activation times in both experimental groups. 
Intraventricular conduction delay could be estimated by studying the earliest and latest 
activation times in each heart. The adjusted dispersion of MAP activation times and Ca2+ 
transient activation times were calculated in each heart by taking the difference between the 
earliest and latest activation time divided by the square root of the number of measured 
·sites. This was used as a measure of intraventricular conduction delay and the results are 
shown in Table 11.6. 
Firstly, it was shown that adjusted dispersion for MAP-AT was increased in the heart failure 
group during atrial pacing when compared to controls (6.6 ± 0.9 ms vs. 4.3 ± 0.2 ms, p < 
0.05). The increased adjusted MAP-AT dispersion suggests that there was a wider range of 
278 
Chapter II Altered conduction and mechanical function in heart failure 
electrical activation times in the failing hearts leading to increased intraventricular 
conduction delay. In the control hearts, the adjusted MAP-AT dispersion increased 
significantly from 4.3 ± 0.2 ms to 9.0 ± 0.8 ms on transition from atrial to ventricular 
pacing (p < 0.01). This was consistent with increased intraventricular conduction delay with 
right ventricular pacing which is known to produce altered intraventricular conduction 
similar to that seen in left bundle branch block. The adjusted MAP-AT dispersion was 6.6 ± 
0.9 ms in the failing hearts during atrial pacing indicating that there was delayed 
intraventricular conduction compared to controls but the magnitude of the delay was 
smaller than that seen in control hearts during ventricular pacing. This suggests that the 
intraventricular conduction delay observed in failing hearts during atrial pacing was less 
than that during left bundle branch block. Unfortunately, this could not be confirmed with 
electrocardiogram as this was not measured but the coronary ligation procedure could not 
have directly caused damage to the conducting system as the infarct produced was typically 
at the left ventricular apex. In the failing hearts, ventricular pacing led to a non-significant 
rise in the adjusted MAP-AT dispersion to 8.4 ± 0.8 ms indicating some further 
intraventricular conduction delay with ventricular pacing compared to atrial pacing. 
The adjusted Ca-AT dispersion followed a similar trend as the adjusted dispersion for 
MAP-AT. However, the significance of an increased adjusted Ca-AT dispersion in the 
failing hearts during atrial and ventricular pacing with a wider range of Ca-A T in failing 
hearts is more difficult to appreciate. It was shown in earlier sections that the delay between 
MAP-AT and Ca-AT was increased in failing hearts. Even in the absence of delayed 
intraventricular conduction, there could have been a wider range of Ca-A T depending on 
the MAP-AT to Ca-AT delay at the various epicardial sites. Increased intraventricular 
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. conduction delay in the failing hearts as shown by the increased MAP-AT dispersion would 
lead to even greater Ca-AT dispersion. 
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Table 11.6 Comparison of adjusted dispersion in Monophasic Action Potential 
activation time (MAP-AT) and Cal+ transient activation time (Ca-AT) (see 
text) in isolated hearts from rabbits with heart failure (HF) and controls 
(Sham) during atrial and ventricular pacing. 
HF Cn =7) Sham Cn = 5) p value 
Adjusted dispersion in MAP-AT (ms) 
Atrial pacing 6.6±O.9 4.3 ±0.2 <0.05 
Ventricular pacing 8.4 ± 0.8 9.0± 0.8 NS 
p value NS < 0.01 
Adjusted dispersion in Ca-A T ems) 
Atrial pacing 19.9 ± 3.9 6.8 ±0.7 <0.02 
Ventricular pacing 16.4 ± 1.5 9.7 ±0.7 < 0.01 
p value NS <0.05 
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Effect of atrial and ventricular pacing on intraventricular conduction delay 
As shown above, the adjusted dispersions for MAP-AT and Ca-AT were increased in the 
failing hearts during atrial pacing and there appeared to be different changes to these 
parameters on switching from atrial to ventricular pacing. A relationship was sought 
between the adjusted MAP-AT and Ca-AT dispersions during atrial pacing and ,the effect of 
switching to ventricular pacing. The adjusted dispersions in each heart during atrial pacing 
were correlated with the change (increase or decrease) in these parameters on switching 
from atrial to ventricular pacing. The results are illustrated in Figures 11.4 and 11.5. 
Figure 11.4 shows that there was a significant association between the adjusted MAP-AT 
dispersion, i.e. intraventricular conduction delay, during atrial pacing and the effect of 
ventricular pacing on dispersion. It shows that hearts which had little intraventricular 
conduction delay during atrial pacing, i.e. all of the control hearts and some of the failing 
hearts, had increased conduction delay on ventricular pacing whilst the remainder of the 
failing hearts which started with significant conduction delay during atrial pacing had little 
change or a small decrease in the intraventricular conduction delay on ventricular pacing. 
Again, a similar trend emerged with the data on adjusted Ca-AT dispersion during atrial 
pacing and the effect of ventricular pacing with Figure 11.5 showing a significant 
association between them. Hearts which had a small adjusted Ca-AT dispersion during 
atrial pacing, i.e. again all the control hearts and some failing hearts, had increased Ca-AT 
dispersion on ventricular pacing whilst the remainder of the failing hearts which had 
increased Ca-AT dispersion during atrial pacing had a decrease in Ca-A T dispersion on 
ventricular pacing. As mentioned above, it is difficult to appreciate the significance of 
increased Ca-AT dispersion in the failing hearts as the relationship between Ca2+ transient 
activation time and MAP activation time could be a complex one. With increased MAP-AT 
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dispersion in the failing hearts and the heterogeneous behaviour of MAP-AT dispersion on 
ventricular pacing, it is even more difficult to understand the true significance of the events 
that occur with Ca-AT dispersion. 
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Figure 11.4 Plot of the change in adjusted dispersion of Monophasic Action Potential 
activation time (MAP-AT dispersion) in each heart on switching from atrial to 
ventricular pacing (VP) against the MAP-AT dispersion during atrial pacing (AP) at a 
cycle length of 350 ms for both control (0) and heart failure (e) groups. The solid 
line represents linear regression of the two variables with the correlation coefficient (r) 
and significance value (p) shown in the shaded box. 
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Figure 11.5 Plot of the change in adjusted dispersion of Ca2+ transient activation 
time (Ca-AT dispersion) in each heart on switching from atrial to ventricular pacing 
(VP) against the Ca-A T dispersion during atrial pacing (AP) at a cycle length of 350 
ms for both control (0) and heart failure (e) groups. The solid line represents 
linear regression of the two variables with the correlation coefficient (r) and 
significance value (p) shown in the shaded box. 
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Effect of altered conduction pattern on cardiac performance 
The above sections showed that the ventricular activation pattern was different during atrial 
and ventricular pacing in normal hearts and intraventricular conduction delay was increased 
during ventricular pacing when compared to atrial pacing. In failing hearts, the ventricular 
activation pattern was different from that in controls during atrial pacing with increased 
intraventricular conduction delay and the response to ventricular pacing was different from 
that in controls. Previous Chapters have demonstrated significant mechanical dysfunction in 
the hearts isolated from rabbits with coronary artery ligation induced heart failure. This 
section investigates the relationship between the altered ventricular activation pattern with 
delayed intraventricular conduction and the impaired mechanical performance in the failing 
hearts. The pressure profile of the 2 experimental groups during atrial and ventricular 
pacing were analysed and the results are shown in Table 11.7. 
Peak systolic pressure 
During atrial pacing, peak systolic pressure was significantly lower in failing hearts as 
compared to controls (36.9 ± 6.3 mmHg vs. 49.6 ± 3.0 mmHg, p < 0.05) indicating 
significant left ventricular dysfunction. The effects of changing from atrial to ventricular 
pacing in typical experiments in a failing heart and a sham-operated heart are shown in 
Figure 11.6. There was a significant decrease in peak systolic pressure in sham-operated 
hearts on changing from atrial to ventricular pacing but not in failing hearts. The difference 
in peak systolic pressure between the 2 groups became marginal on ventricular pacing (36.1 
± 6.4 mmHg in failing hearts vs. 46.7 ± 2.8 mmHg in controls, p = 0.08). 
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Table 11.7 Comparison of pressure profile in isolated Langendorff perfused hearts 
from rabbits with heart failure (HF) and controls (Sham) during atrial and 
ventricular pacing. 
HF (n = 7) Sham (n = 5) p value 
Peak Systolic Pressure (mmHg) 
Atrial pacing 36.9 ±6.3 49.6 ± 3.0 <0.05 
Ventricular pacing 36.1 ± 6.4 46.7 ±2.8 0.08 
p value NS < 0.001 
Maximum rate of pressure rise [+dP.drl~ - mmHg.ms·'J 
Atrial pacing 0.67 ± 0.08 0.99 ± 0.09 <0.02 
Ventricular pacing 0.63 ± 0.08 0.89 ± 0.07 < 0.05 
p value 0.08 < 0.05 
Maximum rate of pressure decay [-dP.dr1U!!.!l!l- mmHg.ms·1] 
Atrial pacing 0.43 ± 0.06 0.64 ± 0.05 < 0.05 
Ventricular pacing 0.41 ± 0.05 0.58 ±0.05 <0.05 
p value NS <0.05 
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Figure 11.6 Top Panel Left ventricular pressure in a control heart (Sham) and a 
failing heart (HF) shown as continuous tracing with arrows marking the change from 
right atrial to right ventricular pacing at a constant cycle length of 350 ms. Middle 
Panel Left ventricular pressure shown in expanded scale for one cardiac cycle at 
steady state during atrial pacing (solid line) and ventricular pacing (broken line), 
aligned at the stimulus impulse. Bottom Panel Expanded pressure tracings for one 
cardiac cycle as in (Middle Panel) normalised and superimposed. 
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Maximum rates of pressure rise and decay 
The results of the maximum rate of pressure rise and of pressure decay followed a similar 
trend as that seen in peak systolic pressure (Table 11.7). These values were lower in the 
heart failure group when compared to controls during atrial and ventricular pacing. On 
changing from atrial to ventricular pacing, there was a significant decrease in both 
parameters in the control hearts but not in the failing hearts. This again illustrated the 
presence of systolic and diastolic dysfunction in the failing hearts. 
Pressure profile vs. Conduction delay 
The changes in peak systolic pressure In both experimental groups with atrial and 
ventricular pacing paralleled those seen in conduction delay as measured by adjusted MAP-
AT dispersion with atrial and ventricular pacing (Tables 11.6 and 11.7). There was a 
significant increase in conduction delay with a significant decrease in systolic pressure in 
the control hearts on changing from atrial to ventricular pacing. There was a slight increase 
in conduction delay and slight decrease in pressure in failing hearts on transition from atrial 
to ventricular pacing but these changes were not significant. It would appear that the 
decrease in systolic pressure on ventricular pacing could be related to the increase in 
conduction delay. Changes in systolic pressure were thus correlated with changes in 
adjusted MAP-AT dispersion on changing from atrial to ventricular pacing and Figure 11.7 
shows that there was a significant association between the 2 parameters (r = -0.75, P < 
0.005). 
289 
Chapter J J Altered conduction and mechanical function in heart failure 
3 
- • C) 2 
J: 
E 1 E 
-a. 0 tn 
• >t en r = -0.75 
c: -1 • P < 0.005 0 0 a. 
-2 •• > 
"-0 
-3 0 0 ts 0 
~ W-4 0 
-4 ~ 0 246 8 10 
Effect ofVP on MAP-AT dispersion (ms) 
Figure 11.7 Plot of the change in peak left ventricular systolic pressure (SysP) on 
switching from atrial to ventricular pacing (VP) in each heart against the 
corresponding change in the adjusted dispersion of Monophasic Action Potential 
activation time for both control (0) and heart failure (e) groups. The solid line is the 
linear regression of the two variables with the correlation coefficient (r) and 
significance value (p) shown in the shaded box. 
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Contribution of conduction delay to mechanical dysfunction in heart failure 
During atrial pacing, adjusted MAP-AT dispersion in failing hearts and hence conduction 
delay was increased when compared to controls (6.6 ± 0.9 ms vs. 4.3 ± 0.2 ms, p < 0.05) but 
this conduction delay in the failing hearts during atrial pacing was smaller in magnitude 
when compared to the conduction delay in control hearts during ventricular pacing (9.0 ± 
0.8 ms). This implies that although there was conduction delay in the failing hearts during 
atrial pacing, the delay was not to the extent of left bundle branch block as would be 
expected from right ventricular pacing in the control hearts. The mean decrease in systolic 
pressure in the control hearts from atrial to ventricular pacing was 2.9 ± 0.4 mmHg and this 
is small when compared to the difference in systolic pressure between failing hearts and 
controls during atrial pacing (36.9 ± 6.3 mmHg vs. 49.6 ± 3.0 mmHg). 
Similarly, the maximum rate of pressure rise and of pressure decay during atrial pacing 
were much lower in the failing hearts, when compared to controls, than would be expected 
simply due to delayed intraventricular conduction in controls hearts on right ventricular 
pacing. Although delayed intraventricular conduction could contribute to systolic and 
diastolic dysfunction, there had to be additional factors leading to the impaired cardiac 
performance in failing hearts. 
Discussion 
The results described in this Chapter showed that ventricular activation pattern was altered 
with delayed intraventricular conduction in hearts from rabbits with heart failure and this 
could explain at least part of the mechanical dysfunction seen in heart failure. 
During atrial pacing, the ventricles should be activated via the specialised conducting His-
Purkinje system in nonnal hearts. The left ventricular activation pattern in the control hearts 
291 
Chapter 11 Altered conduction and mechanical function in heart failure 
during atrial pacing followed a similar pattern as that described by Durrer et al. (1970) with 
early activation near the paraseptal region and late activation near the basal portion of the 
left ventricle. Intraventricular conduction delay was small with a brief total ventricular 
activation time. Right ventricular pacing altered the ventricular activation pattern with 
delayed intraventricular conduction / excitation. Systolic and diastolic performance were 
impaired on ventricular pacing. The better mechanical" performance during atrial pacing 
(when compared to ventricular pacing) could not be attributed to improved left ventricular 
filling with atrial pacing as there was an intraventricular balloon in the left ventricle with 
cardiac contraction being isovolumetric in the Langendorff mode. In addition, the 
pulmonary veins leading to the left atrium were not tied off in these experiments and thus 
atrial contraction would have no haemodynamic consequences on left ventricular filling. 
In the failing hearts, the ventricular activation pattern during atrial pacing was different 
from that in controls. There was early ventricular activation at the posterior part of the left 
ventricle, similar to the pattern seen during right ventricular pacing in either control or 
failing hearts. Intraventricular conduction was delayed during atrial pacing when compared 
to controls. The presence of left bundle branch block in the failing hearts could not be ruled 
out but this was thought not to be the case for several reasons:- (a) the myocardial infarct 
produced in these hearts was consistently at the apical region of the left ventricle and should 
not directly involve the left bundle branch and (b) conduction delay, as measured by 
adjusted MAP-AT dispersion, in the failing heart during atrial pacing was smaller than the 
conduction delay produced by right ventricular pacing in control hearts, which should 
produce ventricular activation similar to left bundle branch block pattern. 
Electrocardiography was not performed in these experiments which should otherwise 
produce extra information on intraventricular conduction and identify any potential 
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conducting system disturbance. One other criticism of this study may be the fact that the 
MAP signals and Ca2+ transients were sequentially measured. Simultaneous measurements 
at the various epicardial sites would have given more accurate activation data but this would 
require much more sophisticated equipment arrangements and more advanced technology. 
The delayed intraventricular conduction seen in failing hearts during atrial pacing could be 
due to intercellular uncoupling within the remodelled myocardium. On ventricular pacing, 
there was further increase in intraventricular conduction delay with ventricular activation 
. possibly resembling that of frank left bundle branch block as with control hearts during 
ventricular pacing. 
Increased intraventricular conduction delay appeared to be associated with decrease in 
mechanical performance in control hearts on changing from atrial to ventricular pacing. 
Intraventricular conduction delay and impaired cardiac performance were both observed in 
failing hearts during atrial pacing. However, the degree of intraventricular conduction delay 
was smaller and the degree of mechanical dysfunction greater than what would be expected 
in control hearts during ventricular pacing. The impaired cardiac performance seen in the 
failing hearts could not be completely but could be partly explained by the delayed 
intraventricular conduction seen. 
These data show that increased intraventricular conduction delay resulting from non-
uniform ventricular activation with ventricular pacing decreased cardiac mechanical 
performance in control hearts and suggest that part of the impaired cardiac performance 
seen in heart failure may be explained by delayed intraventricular conduction and non-
uniform ventricular activation possibly as a result of secondary changes in the failing 
ventricular myocardium. 
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In this thesis, a rabbit coronary artery ligation model was used to study the mechanical 
perfonnance, Ca2+ handling and ventricular activation / repolarisation in heart failure. An 
attempt was made to examine these aspects under conditions as close to those in vivo as 
possible. Mechanical performance was firstly examined in vivo using echocardiography and 
this was also examined in vitro together with the Ca2+ handling and electrical aspects in the 
isolated whole heart paced at a rate close to the physiological heart rate of the rabbit. 
Heart failure in the rabbit coronary artery ligation model 
Cardiac mechanical performance was assessed in the heart failure model in vivo with 
echo cardiography (Chapter 4). By 7 weeks after the ligation of the marginal branch of the 
circumflex coronary artery with the production of an apical infarct, significant abnormalities 
were found in the heart on ultrasound. Ejection fraction was lower and cardiac dimensions 
(left atrial dimension and left ventricular end-diastolic dimension) were increased in the 
rabbits which had coronary artery ligation. Significant organ congestion was also present, 
similar to the human clinical syndrome of heart failure, with increased lung and liver 
weights in the rabbits with heart failure. The degree of congestion appeared to correlate 
with the degree of cardiac dysfunction present, which was presumed to relate to the degree 
of the insult on the heart caused by the initial infarct. Cardiac remodelling and hypertrophy 
were also suggested in the heart failure group by the increased left and right ventricular dry 
weights. These cardiac and systemic changes seen in the rabbit model parallel those 
commonly observed in human heart failure as a result of previous myocardial damage from 
ischaemic heart disease (Parmley, 1989). 
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Mechanical performance of the failing heart in vitro 
Cardiac mechanical performance was also assessed in the heart failure model in vitro in 
isolated hearts both in the working heart configuration and during Langendorff perfusion 
(Chapter 6). At baseline working heart conditions [with a pre-load of 10 cmH20 (8 mmHg) 
and after-load of 75 cmH20 (55 mmHg)], the failing hearts were found to have low cardiac 
output, decreased peak systolic pressure with slowed rate of pressure rise and a high end-
diastolic pressure with slowed rate of relaxation, when compared to controls. Similar 
systolic and diastolic abnormalities were observed with the Langendorff-perfused failing 
hearts. The contractile dysfunction observed in vitro correlated well with that observed in 
vivo on echocardiography. The failing hearts were also found to have reduced passive 
compliance compared to controls which could be the result of cardiac remodelling with 
hypertrophy and fibrosis in the failing hearts. 
The Frank-Starling relationship was examined in the working heart mode to assess the 
ability of the failing heart to respond to the positive inotropic stimulus of an increase in 
muscle length and improve cardiac performance with stepwise increases in pre-load. It was 
found that the Frank-Starling relationship was attenuated in the failing hearts when 
compared to controls. There is debate in the literature as to whether the failing myocardium 
is able to use the Frank-Starling mechanism (Schwinger et al. 1994; Holubarsch et al. 
1996). The results of the current study suggest that the failing hearts were operating at 
different Frank-Starling curves from controls and that the Frank-Starling mechanism was 
altered in the failing hearts but might not be completely absent. These findings would be in 
agreement with a shift of the pressure-volume curve to the right and upwards, which has 
been shown in chronic heart failure with left ventricular dilatation and hypertrophy 
(LeJemtel and Sonnenblick, 1993). 
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The slow response, which is a slow increase in inotropy over time after a step increase in 
muscle length, was also found to be attenuated in the failing hearts when this was studied 
with the increase in pre-load from 10 to 15 cm H20 (i.e. 8 to 11 mmHg). There is evidence 
that the slow response may be mediated via cyclic AMP (Kentish et al. 1992). Down-
regulation of p-adrenoceptors is a well-recognised feature in heart failure (Bristow ef al. 
1982) and reduced basal cyclic AMP level has also been shown in heart failure (Bohm et al. 
1994) which can potentially lead to an attenuated slow response. The slow response has not 
been examined in heart failure and the current study appears to be the first to try and 
address this issue. The attenuated slow response observed suggests that this mechanism, 
which can potentially improve mechanical performance in response to increase in pre-load, 
was impaired in the failing hearts and this could have contributed towards the attenuated 
Frank-Starling relationship seen in the failing hearts. 
Cal + handling in the failing heart 
Ca2+ transients were measured in the isolated Langendorff perfused hearts using an indo-l 
fluorescence system developed to examine the beat-to-beat variation of [Ca2+] at different 
regions over the left ventricular epicardial surface with a single-core light guide. When the 
time course of the Ca2+ transients were analysed, it was found that failing hearts had more 
prolonged Ca2+ transients with a delay in time to peak amplitude and further delay during 
the decay phase of the transients (Chapter 8). The prolongation of Ca2+ transient duration 
was not uniform over the left ventricular epicardial surface in failing hearts with some areas 
having Ca2+ transient durations that were close to the range of values observed in controls 
whilst the Ca2+ transient durations at other areas were markedly prolonged. As a result, there 
was wider variation or increased dispersion of Ca2+ transient duration in the failing hearts 
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compared to controls. However, there was no consistent relationship between the prolonged 
Ca2+ transient duration and the left ventricular epicardial location. 
The finding of prolonged Ca2+ transient durations in the failing heart concurs with published 
reports on prolonged Ca2+ transients in failing myocardial tissues (Gwathmey et al. 1987~ 
Perreault et ai. 1992) and myocytes (Beuckelmann et al. 1992; Capasso et ai. 1993). The 
current study appears to be the first to show prolonged Ca2+ transient durations in the whole 
heart at a near-physiological heart rate. It was also shown in this study that the prolongation 
of the Ca2+ transient was associated with delayed relaxation in the failing hearts. Abnormal 
sarcoplasmic reticulwn (SR) function is believed to be the main cause of abnormal Ca2+ 
transients in heart failure (Phillips et al. 1998). The prolonged Ca2+ transients observed in 
the current study suggest abnormal Ca2+ handling in the failing hearts which is consistent 
with abnormal SR Ca2+-release and / or Ca2+-reuptake. The increased dispersion of Ca2+ 
transient duration and lack of association between the prolonged Ca2+ transient duration and 
left ventricular epicardial location suggest that there is a regional heterogeneity to the 
abnormal Ca2+ handling in heart failure. 
Ventricular repolarisation in heart failure 
Electrical events were examined in heart failure by measuring Monophasic Action 
Potentials (MAPs) at the same sites over the left ventricular epicardial surface of the 
Langendorff perfused hearts from where the Ca2+ transients were measured. A similar 
pattern as that of the Ca2+ transients emerged when the time course of the MAP signals were 
analysed and their durations measured (Chapter 9). Failing hearts were shown to have 
prolonged MAP durations and there was an increased dispersion of MAP durations when 
compared to controls. Again, there was no consistent relationship between the prolonged 
MAP duration and left ventricular epicardial location. 
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Action potential prolongation is the most consistent electrophysiological abnormality in 
heart failure and it has been shown in failing myocytes (Rossner and Sachs, 1978; 
Beuckelmann et al. 1993; Ming et al. 1994; Kaab et al. 1996; Qiu et al. 1996; Rozanski et 
al. 1997) and myocardial tissues (Gwathmey et al. 1987; Beuckelmann et 01. 1993). The 
finding of prolonged MAP durations in the failing heart in the current study is in agreement 
with such findings. Similar results have been shown in isolated hearts from a pacing-
induced heart failure model in the dog (Wang et al. 1994). The prolonged action potential in 
heart failure is believed to be the result of changes in ion channel activity, a process termed 
electrical remodelling; and it appears that alterations in the activities of certain K+ channels 
are involved in this process (Nabauer and Kaab, 1998). 
Increased QT dispersion has been shown in patients in heart failure (Barr et al. 1994; Fu et 
a/. 1997) and was associated with an increased risk of sudden death (presumed to be 
arrhythmic in origin). The QT interval is the electrocardiographic representation of the 
ventricular repolarisation phase. Increased dispersion of repolarisation or refractoriness has 
also been shown in patients with dilated cardiomyopathy (Dinerman et al. 1997) and in the 
surviving, remodelled myocardium in patients with previous myocardial infarction 
(Vassallo et al. 1988; Ramdat-Misier et al. 1995). The findings of prolonged MAP duration 
together with an increased dispersion of MAP duration in the current study suggest that the 
electrical remodelling process in heart failure may well be a heterogeneous one. 
It was also shown in this study that there was an association between the prolonged Ca2+ 
transient and MAP durations in the failing hearts (Chapter 10). In other words, the results 
suggest that the abnormal SR Ca2+-release and / or Ca2+-reuptake activity may be associated 
with the electrical remodelling process in heart failure. The two pathophysiological 
299 
Chapter 12 Synopsis 
processes may be interrelated with a mutual, causal relationship or they may have arisen 
from a common stimulus. 
Altered ventricular activation and mechanical performance in the failing heart 
In addition to ventricular repolarisation data, the MAP signals measured also gave 
information on ventricular activation over the left ventricular epicardial surface of the 
Langendorff-perfused heart. It was shown that there was greater dispersion of the MAP 
activation times in the failing hearts during atrial pacing when the ventricles were activated 
via the His-Purkinje system as in sinus rhythm. This suggested that there was delayed 
ventricular activation over the epicardial surface or delayed intraventricular conduction in 
the failing hearts (Chapter 11). Right ventricular pacing increased this delay in ventricular 
activation in both failing hearts and controls so that the intraventricular conduction delay 
was similar in both groups - presumably by creating an activation pattern similar to left 
bundle branch block. 
It was also shown that the ventricular activation pattern during atrial pacing was altered in 
the failing hearts. The activation pattern in controls during atrial pacing followed what 
would be expected with normal intraventricular conduction whilst that in failing hearts 
followed a pattern similar to that during right ventricular pacing. The lesser degree of 
intraventricular delay during atrial pacing in the failing hearts than during ventricular pacing 
suggested against frank left bundle branch block during atrial pacing although this could not 
be excluded. 
Increased dispersion of ventricular activation has been shown in patients with dilated 
cardiomyopathy (Dinerman et al. 1997), similar to the findings in the current study. This 
may be the result of disease in the specialised conducting system or could be due to cellular 
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uncoupling which has been suggested by alterations in gap junctions in the remodelled 
myocardium (Peters et al. 1993). 
The possibility that mechanical performance in failing hearts could be affected by altered 
conduction pattern was investigated by observing the isovolumic pressure profile of the 
isolated hearts during atrial and ventricular pacing. It was found that mechanical 
perfonnance was impaired, with lower peak systolic pressure and slowed rate of contraction 
and relaxation, in controls when changing from atrial to ventricular pacing indicating that 
increased intraventricular conduction delay resulted in a deterioration in mechanical 
perfonnance. On the other hand, the failing hearts were not significantly affected by such a 
manoeuvre whilst their mechanical performance was significantly reduced when compared 
to controls during atrial pacing. The interpretation of these results would be that ventricular 
activation was abnormal in the failing hearts during atrial pacing which contributed to 
impaired mechanical performance and further intraventricular conduction delay induced 
with ventricular pacing did not cause further deterioration in mechanical performance. 
What next? 
The experiments included in this thesis have shown that there were abnormalities in 
intracellular Ca2+ handling and in ventricular electrical events in isolated hearts from rabbits 
with heart failure. These abnormalities can contribute towards the mechanical dysfunction 
and arrhytlunogenic tendency seen in heart failure. One major limitation of the study was 
that the Ca2+ transient and Monophasic Action Potential (MAP) measurements were made 
sequentially at the various left ventricular epicardial sites with MAP measurements being 
made after the Ca2+ transient measurements. The relationship between these measurements 
and their variations over the ventricular epicardial surface could be better elucidated with 
simultaneous, multi-site measurements of both Ca2+ transients and MAPs. This would 
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require the development of alternative experimental set-up and possibly more advanced 
technology. 
Another potential area of future research based on the Ca2+ measurement techniques 
developed could be the study of Ca2+ transients during ventricular arrhythmias in heart 
failure. As mentioned in Chapter 1, there appears to be an association between abnormal 
intracellular [Ca2+] and the induction and maintenance of ventricular fibrillation (Merillat et 
al. 1990; Kihara and Morgan, 1991). The possibility that abnormal Ca2+ handling may have 
a role to play in the arrhythmogenic tendency in heart failure could be investigated in the 
isolated heart with Ca2+ and MAP measurements (as described in this thesis) during 
arrhythmias e.g. ventricular fibrillation and the characteristics during arrhythmia induction 
can also be studied. 
There is growing interest in the prospect of improving sarcoplasmic reticulum (SR) function 
via adenovirus gene transfer techniques (Hajjar et al. 1997). Such transgenic techniques 
may be used to try and restore SR function in heart failure. For example, the effects of 
upregulation of SR Ca2+-ATPase on mechanical performance, intracellular Ca2+ handling 
and possibly electrical events in heart failure may be investigated in the whole heart using 
an animal model like the rabbit coronary artery ligation model and techniques outlined in 
this thesis. 
The subject of 41Dispersion" is an interesting one and an increased dispersion or variation in 
many parameters appear to be the feature in heart failure. The results in this thesis have 
shown increased dispersion in the time course of Ca2+ transients, time course of MAP 
signals and in ventricular activation in heart failure with increased spatial variation of such 
parameters over the epicardial surface of the left ventricles. There is recent evidence that 
there may be increased temporal variation in some phenomena in heart failure as well 
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(Berger et al. 1997). Berger et al. (1997) showed that there were increased beat-to-beat 
fluctuations in QT interval in patients with dilated cardiomyopathy suggesting temporal 
lability in ventricular repolarisation. This adds a further dimension to the subject of 
"Dispersion II which already carries a rather unpredictable notion. Increased dispersion 
implies heterogeneity, disorder and a non-uniform or chaotic pattern and increased 
dispersion of recovery of excitability has been known to predispose to ventricular 
fibrillation (Han and Moe, 1963), which has been regarded as a chaotic rhythm (Billman, 
1992). However, there is recent evidence that even this most disorderly of cardiac rhythms, 
ventricular fibrillation, appears to have some periodicity and spatio-temporal order (Gray et 
al. 1998; Witkowski et al. 1998). These may have important implications in further studies 
in the cellular basis for the arrhythmogenic tendency and mechanical dysfunction in heart 
failure. 
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